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ABSTRACT 
Phytocannabinoids are the active substances responsible for the medicinal and psychotropic 
effects of Cannabis sativa. Although the bioactivity of cannabis and its preparations have been 
known for millennia, several steps in the biosynthetic pathway leading to phytocannabinoids 
remain unclear. Phytocannabinoids are prenylated resorcylic acids which are formed in 
specialized plant organs called glandular trichomes. Following the analysis of a pre-generated 
cannabis trichome cDNA library, a type III polyketide synthase (tetraketide synthase; TKS) was 
identified and assayed, yielding three major compounds, hexanoyl triacetic acid lactone (HTAL), 
pentyl diacetic acid lactone (PDAL), and olivetol, yet no resorcylic acid was detected. This lack 
of resorcylic acid in enzyme assays has instigated the characterization of TKS and a search for 
putative cyclases in the cannabis trichome cDNA library, and involved protein pulldown, co-
immunoprecipitation, and co-assay experiments. These experiments led to the discovery of a 
novel polyketide cyclase protein named olivetolic acid cyclase (OAC) responsible for the proper 
cyclization of a polyketide intermediate produced by TKS. This thesis shows that TKS assays 
conducted with OAC produce olivetolic acid (OA), an intermediate required during the 
biosynthesis of cannabinoids. The TKS/OAC spatial relationship was also investigated following 
the creation of fluorescent fusion proteins which show that the enzymes co-localized in vivo 
when viewed with confocal microscopy. Furthermore, yeast two-hybrid assays using TKS and 
OAC were performed to establish whether the enzymes physically interact. Finally, an attempt to 
determine the responsible amino acids involved in OAC’s mechanism was conducted by 
comparing the activity of single point OAC mutants with the wild-type OAC. Based on the 
available data, mechanisms for the production of HTAL, PDAL, olivetol, and OA are proposed. 
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1. INTRODUCTION 
 
Cannabis sativa is one of the most recognizable plants in our society having been harvested 
since antiquity as food and fibre, and due to its unique pharmaceutical properties. Due to its 
medicinal and psychotropic effects, the plant has attracted substantial attention, and is the source 
of controversy and close scrutiny by the international community. Yet, despite its importance, 
the legal status of cannabis has impeded its research, and the biosynthesis of the compounds 
known as cannabinoids, which are exclusively produced in cannabis, has remained unclear. It is 
the purpose of this dissertation to provide insight into a key step in the cannabinoid biosynthetic 
pathway, and to provide evidence that a type III polyketide synthase (PKS) and a dimeric α + β 
barrel (DABB) polyketide cyclase are both responsible and required for olivetolic acid (OA) 
biosynthesis. Tetraketide synthase (TKS) is a type III PKS initially identified from a cannabis 
trichome-specific cDNA library. Although it was anticipated that TKS was responsible for the 
biosynthesis of OA, a precursor involved in cannabinoid biosynthesis, the enzyme cannot 
independently produce OA, and instead yields a decarboxylated analog. This lack of OA-forming 
activity prompted an investigation into TKS, which eventually led to the discovery of a DABB 
protein called olivetolic acid cyclase (OAC).  
Formally, this dissertation describes the initial characterization of TKS and the steps that 
resulted in the identification of OAC (Chapter 3), followed by a report on the in vitro 
optimization of the OA biosynthetic reaction (Chapter 4). Subcellular localization experiments 
and yeast two-hybrid assays were employed to determine if TKS and OAC physically interact, 
and progressed to the use of protein pulldowns and micro-dialysis experiments to further probe 
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the nature of the TKS/OAC reaction (Chapter 5). Furthermore, an attempt to determine which 
amino acids are involved in the OAC mechanism was conducted by monitoring and comparing 
the activity of 15 single point OAC mutants alongside the wild-type OAC (Chapter 6). 
Observations made within the course of this work support the hypothesis that OA biosynthesis 
requires 1) TKS to generate a labile tetraketide intermediate and 2) OAC for the intermediate’s 
proper cyclization. This led to the MS/MS screening of TKS/OAC reactions for tetraketo-CoA 
linked analytes, including a theoretical short-lived polyketide intermediate (Chapter 6).  
1.1 Research Goals and Objectives 
The initial goal of this research was to determine why OA was not being produced from TKS. 
This required the characterization of TKS, the testing of alternative assay conditions to induce 
TKS to produce OA, and to identify putative cyclases identified in a cannabis trichome cDNA 
library (Stout et al.  2012). Once the polyketide cyclase OAC was identified, it was characterized 
and an attempt to delineate its underlying mechanism was conducted. This involved determining 
if TKS and OAC co-localized, physically interacted, and could produce OA when physically 
separated. Structure/function studies were also conducted in an attempt to discern amino acids 
involved in OAC’s mechanism. It is also a goal of this research to implicate TKS and OAC as 
two principle enzymes required for the biosynthesis of OA, which are therefore components of 
the cannabinoid biosynthetic pathway. The information resulting from this thesis supports the 
hypothesis in favor of the existence of a transient linear tetraketide. 
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2. LITERATURE REVIEW 
 
2.1 Overview of Cannabis sativa and Cannabinoids 
Cannabis has been a multipurpose resource for thousands of years. Humans and other hominids 
have ingested its seeds since prehistoric times (Callaway, 2004). Archaeological evidence 
indicates that it was cultivated for its use as a textile in Neolithic China (i.e. 6500 before present; 
BP) (Fleming and Clarke, 1998). It is unknown when the psychoactive properties of cannabis 
were first discovered, although physical evidence suggests they were known as early as 2700 BP 
(Jiang et al., 2006; Russo et al., 2008). The earliest record of medicinal cannabis appeared in the 
first century in the pen-ts'ao ching, where it was recognized as a treatment for numerous ailments 
including rheumatism, constipation and malaria (Touwn, 1981). Cannabis was also used in 
western medicine during the early 20
th
 century, before it was outlawed and subsequently 
removed from the British and American pharmacopoeias in 1932 and 1944, respectively. The 
history of cannabis and its uses has been well reviewed by several authors (Abel, 1980; Fleming 
and Clarke, 1998; Russo et al., 2008; Zuardi, 2006). 
The psychoactive properties of cannabis have long been the cause for scientific 
examination of the responsible biological compounds. The bioactive fraction from cannabis, 
which is now known to consist of many cannabinoids, was initially distilled from hemp resin and 
described as a red oil in 1896; the acetate crystals obtained from this oil were named cannabinol 
(CBN) and at the time were believed to be the psychoactive agent in cannabis (Wood et al., 
1896). It was not until 35 years later that similar experiments were successfully reproduced, and 
that a partial structural elucidation of CBN was published (Cahn, 1932). In 1940, a second 
  
4 
 
cannabinoid named cannabidiol (CBD) was also isolated from red oil, but both CBN and CBD 
were found to be  pharmacologically inert and lacked ‘marihuana activity’ (Adams et al., 1940a; 
Loewe, 1945). The psychoactive cannabinoid ∆9-tetrahydrocannabinol (THC) was later 
discovered in 1940 as a product of in vitro CBD isomerisation, and was not isolated from 
cannabis, albeit in an impure form, until the following year (Adams et al., 1940b; Wollner et al., 
1942). The isolation of pure THC from cannabis was eventually achieved in 1964, and its 
structure was determined in 1971 (Gaoni and Mechoulam, 1964; Gaoni and Mechoulam, 1971) 
(Figure 2.1). 
Since the pioneering days of cannabis research, more than 100 cannabinoids exclusively 
produced in cannabis have been identified (Mechoulam and Hanus, 2000; Russo, 2011). 
Cannabinoids are a unique class of chemicals that are composed of terpene and phenolic moieties 
(i.e. terpenophenolics, or prenylated polyketides). They do not contain any nitrogen, although 
cannabis alkaloids have also been reported (Mechoulam, 1988). The structural elucidation and 
synthesis of THC allowed for the identification of their endogenous targets, the CB1 and CB2 
receptors (Devane et al., 1988; Munro et al., 1993). In turn, the discovery of the cannabinoid 
receptors led to the identification of their endogenous ligands, arachidonoylethanolamide 
(anandamide) and 2-arachidonoylglycerol, and have since been recognized as components of the 
endocannabinoid system (Devane et al., 1992; Mechoulam et al., 1995) (Figure 2.1). 
Cannabinoids that are produced in planta are sometimes referred to as phytocannabinoids to 
distinguish them from endogenously produced CB1 and CB2 ligands, which are collectively 
known as endocannabinoids (Russo, 2011). Phytocannabinoids are produced as acids in planta 
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but are decarboxylated to their neutral form upon heating and storage (Kimura and Okamoto, 
1970; Turner et al., 1980; Yamauchi et al., 1967). 
2.1.1 The Biology of Cannabis 
Cannabis is a dioecious annual herb that produces either male staminate or female pistillate 
flowers, although monoecious varieties are also known to exist (Figure 2.2). Staminate flowers 
develop five stamens with near sessile anthers that are surrounded by a calyx of five sepals. The 
male inflorescences are indeterminate racemes that form into a panicle arrangement of flowers 
that tend to bloom slightly earlier than their female counterparts. The pollen is released during 
the bloom and is normally dependent on wind to fertilize nearby female plants. Soon after 
staminate plants shed their pollen, they enter senescence and die. Female plants bear pistillate 
flowers which initially appear late during the long-day vegetative cycle as two elongate stigmas 
at branching nodes. During the short-day flowering cycle, the nodal bracts blossom and 
accumulate more stigmas, each surrounded by short lobed calyces that protect the developing 
fruits, known as achenes, or more commonly as seeds (Stearn, 1970). Although the existence of 
sexual dimorphism in cannabis is evident, the determining mechanism is not completely 
understood nor is it completely agreed upon. Some models for sexual determination have implied 
x/autosomal dosage mechanisms, although a growing body of evidence, including RAPD and  
cDNA-AFLP analysis suggests that a heterogametic X/Y system exists (Ainsworth, 2000; 
Mandolino et al., 2002; Moliterni et al., 2004).  
Prior to 1998, cannabis belonged to the Urticales order, but since then this order has been 
embedded into the Rosales order (Sytsma et al., 2002). Cannabis is now circumscribed as an 
urticalean rosid (Rosales) and belongs to the Cannabaceae family (Soltis et al., 2011). The 
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Cannabaceae family is now recognized as sensu lato to include the Celtis genus (hackberry), or 
as sensu stricto as to only include the Humulus genus (hops). Analysis of cpDNA restriction sites 
support the relationship between Cannabaceae and Celtidaceae families (Song et al., 2001). 
 
 
 
Figure 2.1  Structures for olivetol, OA, PDAL, HTAL and select cannabinoids 
Resorcylates and pyrones are the main focus of this study; they are in vitro products from 
enzymes involved in the biosynthesis of phytocannabinoids. Phytocannabinoids are produced in 
plants, whereas endocannabinoids occur in animals. 
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Figure 2.2  A female cannabis plant. 
Cannabis trichomes used in this study were obtained from plants such as this Cannabis sativa 
cultivar Finola. This plant has reached maturity evident by the developed inflorescence. 
 
Some confusion also exists as to whether Cannabis is a monotypic or polytypic taxon; 
some authors believe only one taxon exists, Cannabis sativa L. (Small and Beckstead, 1973), 
whereas other authors claim that three distinct species exist: C. sativa, Cannabis indica, and 
Cannabis ruderalis (Schultes et al., 1974). This work will consider cannabis as an inclusive 
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species called Cannabis sativa and will not discriminate between sub-species and/or cultivars. 
Perhaps more importantly is the classification of the different chemical phenotypes. Varieties of 
cannabis grown as industrial hemp for the production of fibre and seeds generally contain lower 
amounts of tetrahydrocannabinolic acid (THCA), which is the precursor to the psychoactive 
THC, and higher amounts of the non-psychoactive compound cannabidiolic acid (CBDA). Drug-
type cannabis, which is grown both for recreational and medicinal use, contains  significantly 
more THCA than CBDA (Fetterman et al., 1971; Small and Beckstead, 1973; Toffoli et al., 
1968).  
Cannabinoids are primarily biosynthesized in specialized structures known as glandular 
trichomes (Kim and Mahlberg, 1997; Potter, 2009). Trichomes are differentiated epidermal 
outgrowths which are specialized in form and function in many plants (Schilmiller et al., 2008). 
Four types of trichomes are found on cannabis plants; non-glandular hair-type trichomes, and 
three secretory-type trichomes: bulbous, capitate-sessile, and capitate-stalked glandular 
trichomes (Dayanandan and Kaufman, 1976; Hammond and Mahlberg, 1973) (Figure 2.3). Non-
glandular trichomes are non-secretory, unicellular, and are prominently cystolith hairs containing 
high concentrations of silicon. Amongst the glandular trichomes, the capitate-stalked trichomes 
(150 to 500 µm) are the largest accumulators of cannabinoids, developing during the mature 
flowering stage. They are similar to capitate-sessile trichomes, but include a stalk in addition to a 
secretory disc and a subcuticular cavity. The secretory disc, which is a convex rosette of 8 – 13 
cells, is the site of synthesis for fatty acids, terpenes, and cannabinoids which accumulate in the 
subcuticular cavity, giving the capitate gland a globular appearance (Dayanandan and Kaufman, 
1976). Several studies have implicated disc cells in glandular trichomes to be responsible for the 
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production and secretion of secondary metabolites (Wagner, 1991). Sirikantaramas et al. (2005) 
found that the presence of mRNA for the enzyme THCA synthase was exclusively detected by 
RT-PCR in cannabis trichome disc cells, and furthermore, when heterologously expressed in 
tobacco, a THCA synthase-green fluorescent protein localized to the plant’s trichomes (Figure 
2.3). 
The glandular trichome is understood as being the site of unique gene expression related 
to the production of secondary metabolites. Some evidence was provided by Keene and Wagner 
who purified glands from tobacco that were capable of efficiently producing diterpenes and 
sucrose esters, although surrounding tissues (epidermal and subepidermal cells) could not (Keene 
and Wagner, 1985). The genomic analysis of glandular trichomes, which typically involves the 
construction of a cDNA library derived from isolated trichomes, has been successful in 
elucidating specialized metabolic pathways and identifying enzymes specific to the trichome 
(Fridman and Pichersky, 2005). The specialized peltate glands from sweet basil were 
successfully analyzed this way, leading to the identification of a methyltransferase responsible 
for the biosynthesis of methylchavicol (Gang et al., 2001; Iijima et al., 2004). Sesquiterpene 
biosynthesis in wild tomato Solanum habrochaites was also determined by evaluating trichome-
specific EST data, leading to the identification of two terpene synthases (Sallaud et al., 2009). 
The lupulin glands from Humulus lupulus were also separated and used to create a large set of 
ESTs which were then used to identify an O-methyltransferase (OMT-1) required in the 
conversion of desmethylxanthohumol to xanthohumol (Nagel et al., 2008). Trichome-specific 
cDNA libraries have also been used for gene discovery in cannabis, resulting in the detection of 
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a type III PKS capable of synthesizing olivetol and an acyl-activating enzyme responsible for the 
generation of hexanoyl-CoA (Marks et al., 2009; Stout et al., 2012).  
 
Figure 2.3  Trichomes are the site of cannabinoid biosynthesis. 
The cannabinoids of Cannabis sativa are synthesized and stored in glandular trichomes found on 
the female flower. The inset shows the localization (green) of an enzyme of the cannabinoid 
biosynthetic pathway, tetrahydrocannabinolic acid synthase, using a green fluorescent protein-
labeled probe to the head of a glandular trichome. Reproduced with permission from Jirschitzka 
et al. (2013). 
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2.1.2 Bioactivity of Cannabinoids 
One of the earliest evaluations of cannabis in western medicine was conducted by William 
O’Shaughnessy in 1838, wherein he describes the anaesthetic, orexigenic, antiemetic, and 
anticonvulsant properties of the drug (O'Shaughnessy, 1843). Cannabinoids are now recognized 
as therapeutic agents for a number of debilitating ailments including chemotherapy-associated 
nausea, epilepsy, glaucoma, Parkinson’s disease, dystonia, multiple sclerosis, and pain (Amar, 
2006). The antineoplastic properties of certain cannabinoids, namely THC, have been reported as 
early as 1975, and although still requiring conclusive study, cannabinoids show great potential as 
antiproliferative, tumor-selective apoptotic agents (Brown et al., 2012; Munson et al., 1975). 
Generally, the mechanism of cannabinoids are related to their binding to the endogenous CB1 
and CB2 receptors, but has also been shown to involve the ankyrin, melastatin, and vanilloid 
transient potential receptors (Pertwee et al., 2010). Cannabinoids acting on the classical 
cannabinoid receptors, which are G-protein coupled receptors, inhibit adenylcyclase and result in 
the modulation of the MAPK/ERK pathway.  
2.1.3 The Current Understanding of Cannabinoid Biosynthesis 
In the last 80 years several groups have proposed different cannabinoid biosynthesis pathways. 
The earliest proposal was offered by Simonsen and Todd (1942), after Adams (1940) showed 
that CBD could be converted to THC and CBN in vitro; they proposed that a cannabidiol-like 
compound formed by the condensation of menthatriene (2-methyl-5-prop-1-en-2-ylcyclohexa-
1,3-diene) and olivetol cyclized to THC and later to CBN(Adams, 1940; Simonsen and Todd, 
1942). Following the Birch (1957) proposal for phenol biosynthesis, Farmilo and Davis (1961) 
suggested that hexanoic acid condenses with three molecules of acetic acid yielding a 
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hexenedionic acid that could enolize to OA. Farmilo and Davis (1961) were the first to depict 
cannabinoids in their natural acidic form. These earlier accounts for cannabinoid biosynthesis 
were presented without the knowledge of cannabigerolic acid (CBGA) and were based on the 
belief that THC production was a result of CBD isomerization. Gaoni and Mechoulam (1964) 
realized that cannabigerol (CBG) was a missing intermediate in the cannabinoid biosynthetic 
pathway and suggested that two alternative pathways existed; one pathway each dedicated to the 
biosynthesis of either the acid or neutral cannabinoids, but both these pathways were believed to 
require the condensation of geranyl diphosphate (GPP) with olivetol (or OA in the case of acidic 
forms) (Gaoni and Mechoulam, 1964). Shoyama et al. (1970) later proposed a model for the 
cannabinoid biosynthesis pathway accounting for alternate forms of cannabinoids, namely 
cannabichromenic acid (CBCA) and CBGA. Shoyama et al. (1975) later published data from 
experiments with 
14
C-labelled malonate/mevalonate and 
3
H-labelled geraniol, indicating that 
CBGA is formed by the condensation of geraniol and a polyketide derived from malonate. These 
findings have provided the basis for some of the current understanding of the cannabinoid 
biosynthetic pathway.  
Cannabinoids are terpenophenolic compounds that originate from the prenylation of the 
polyketide-derived OA with GPP, converting it to the first cannabinoid in the cannabinoid 
biosynthesis pathway, CBGA (reviewed by (Taura et al., 2007) (Figure 2.4).  A 
geranylpyrophosphate:olivetolate transferase (GOT) was proposed to prenylate OA after 
observing that CBGA is produced by cannabis cell extracts when provided with GPP and OA 
(Fellermeier and Zenk, 1998). Importantly, this study concluded that OA served as the phenolic 
substrate for GOT and not its decarboxylated derivative, olivetol. The Zenk group provided  
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Figure 2.4  Understanding of cannabinoid biosynthesis based on current literature. 
The intermediate CBGA is produced by the prenylation of OA by GOT. Whereas GPP is derived 
from the MEP pathway, OA has been proposed to be synthesized by a PKS capable of accepting 
hexanoyl-CoA esters once they are activated by an acyl-CoA synthetase. CBGA is converted to 
CBDA, THCA, CBCA by CBDA synthase, THCA synthase, and CBCA synthase, respectively.  
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evidence that the terpenoid substrates responsible for the generation of GPP, isopentenyl 
diphosphate (IPP) and dimethylallyldiphosphate (DMAPP), are derived from the deoxyxylulose 
phosphate pathway (Fellermeier et al., 2001). Their work strongly suggested that the phenolic 
moiety is a polyketide-derived compound. 
The prenylation reaction resulting in the biosynthesis of CBGA is followed by the 
conversion into CBDA or THCA catalyzed by the enzymes, CBDA synthase and THCA 
synthase, respectively (Taura et al., 1996; Taura et al., 1995).  It is important to note that the 
neutral form of CBGA, CBG is not accepted by THCA synthase or CBDA synthase as a 
substrate. CBGA also acts as the substrate for other cannabinoid synthases such as CBCA 
synthase (Morimoto et al., 1997; Morimoto et al., 1998) (Figure 2.4). These cannabinoids, their 
analogs, and a variety of others can be further classified into ten distinct classes of cannabinoids 
based on their structural backbone (Sanchez and Verpoorte, 2008).  
2.2 Olivetolic Acid Biosynthesis 
The concept that OA originates from a polyketide is based on the biosynthetic speculations made 
by both Collie and Birch, who independently proposed that phenolic natural products are derived 
from β-polyketones (Hill and Staunton, 2010). In this Section, an overview of type III PKSs and 
the early accounts of experiments suggesting the involvement of a PKS during OA biosynthesis 
is presented. Past attempts to detect and isolate a PKS capable of OA biosynthesis are reviewed.  
2.2.1 Type III PKSs: Diversity, Structure and Mechanism 
PKSs are enzymes that are distributed in the bacterial, fungal, animal and plant kingdoms. They 
are responsible for the generation of acetate-based β-polyketo compounds known as polyketides 
and are involved in the biosynthesis of many secondary metabolites. Many polyketides are 
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bioactive and play an important role in medicine, where they are used as antibiotics, 
immunosuppressants, statins, and cytostatics (Shen, 2003; Staunton and Weissman, 2001; 
Weissman, 2009). PKSs conduct the repeated condensation of malonyl esters with an appropriate 
starter molecule, resulting in an elongated polyketide, a process reminiscent of fatty acid 
biosynthesis. Not surprisingly, these enzymes are thought to have evolved from fatty acid 
synthases, which in addition to their similar activity share a highly conserved structural fold 
(Austin and Noel, 2003; Jenke-Kodama et al., 2005). PKSs are categorized as type I, II, or III: 
type I PKSs are large modular enzymes found in fungi, bacteria, and animals (Castoe et al., 
2007; Keatinge-Clay, 2012); type II PKSs are part of multi-enzyme aggregates found in bacteria 
(Zhan, 2009); type III PKSs are small homodimeric proteins found in plants, bacteria, and more 
recently in fungi (Austin and Noel, 2003; Muggia and Grube, 2010).  
Type III PKSs constitute their own family of enzymes that are believed to have evolved 
from fatty acid synthases, although they are structurally different than type I and II PKSs. The 
type III PKS family, also known as the chalcone/stilbene synthase family, is ubiquitous in higher 
plants and is involved in the biosynthesis of chalcones and stilbenes, which are themselves 
precursors for more complex secondary metabolites, including flavonoids and anthocyanins 
(Austin and Noel, 2003). Whereas type I and II PKSs require an acyl carrier protein (ACP) to 
activate malonyl extender units, type III PKSs utilize malonyl-CoA esters. Also, type III PKSs 
have greater diversity in their use of starter substrates compared to type I and type II PKSs, as is 
the case in the chalcone-forming reaction (Figure 2.5). The chalcone synthase (CHS) reaction 
performed by type III PKSs iteratively adds acetate units to a p-coumaroyl-CoA starter by the 
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decarboxylative condensation of malonyl-CoA. The resultant tetraketide intermediate is 
transformed into naringenin chalcone by an intramolecular Claisen condensation.  
 
Figure 2.5  Type III PKS reactions. 
Reactions include (A) the biosynthesis of chalcones such as chalcone naringenin by CHSs, and 
(B) the biosynthesis of stilbenes such as resveratrol by STSs. Both CHSs and STSs synthesize 
the same tetraketide intermediate, although (C) the cyclization of the reactive intermediate 
proceeds in either (blue arrow) a Claisen condensation or (red arrow) an aldol reaction. The R 
substituent indicates attachement to an enzyme’s active site. 
Type III PKSs do not solely synthesize naringenin chalcone, neither do they all involve a 
terminating Claisen condensation. Stilbene synthases (STS) are also type III PKSs which 
catalyze the synthesis of stilbenes, including the well known compound resveratrol (Figure 2.5)  
(Hathway and Seakin, 1959; Schröder et al., 1988; Takaoka, 1939). The initial steps of PKS 
reaction are identical in CHS and STS, where both form a tetraketide intermediate, although a 
different cyclization reaction takes place in the final steps of product formation. The CHS 
reaction depends on a C6  C1 Claisen  condensation, whereas STSs catalyze a C2  C7 aldol 
reaction followed by a C1 decarboxylation (Austin and Noel, 2003). The cyclization appears to 
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be controlled by electronic effects of specific AAs in respective enzymes. This was shown by 
Austin et al. (2004) after converting the CHS from Medicago sativa into a functional STS, which 
they engineered using Pinus sylvestris STS as a model. A third alternative reaction also 
conducted by these enzymes is a C5O  C1 cyclization resulting in the generation of pyrone 
products (Figure 2.6). Pyrone products such as CTAL are commonly referred to as derailment 
products, and are regarded as incomplete reaction products. Austin et al. (2004) suggested that 
pyrone products may slowly and spontaneously cyclize when tetraketide intermediates are 
released by the enzyme, or that an unidentified enzyme may catalyze the final cyclization of 
released intermediates (Austin et al., 2004). It is important to note that some plants, such as 
Gerbera hybrida and Piper methysticum, do accumulate pyrone products  (Eckermann et al., 
1998; Seigler, 1998). 
Stilbene carboxylate synthases (STCS) are a hypothetical subset of type III PKSs which 
possess a similar activity to STSs, but differ in that they retain the C1 carboxyl moiety following 
a C2  C7 cyclization (Figure 2.6) Although there is less support for the existence of STCSs, 
they are assumed to biosynthesize phenolic acid metabolites in planta. One STCS, HmSTCS1a, 
has been reported to occur in Hydrangea macrophylla, an ornamental that produces the rare 
hydrangeic and lunularic acids (Figure 2.7). HmSTCS1a was isolated from Hydrangea cDNA 
and shares 65-70% sequence identity with other chalcone and stilbene synthases; however, the 
enzyme contains unusual residues in positions conserved in other CHS-like proteins. Although 
Eckermann et al. (2003) cloned HmSTCS1a, the hypothesized final product, 5-hydroxy-
hydrangeic acid was never detected during assays, and instead the derailment product CTAL 
accumulated (Figure 2.7). The formation of the CTAL pyrone was regarded as an artefact 
  
18 
 
 
Figure 2.6  Polyketides are composed of acetate units. 
Polyketide synthases use an array of different starter molecules (R) and iteratively couple them 
to acetate residues by the decarboxylative condensation of malonyl-CoA. The cyclizations of 
longer polyketide intermediates result in the formation of pyrones, whereas the cyclization of 
tetraketides can result in pyrones, chalcones, stilbenes, and stilbene carboxylates. Figure adapted 
from Schröder (2009). 
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Figure 2.7  Type III PKS reactions can yield unanticipated pyrones. 
Certain recombinant CHS-like PKSs putatively involved in the biosynthesis of natural products 
do not always yield the anticipated products when assayed in vitro. Examples include (A) the 
biosynthesis of 5-hydroxy-hydrangeic acid by H. macrophylla HmSTCS1, (B) the biosynthesis 
of chrysophanol anthrone by A. arborescens OKS, and (C) the biosynthesis of emodin anthrone 
by H. perforatum HpPKS2. Instead these reactions synthesized pyrone products. 
  
20 
 
of sub-optimal in vitro conditions that did not allow for the appropriate cyclization to occur. 
Eckermann et al. (2003) also described the in vitro biosynthesis of 5-hydroxylunularic acid, but 
only after a different starter substrate was used (i.e. dihydro-4-coumaroyl-CoA instead of 4-
coumaroyl-CoA) and after the permethylation of assay products was performed.  
Other examples of CHS-like enzymes incapable of cyclizing polyketide intermediates to 
the anticipated final products have also been reported in other plants. Aloe arborescens 
octaketide synthase is a type III PKS thought to be involved in the biosynthesis of chrysophanol 
anthrone, but which instead accumulates the pyrones SEK4 and SEK4b when the recombinant 
enzyme is assayed (Figure 2.7) (Abe et al., 2005). Similarly, HpPKS1 and HpPKS2 are two 
CHS-like enzymes putatively involved in the biosynthesis of the biologically active hyperforin 
and hypericin in Hypericum perforatum L. (St. John’s Wort) (Karppinen and Hohtola, 2008). 
Although the production of emodin anthrone was anticipated, the in vitro analysis of the 
HpPKS2 enzyme produced tri- to octaketide products, as well as the octaketide pyrones SEK4 
and SEK4b, and the heptaketide aloesone, yet no emodin anthrone was detected (Figure 2.7). 
Whether these enzymes are involved in the respective reactions, or another putative enzyme or 
co-factor is required for the proper cyclization of the polyketide chain is not known. 
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2.2.2 Instances of Olivetolic Acid Biosynthesis 
The occurrence of OA is rare in nature, but has been reported to accumulate in the fungal, plant, 
and animal kingdoms. OA is found in Primula obconica, where it is used as a substrate for the 
natural products primin and miconidin (Horper and Marner, 1995). In animals, the release of OA 
from metapleural glands in some Crematogaster ants has been reported (Jones et al., 2005). OA 
is also recognized as a component of depsides in numerous lichens (Armaleo et al., 2011; Elix, 
1974; Elix, 1994). Additionally, OA analogs that incorporate longer alkyl chains than the pentyl 
chain in OA, also occur in nature, and could presumably be the result of similar cyclization 
reactions since the carboxylate moiety is retained in the final products. These analogs are found 
in numerous fungi and plants including Evernia prunastri (oakmoss), Merulius incarnates 
(mushroom), Grevillea robusta (silver oak), and several cereals and grains (Baerson et al., 2010; 
Hassani and Razzoul, 2005; Jin and Zjawiony, 2006; Yamashita et al., 2008; Yamashita et al., 
2010; Yao, 2011). More recently the first example of a type III PKS capable of forming 
alkylresorcylic acids was reported in Oryza sativa (rice) (Matsuzawa et al., 2010). 
2.2.3 The Biosynthesis of Olivetolic Acid Requires a Polyketide Synthase 
Most of the data suggesting that OA is synthesized via an acetate polyketide pathway was 
provided by heavy isotope labeling experiments conducted in cannabis. The earliest account for 
PKS involvement was provided by Shoyama et al. (1975), after 
14
C-malonate was incorporated 
into cannabinoids during isotope feeding experiments (Shoyama et al., 1975). The involvement 
of a PKS was also implied after Fellermeier et al. (2001) used 
13
C-glucose to discern the 
positions of the isotopes incorporated into cannabinoids. Similarly, after conducting 
3
H-acetate 
labeling studies in Primula obconica, Horper et al. (1996) suggested that a PKS was involved in 
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the biosynthesis of OA, as well as predicting that the starter moiety was hexanoic acid. Results 
from these groups indicate that an acetate-derived polyketide corresponds well to the NMR 
labelling patterns they obtained.  By the year 2000, the search for an OA-producing enzyme had 
begun, with the focus that a type III PKS was responsible for the generation of the necessary 
substrate. 
2.2.4 Type III PKSs from Cannabis 
One of the earliest attempts to detect polyketide synthase activity in cannabis was conducted by 
assaying the crude extracts from various parts of the plant (Raharjo et al., 2004a). The extracts 
were incubated with hexanoyl-CoA and malonyl-CoA esters, and although the authors were able 
to detect olivetol, they found no OA. These experiments provided the basis for further rigorous 
examination into the enzyme(s) responsible for OA biosynthesis. Raharjo et al. (2004c) 
continued their search using a proteomics approach that compared the differential expression of 
proteins and mRNA within tissues capable and incapable of cannabinoid biosynthesis. The 
authors were unable to determine any of the cannabinoid biosynthetic enzymes during their 
proteomic analysis of leaves, flowers, and trichomes. Furthermore, Raharjo et al. (2004c) also 
attempted to identify cannabis PKSs using a Pinus sylvestris chalcone synthase antibody, and 
were partially successful in that they detected a PKS similar to the H. lupulus chalcone and 
phloroisovalerophenone synthases (Matousek et al., 2005; Paniego et al., 1999). Determined to 
isolate the recently detected PKS, Raharjo et al. (2004b) conducted degenerate reverse 
transcriptase-polymerase chain reaction (RT-PCR) using primers modeled after the H. lupulus 
CHS and phloroisovalerophenone synthase, and did successfully clone the first cannabis PKS. 
This enzyme (deposited in Genbank AAL92879) showed chalcone and phloroisovalerophenone 
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synthase activity, but was incapable of olivetol and OA biosynthesis, and was assigned as simply 
a cannabis CHS. 
In 2009, a new cannabis PKS named olivetol synthase (OLS; annotated BAG14339) was 
isolated from cannabis leaves using degenerate primers, and reported to biosynthesize olivetol 
from hexanoyl-CoA and malonyl-CoA (Taguchi et al., 2008; Taura et al., 2009). OLS also 
synthesizes two other products, namely a triketide pyrone called pentyl diacetic acid lactone 
(PDAL) and a tetraketide pyrone named hexanoyl triacetic acid lactone (HTAL) (Figure 2.8).  
Almost simultaneously with the Taura et al. (2009) publication, Marks et al. (2009) also 
reported the identification of a type III PKS possessing olivetol synthase activity. This discovery 
was made after a trichome-specific cDNA library was generated in an attempt to identify 
cannabinoid biosynthetic genes (Marks et al., 2009). Marks et al. (2009) reported a cDNA library 
of 1075 unigenes, of which three were putative type III PKSs named CAN24, CAN383, and 
CAN1069. Whereas CAN1069 was identical to the cannabis CHS previously reported by 
Raharjo et al. (2004b), CAN24 and CAN383 were reported as novel PKSs due to their divergent 
sequence. The authors characterized CAN24 and speculated that it produced pyrones and 
olivetol, since their results were inconclusive due to unsatisfactory HPLC analysis. It is now 
clear that CAN24 is identical to OLS based on sequence comparisons. Despite the successful 
identification of the novel type III PKS in cannabis, the characterization of OLS/CAN24 
indicated that OA was not synthesized, and instead only its decarboxylated analog, olivetol, 
could be produced. 
Another noteworthy analysis of cannabis PKSs was reported by Flores-Sanchez et al. 
(2010) after isolating a variety of PKS cDNAs from cannabis glandular trichomes by RT-PCR. 
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The authors described five different PKSs, PKSG1 (annotated EU551163), PKSG2 (annotated 
EU551164), PKSF3 (annotated EU551162), PKSG4 (annotated EU551165), and PKSG5 
(annotated EU551166), that are 97% homologous over their 385 amino acid span. The largest 
difference between these PKSs appears in the size of their untranslated regions, which Flores-
Sanchez et al. (2010) attributed to alternative transcription initiation and polyadenylation sites. 
None of the PKSs identified were identical to OLS/CAN24, although they all shared greater than 
97% sequence similarity at the amino acid level with it. This small difference in sequence is 
believed to be due to the varieties of cannabis used in each study, although these individual 
isozymes have not been fully characterized. Flores-Sanchez et al. (2010) noted that the 
biochemical characterization of these PKSs should be conducted to better understand their 
function and diversity. 
 
Figure 2.8  A PKS from cannabis is capable of producing PDAL, HTAL, and olivetol. 
Although this type III PKS can produce olivetol, it cannot produce OA, the suspected 
intermediate required for further cannabinoid biosynthesis. 
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2.3 Polyketide Cyclization and DABB Proteins 
2.3.1 Polyketide Cyclases 
Generally, in all types of PKS systems, the biosynthesis of aromatic polyketides is a 
process that not only depends on the iterative condensation of acetate units, but also on the 
proper cyclization and tailoring of intermediates. A polyketide intermediate may be cyclized into 
several different products, for which only one specific enzyme may be capable of achieving. 
Cyclization reactions, with limited exception, differ substantially between fungal, bacterial, and 
plant systems, and have each been shown to employ different strategies to achieve the diverse 
product biosynthesis observed in nature. The biosynthesis of fungal polyketides is accomplished 
by megasynthases that incorporate a folding pattern (F mode) completely different than the 
folding pattern used by the actinobacterial species (S mode), which use dissociable multi-enzyme 
complexes during polyketide biosynthesis (Thomas, 2001). The S and F modes proposed by 
Thomas (2001) involve the cyclization of the initial ring in polyaromatic polyketides, and have 
been observed during  many 
13
C-acetate labeling experiments allowing the comparison of fungal 
and streptomycete polyketide biosynthesis, such as viridicatumtoxin biosynthesis in Penicillium 
viridicatum with oxytetracycline biosynthesis in Streptomyces rimosus (de Jesus et al., 1982; 
Thomas and Williams, 1983) (Figure 2.9). Based on these observations, Thomas (2001) designed 
a general set of guidelines for S and F modes, which indicated that F-mode cyclization results in 
the synthesis of an initial cyclohexane ring containing two intact 
13
C-acetate moieties attached to 
two adjacent odd-numbered chains. Conversely, S-mode cyclization results in a cyclohexane 
containing three intact 
13
C-acetate units with two even-numbered adjacent chains. Furthermore, 
the cyclization of polyketides is not simply a matter of S or F designation, but is also dependent 
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on several influencing factors including the oxidative state of the polyketide (especially around 
C9), the priming-compound used, the size of the substrate binding cavity or product template 
domain, the fusion of other polyketide intermediates, and the presence of other polyketide 
cyclases (Zhou et al., 2010). In their conceptual review, Zhou et al. (2010) have further 
categorized type II PKS cyclization based on the initial ring-folding pattern commonly occurring 
at the C7-C12 position, which generates the tetracycline, aureolic acid, anthracycline, and 
benzoisochromanequinone backbones, or at the C9-C14 position, which gives rise to the 
tetracenomycin scaffold. Zhou et al. (2010) suggest that the folding pattern mostly governed by 
the chain length factor, which does not only determine the size of a nascent polyketide, but also 
coordinates the polyketide after it buckles back, due to the limited space in the substrate-binding 
cavity. Additionally, these authors indicate that bacterial cyclases directly influence the initial 
ring cyclization pattern, such as seen with ZhuI and TcmN aromatases, which are able to 
coordinate C7-C12 and C9-C14 cyclizations, respectively. Although ZhuI and TcmN share 
structural similarity, a comparison of their structures indicates that ZhuI contains a smaller 
substrate-binding pocket which forces the nascent polyketide to bend at C7 instead of C9 (Ames 
et al., 2011). Ketoreductases, such as Streptomyces coelicolor ActIII, are involved in the 
reduction of polyketides at the C9 position, and have also been shown to influence C7-C12 
cyclization in systems incapable of such cyclizations, such as in Gibberella fujikuroi PKS4 
(Hadfield et al., 2004; Ma et al., 2007).  
In plants, the folding of polyaromatic polyketides is accomplished by the simultaneous 
use of both S and F modes (Thomas, 2001). Aside from the CHS/STS folding pattern previously 
discussed (Section 2.2.4), Thomas (2001) refers to 2-methylanthraquinone chrysophanol and its  
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Figure 2.9  The F and S modes of polyketide cyclization. 
(A) Fungal and streptomycete folding patterns differ during initial ring cyclization, where in F 
mode a C6-C11 bond forms, and in S mode a C7-C12 bond is formed. (B) The incorporation of 
13
C-acetate during the biosynthesis of viridicatumtoxin and oxytetracycline is one example that 
illustrates F and S modes, respectively. (C) It has been suggested that the biosynthesis of 
chrysophanol and aloesponarin in Aloe occurs via a bimodal folding process. Chrysophanol can 
also be biosynthesized by P. islandicum, whereas aloesaponarin can be produced in 
streptomycetes. Figure adapted from Thomas (2001). 
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isomer, 1-methylanthraquinone aloesaponarin II, to exemplify the bimodal process in plants 
(Figure 2.9). Whereas both compounds are produced in Aloe species, chrysophanol is also 
produced in Penicillium islandicum through a decarboxylative F-mode cyclization, and 
aloesaponarin I can be biosynthesized in recombinant streptomycetes via an S-mode folding 
pattern. The occurrences of both these compounds in Aloe suggest an F/S bimodal cyclization 
process is responsible. 
2.3.1.1 Secondary Polyketide Cyclases 
Following primary ring cyclization, type II PKS systems use dissociable cyclases to fold the 
remaining rings during polyketide biosynthesis. These cyclases may act independently or may 
require other cyclases to synergistically achieve the correct folding pattern resulting in either 
linear or angular fused polyketides. In their review, Zhou et al. (2010) have divided these 
polyketides by their primary ring cyclization, but also by whether or not they form linear or 
angular fused rings, as well as by their secondary, tertiary, and in some cases quaternary 
cyclizations which result in several families of compounds that share a similar scaffold. For 
example, tetracyclines and aureolic acids are classified together as linear fused aromatics that are 
the result of C7–C12, C5–C14, C3–C16, and C1–C18 regiospecific cyclizations, whereas 
tetracenomycins are also linearly fused aromatics, but form their own class of compounds since 
they are generated following C9–C14, C7–C16, C5–C18, and C2–C19 cyclizations. The 
involvement of regioselective cyclases is required regardless of which class of fusion the 
polyketides belong to. In the case of tetracycline biosynthesis, it has been demonstrated that, in 
S. coelicolor, the cyclization of the four rings in the naphthacene backbone are achieved by only 
two cyclases; OxyK is responsible for the initial C7-C12 cyclization and OxyN is responsible for 
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the second ring C5-C14 cyclization (Petkovic et al., 1999; Zhang et al., 2007). The third ring is 
believed to result from spontaneous cyclization, but no enzyme has been identified as being 
responsible for the fourth ring cyclization. Similarly, the biosynthesis of tetracenomycin C 
requires a primary ring, and in this case secondary ring, cyclase, but also requires TcmI to 
complete the C2-C19 cyclization of the fourth ring. The mechanism for the third ring cyclization 
is still not well understood (Zhou et al. 2010).  
2.3.1.2 A Possible Role for Polyketide Cyclases in Cannabinoid Biosynthesis 
In an attempt to better understand the cyclization to OA, a general review of similar mechanisms 
incorporating the cyclization of polyketide intermediates was conducted. This overview of 
cyclization mechanisms capable of retaining a carboxylate moiety in the final or intermediate 
products led to the identification of similar phenomena occurring in Actinobacteria. 
Actinobacteria are a rich source of diverse secondary metabolites from which hundreds of 
antibiotics have been isolated. Particularly, the biosynthesis of tetracenomycin in Streptomyces 
glaucescens played an important role in the identification of enzymes putatively involved during 
the cyclization of OA. The biosynthesis of tetracenomycin is a multistep reaction that recruits a 
type II PKS responsible for the generation of a nonaketide intermediate (via TcmJKLM), that is 
initially cyclized to TcmF2 (via TcmN), and is cyclized once more, in a step that retains the 
carboxyl moiety by a type II polyketide cyclase known as TcmI (Thompson et al., 2004). The 
similarity of this reaction led to the exploration of similar proteins in cannabis, which eventually 
led to the successful progress described in this thesis. TcmI is classified as a polyketide cyclase 
(PKC), a family of proteins that harbor a specific dimeric α + β barrel (DABB) domain. 
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2.3.2 DABB Proteins 
The DABB domain is a common structural motif found in many proteins distributed throughout 
nature that form a superfamily of structurally related proteins with some very common features. 
Some of these proteins play critical roles during important processes involving drug 
biosynthesis, environmental detoxification, and pathogenicity. Although DABB proteins share 
striking structural similarity, they are not necessarily derived from a common evolutionary origin 
and may not share strong sequence similarity. The dissimilarity in protein sequence is often seen 
at the family level where members sharing less than 20% sequence identity may have structures 
that superimpose to a root mean square deviation (rmsd) of ≤ 2.0Å. Proteins are typically 
categorized based on their similarities in sequence, function, and structure; traits that are 
classified differently by the available bioinformatic tools which lead to varying degrees of 
clustering by accessible databases (Martinez, 2011). DABB proteins are not excluded from this 
ambiguity and are represented differently depending on the database used. For example, the 
Structural Classification of Proteins database (SCOP) recognizes DABB proteins as a 
superfamily based on their three-dimensional domain, and partitions the superfamily into 23 sub-
families (annotated 54909), whereas the PFAM database recognizes the signature motif for the 
DABB clan (annotated CL0032) which is further separated into 15 distinct families (Bateman et 
al., 2004; Murzin et al., 1995). As well, the two popular web-based resources, Interpro and the 
Conserved Domain Database (CDD), which similarly integrate information from several 
databases, distinguish the DABB superfamily very differently; Interpro recognizes DABB 
proteins as the parent of several sub-groups/families (annotated IPR011008), one of which the 
CDD narrowly defines as the DABB superfamily (Marchler-Bauer et al., 2011; Mulder et al., 
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2005). In this study, the superfamily of DABB proteins is recognized as a larger superfamily 
represented by both SCOP and PFAM, although it focuses more on some functionally similar 
families, namely the antibiotic biosynthetic monooxygenases (ABMs), the PKCs, and the stress-
responsive α + β barrel proteins (SRABBs). 
2.3.2.1 The Structure and Occurrence of DABB Proteins 
There are many protein structures available for DABB proteins that display common 
fundamental features. DABBs are α + β - classed structures displaying a repeated ferredoxin-like 
βαβ fold (Figure 2.10). These structurally analogous domains are characterized by independent 
segments of α-helices pressed against a 4-5 strand β-sheet, sometimes referred to as α-β 
sandwiches due to the distinct layering of the α-helices and β-sheet (Orengo and Thornton, 
1993). DABB proteins typically dimerize at the β-sheet interface and form an anti-parallel β-
barrel structure (Figure 2.10). The α-helices found in the repeated βαβ elements are sometimes 
segmented or kinked and form 1-2 arches which protrude away from the β-sheet, shaping a 
crevice between the secondary structures. This crevice is purported as the active site in several 
DABB members (Goblirsch et al., 2010; Sciara et al., 2003; Sugano et al., 2007). Although many 
DABB proteins display higher-ordered quaternary structure, they typically form dimers which 
may or may not continue to oligomerize. The formation of dimers is partly due to hydrophobic 
interactions between the residues of two subunit β-sheets that are not necessarily conserved yet 
result in similar β-barrel structures. Sciara et al. (2003) pointed out two highly conserved 
residues, Tyr63 and His52, in Streptomyces coelicolor ActVa-Orf6 homologs, which facilitate 
dimer stabilization through tyrosine-tyrosine aromatic stacking and tyrosine-histidine hydrogen 
bonds and demonstrated that replacement of His52 by site-directed mutagenesis (SDM) led to a 
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severe loss of activity due to the disruption of the dimer interface. Additionally, in ActVa-Orf6 
each monomeric C-terminus was shown to contribute to dimer formation by swapping strands 
with the opposing β-sheet, also contributing to the bottom portion of the active site. But these 
features are not universal in DABB proteins. The Staphylococcus aureus IsdG, which shares 
only 15% identity at the amino acid level with ActVa-Orf6, yet can be superimposed to a rmsd of 
1.92 Å, does not use the same residues as ActVa-Orf6 to achieve dimerization, and relies on 
different hydrophobic interactions to achieve its similar structure (Wu et al., 2005). Essentially, 
the involvement of hydrophobic residues is necessary for dimer interaction normally seen at the 
β-sheet interface. As well, strand swapping is not always observed in DABB members as it is in 
ActVa-Orf6. In Escherichia coli YgiN, there is an extended loop between the β2 and β3 strands 
which helps to form the opposing monomer’s β-sheet instead of the strand swapping observed in 
ActVa-Orf6, yet structural similarity between ActVa-Orf6 and YgiN is maintained to an overall 
rmsd of 1.9 Å (Adams and Jia, 2005).  
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Figure 2.10 The structure of S. coelicolor ActVa-Orf6. 
 (A) ActVa-Orf6 is pictured as a dimer. The (blue) monomer carboxyl terminus is seen strand 
swapping with the opposing (green) monomer β-sheet strengthening the dimeric interaction and 
completing the β-barrel structure. The (red) substrate (Nanaomycin D) is shown in the putative 
active site found between the α-helices and β-pleats. (B) ActVa-Orf6 is shown at a different 
angle allowing the β-barrel structure to be seen. Figure adapted from Sciara et al. (2003).  
 
2.3.2.2 The Function of DABB Proteins 
DABB proteins are involved in catalyzing a diverse set of reactions including the oxygenation of 
polyaromatic compounds, isomerization of methyl muconolactone, and the cyclization of 
polyketides (Figure 2.11). The functionality of the different DABB proteins has been 
instrumental in the assignment of subfamilies within the superfamily of proteins. As the name 
implies, the ABM family is involved in the oxygenation of cyclic polyketide-derived antibiotic 
compounds. The S. coelicolor ActVa-Orf6 serves as the prototypical monooxygenase 
representative of the ABM family from which the ABM family name was initially derived. 
ActVa-Orf6 catalyzes the oxidation of 6-deoxydihydrokalafungin (6-DDHK) to 
dihydrokalafungin (DHK), an intermediate in the actinorhodin biosynthetic pathway (Kendrew et 
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al., 1997) (Figure 2.11). Other members of this family include Streptomyces galilaeus AknX and 
Streptomyces nogalater SnoaB involved in aclarubicin and nogalamycin biosynthesis 
respectively (Raty et al., 2002; Ylihonko et al., 1996).  
Methylmuconolactone methyl isomerases (MLMIs) are involved in the degradation of 
methyl and chloro-substituted aromatics following ortho-(intradiol) cleavage. The cleavage of 4-
methylcatechols form 4-methylmuconolactones which cannot be further processed by the 3-
oxoadipate pathway unless they are initially isomerized to 3-methylmuconolactone by MLMIs 
(Figure 2.11). These enzymes have been described in Cupriavidus necator JMP132 (Pieper et al., 
1990), Rhodococcus rhodochronous N75 (Bruce et al., 1989), and Pseudomonas reinekei MT1 
(Camara et al., 2007). In addition to 4-methylmuconolactone isomerization, MLMIs have been 
shown to synthesize 3-methylmuconolactone using 1-methylbislactone as substrate indicative of 
MLMI’s ability to open and close lactone rings (Pieper et al., 1990).  
The PKCs form a separate family of DABB enzymes that are found exclusively in 
Actinobacteria. This family is exemplified by TcmI, the only functionally and structurally 
characterized PKC from this family to date. TcmI is part of the tetracenomycin biosynthesis gene 
cluster found in S. glaucescens and was shown to cyclize Tcm F2 to Tcm F1, both intermediates 
involved in the biosynthesis of the antitumor antibiotic Tcm C, without requiring a cofactor or 
metal ion (Figure 2.11) (Shen and Hutchinson, 1993a). It is important to note that this cyclization 
occurs while retaining the carboxyl moiety in the intermediates. Although the functionalities of 
these DABB proteins are quite diverse, the ability of the enzymes to bind and modify larger 
cyclic compounds appears universally conserved. 
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Figure 2.11 Examples of DABB protein activity. 
(A) The oxidation of 6-DDHK to DHK is catalyzed by ActVa-Orf6. (B) TcmF2 is cyclized to 
TcmF1 by the TcmI cyclase. (C) Cyclization reactions which retain the carboxyl moietiy 
throughout are conducted by TcmI and are reminiscent of those coordinated by SnoaL enzymes 
which are sometimes fused to DABB motifs,. (D) MLMIs convert 4-methylcatechol  to 3-
methylmuconolactone. 
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2.3.3 Aldolases 
Aldolases are enzymes capable of making or breaking an aldol bond, which are catoregized as 
being either class I or class II. Whereas class I aldolases, occurring primarily in animals and 
higher plants, form Schiff bases with their substrates via a lysine residue in the enzyme active 
site, the class II aldolases, which occur in bacteria and fungi, use a Zn
2+
 cofactor that acts as a 
Lewis acid during the reaction. The aldolases are important enzymes to consider in the context of 
this study, and are later discussed with regard to their distinct mechanisms; see Gijsen (1996) and 
Fessner (1996). Aldolase reactions are notable since they result in a donor retaining its carboxyl 
moiety, a phenomena which also occurs during the biosynthesis of OA.  
 
Figure 2.12 Type I and II Aldolase Reactions 
In the case of type I aldolases, the donor compound is attached to the enzyme by a Schiff base 
prior to the aldol reaction, whereas type II aldolase reactions require a metal to coordinate the 
donor and the acceptor compounds. The substituent (R) shown in the acceptor compound may be 
a variety of monosaccaryl or oligosaccharyl chains.   
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3. THE TKS REACTION 
 
3.1 Introduction 
This study was preceded by experiments on trichome-specific cDNA library containing over 
4,000 unigenes generated from high-THCA cannabis (Stout et al., 2012). This library was 
created by sequencing cDNA synthesized from glandular trichome mRNA and was used as a tool 
for the identification of enzymes involved in the biosynthesis of cannabinoids, one of which 
Stout et al. (2012) described as a hexanoyl-CoA synthetase. Displayed in Table 3.1 are the most 
highly expressed transcripts identified in the cDNA library along with their descriptors 
determined by BLAST searches against the Universal Protein Resource database (Uniprot). The 
most highly expressed transcript in this cDNA library was CL1Contig3, a sequence with 74% 
protein identity with Humulus lupus CHS (annotated BAB47196). The involvement of a type III 
PKS in the biosynthesis of OA had been previously suggested (Fellermeier et al., 2001; Horper 
and Marner, 1996; Shoyama et al., 1975), and soon after the identification of the type III PKS 
candidate by the Page laboratory (unpublished), several cannabis PKSs were reported in the 
literature (Flores-Sanchez et al., 2010; Marks et al., 2009; Taura et al., 2009). These reports 
included a similar trichome-derived cDNA library (Marks et al., 2009) and the characterization 
of olivetol synthase (OLS), which shares 99% protein identity to our PKS candidate (Taguchi et 
al., 2008; Taura et al., 2009). Some of the work conducted on the PKS candidate presented in 
this thesis occurred prior to any of these reports on type III PKSs were publushed, and at the time 
this work was started, the PKS candidate had already been successfully subcloned, 
heterologously expressed, and purified by Ryan Taschuk, a member of the Page laboratory. 
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Table 3.1 Transcripts detected in a C. sativa glandular trichome cDNA library 
Descriptions are from BLASTX comparison against the Uniprot database. Candidate cyclases assayed in this work 
are highlighted in yellow and include CHI (Q6V7U9), DABB/OAC (Probable protein POP3) (Q9LUV2), and MLP 
(B5KVN9). The most abundant transcript was TKS (B1Q2B6), initially described as OLS/polyketide synthase, is 
highlighted in pink. THCA synthase, another protein involved in cannabinoid biosynthesis, is also highlighted in 
pink. Adapted from an earlier publication that used the same cDNA library as in this study (Stout et al., 2012).   
 
Description UniProt # Organism Contig size %  ESTs
Olivetol synthase / polyketide synthase B1Q2B6 Cannabis sativa 339 3.70
BURP domain-containing protein B2ZPK5 Solanum tuberosum 192 2.10
4-hydroxy-3-methylbut-2-enyl diphosphate reductase B9RZD3 Ricinus communis 185 2.02
Malic enzyme B9RQE8 Ricinus communis 182 1.99
PAR-1c protein Q43589 Nicotiana tabacum 87 0.95
Limonene synthase A7IZZ1 Cannabis sativa 65 0.71
Delta12-oleic acid desaturase Q6RXX0 Euphorbia lagascae 62 0.68
D12 oleate desaturase Q41305 Solanum commersonii 53 0.58
Putative chalcone isomerase Q6V7U9 Solanum lycopersicum 51 0.56
Non-specific lipid-transfer protein Q850K8 Vitis hybrid 49 0.54
Tetrahydrocannabinolic acid synthase Q8GTB6 Cannabis sativa 48 0.52
Isopentenyl pyrophosphate isomerase Q6EJD1 Pueraria lobata 48 0.52
Elongation factor 1-alpha B9SPV9 Ricinus communis 46 0.50
Cystathionine gamma-synthase B9RYU1 Ricinus communis 44 0.48
Probable protein Pop3 Q9LUV2 Arabidopsis thaliana 41 0.45
Cytochrome P450 B9SG22 Ricinus communis 39 0.43
Alpha-pinene synthase A7IZZ2 Cannabis sativa 38 0.41
Monoterpene synthase B6SCF4 Humulus lupulus 35 0.38
4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase A9ZN14 Hevea brasiliensis 33 0.36
ATP-citrate synthase B9SHC9 Ricinus communis 31 0.34
Sesquiterpene synthase B6SCF5 Humulus lupulus 31 0.34
Acetoacetyl-CoA thiolase Q2L8A7 Picrorhiza kurrooa 28 0.31
Fructose-bisphosphate aldolase Q9M4M9 Persea americana 28 0.31
Translationally-controlled tumor protein B9RT61 Ricinus communis 28 0.31
Sesquiterpene synthase B6SCF5 Humulus lupulus 27 0.29
Isoflavone reductase related protein O81355 Pyrus communis 26 0.28
Short-chain dehydrogenase B9RXD8 Ricinus communis 26 0.28
Salutaridinol 7-O-acetyltransferase B9RML2 Ricinus communis 26 0.28
Lipoxygenase C4NZX3 Camellia sinensis 25 0.27
Cysteine protease A9UFX8 Vitis vinifera 25 0.27
Dessication-related protein Q8LAU8 Arabidopsis thaliana 25 0.27
Anthranilate N-benzoyltransferase protein B9S035 Ricinus communis 25 0.27
Hevein-like protein Q944B8 Sambucus nigra 23 0.25
Pathogenesis related protein PR10 B5KVN9 Prunus domestica 23 0.25
Delta12-oleic acid desaturase Q6RXX0 Euphorbia lagascae 22 0.24
Acetyl-CoA synthetase B9RE68 Ricinus communis 22 0.24
Pyruvate decarboxylase B9SWY1 Ricinus communis 21 0.23
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In this chapter, experiments were designed to characterize the type III PKS, which was 
named tetraketide synthase (TKS), and set out to determine if an unknown chemical or biological 
factor played an accessory role in the biosynthesis of OA. Another goal of these experiemtns was 
to develop analytical techniques capable of detecting products from TKS assays performed in 
vitro. Recombinant TKS was assayed in a variety of buffers, pH ranges, and substrate 
concentrations to determine the optimal conditions for tetraketide formation. Rabbit anti-TKS 
polyclonal antibodies were also generated from purified TKS and used in co-
immunoprecipitation and protein pull-down screens in an attempt to discover accessory proteins 
putatively involved in OA cyclization. These screening methods required a protein solution 
derived from isolated trichomes, which was assayed prior to any co-immunoprecipitation 
attempts. Recombinant TKS was also assayed in the presence of candidate proteins that were 
potentially involved in the cyclization of linear tetraketides. This chapter focuses on TKS and 
trichome assay results that collectively led to the discovery of OAC. 
3.2 Materials and Methods 
3.2.1 Tetraketide Synthase Assay Methods 
All compounds used throughout this work were purchased (Sigma), except for PDAL, HTAL, 
and OA which were synthesized by Ms. Nikki Theaker using previously published methods 
(Horper and Marner, 1996). 
3.2.2 The Expression and Purification of TKS 
An E. coli BL21 (DE3) transformant 472-28A harboring pRT31A6 (i.e. TKS in pHIS8GW) was 
provided by Dr. Jonathan Page. The culture was streaked onto an LB plate, grown overnight at 
37°C, and a single colony used to inoculate 5 mL of LB. Following overnight culture at 37°C, a 
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1 mL aliquot was transferred to start a larger overnight 50 mL culture. Frozen stocks were 
prepared by adding 100 µL of culture to 500 µL of 80% glycerol (v/v) and storing them at -80°C. 
The 50 mL culture was added to 1 L of AUTOINDUCTION MEDIUM (1.2% tryptone, 2.4% 
yeast extract, 0.0125% glucose, 0.05% α-lactose monohydrate, 50 mM glycerol, 50 mM 
Na2HPO4. 50 mM KH2PO4, 25 mM (NH4)2SO4, 1 mM MgSO4), and grown overnight at 30°C. 
The overnight culture was further induced by adding IPTG to a final concentration of 0.5 mM, 
and was grown for an additional 4 h at 30°C. The culture was pelleted at 10,000 g for 20 min at 
4°C, and then transferred to a 50 mL tube before it was stored overnight at -80°C. All the media 
described contained 50 µg/mL kanamycin as a selective agent. Cultures were shaken at 200 rpm. 
Frozen pellets were thawed on ice for 30 min in the presence of 50 mL LYSIS BUFFER (50 mM 
TRIS-HCl [pH 7], 500 mM NaCl, 2.5 mM imidazole, 10% glycerol (v/v), 10 mM β-
mercaptoethanol, 750 µg/mL lysozyme (Sigma)). The solution was homogenized using a 
vortexer, then sonicated on ice for 2 x 2 min bursts using a LabsonicU sonicator (B. Braun 
Biotech International). The cell suspension was centrifuged for 20 min at 12,000 g at 4°C and the 
supernatant was transferred to a 50 mL tube. In preparation of immobilized metal affinity 
chromatography (IMAC), a 1 mL suspension of Talon resin (Clontech) equilibrated in WASH 
BUFFER (50 mM TRIS-HCl [pH 7], 500 mM NaCl, 10 mM imidazole, 10% glycerol (v/v), 10 
mM β-mercaptoethanol) was added to the cell suspension and then tumbled at 4°C for 40 min. 
Talon resin was pelleted by centrifugation for 1 min at 1,000 g, and the supernatant was 
discarded. Talon resin was washed five times using 10 mL of wash buffer each wash, where each 
wash was removed by centrifugation for 1 min at 1,000 g. The washed Talon was transferred to a 
10 mL gravity flow column and rinsed with 10 mL wash buffer. Purified TKS was eluted using 
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10 mL ELUTION BUFFER (50 mM TRIS-HCl [pH 7], 150 mM NaCl, 100 mM imidazole, 10% 
glycerol (v/v), 10 mM β-mercaptoethanol), and concentrated to 1 mL using a YM10 centrifugal 
filter device (Millipore). The protein solution was desalted and the buffer exchanged by 
suspending it in 5 mL of STORAGE BUFFER (20 mM HEPES [pH 7.5] containing 25 mM 
NaCl, 10% glycerol (v/v), and 5 mM dithiothreitol (DTT)) and centrifuging the filtration device 
until the solution was concentrated to 1 mL. This dilution process was repeated two more times. 
Purification work was conducted at 4°C. Enzyme preparations were stored at -20°C. 
3.2.3 TKS Assays 
Unless stated otherwise, 50 µL reactions were conducted using 25 µg of TKS, 0.2 mM hexanoyl-
CoA, 0.6 mM malonyl-CoA, and 5 mM DTT. Reactions were normally extracted twice using 
250 µL ethyl acetate. Extracts were dried under vacuum and dissolved in 30 µL 
RESUSPENSION SOLUTION consisting of (v/v) 70% water, 30% acetonitrile, and 0.05% 
formic acid. Product analysis was generally conducted by liquid chromatography coupled to 
mass spectrometry (LCMS) and was normally performed using 10 µL injections of sample in a 
Waters Alliance 2695 separation module (Waters) attached to a 2996 photodiode array (PDA) 
detector (Waters), a 3100 single quad-mass detector (Waters), and a Symmetry C18 3.5 µm (2.1 
x 100 mm) column (Waters). Products were monitored over 13 min isocratic runs using LCMS 
RUNNING SOLVENT consisting of (v/v) 63% water, 37% acetonitrile, and 0.05% formic acid. 
Flow rate was maintained at 0.2 mL/min with a 30°C column temperature. Results were 
processed using the Empower2 software suite (Waters). Assay products (HTAL, PDAL, OA, and 
olivetol) were detected by both LC-PDA and MS methods. Products detected by LC-PDA at 270 
nm. MS was set to ES
+
 mode where three selective ion monitoring (SIR) channels were used to 
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detect ions of m/z 181 (cone voltage = 25 V, dwell = 0.010 s), m/z 183 (cone voltage = 40 V, 
dwell = 0.010s), and m/z 225 (cone voltage = 25 V, dwell = 0.010 s). Ions were selected for the 
specific detection of olivetol (180 g/mol), PDAL (182 g/mol), and both HTAL and olivetolic 
acid (224 g/mol).  
Some analyses were conducted solely by high performance liquid chromatography 
(HPLC) that used a Waters Alliance 2695 separation module (Waters) and 2996 photo array 
detector (PDA) (Waters) and a SunFire C18 10 µm (4.6 mm x 150 mm) (Waters). During HPLC 
analysis, samples were resuspended in 30 µL methanol, where 10 µL injections were monitored 
over 15 min gradient runs starting with (v/v) 59.9% water, 40% acetonitrile, and 0.1% 
trifluoroacetic acid and ending with 29.9% water, 60% acetonitrile and 0.1% trifluoroacetic acid. 
Flow rate was maintained at 1 mL/min with a 30°C column temperature. Reaction products were 
monitored at 270 nm, and results were processed using the Empower2 software suite. TKS 
reaction products were quantified using standard curves generated from 100 μM stock solutions 
prepared in LCMS running buffer. Solutions were diluted and 5 μL injections were used to 
construct 25 to 500 pmol standard curves following LCMS analysis (Appendix A).  All curves 
presented a R
2
 value  0.998 when analyzed by linear regression.  
3.2.3.1 In the Presence of 14C Malonyl-CoA and Hexanoyl-CoA 
Aliquots of 25 µg TKS were assayed in 50 µL solutions containing 70 mM HEPES [pH 7.0], 20 
µM malonyl-CoA, 20 µM hexanoyl-CoA and 1 µL of malonyl(2-
14
C)-CoA (American 
Radiolabeled Chemicals Inc., 0.1 mCi/ml, specific activity 55 mCi/mmol) for 30 min at 30°C. 
Reactions were stopped and extracted using 200 µL ethyl acetate. Extracts were dried under 
vacuum, then resuspended in 10 µL of ethyl acetate before being spotted on a HPTLC-RP18F 
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plate (Analtech). The plate was developed over 60 min using a solvent consisting of 75% 
methanol, 24% water, and 1% acetic acid. The plate was analyzed by radio-TLC scanning using 
a LS6500 scintillation counter (Beckman Coulter) and by phosphorimaging using a Storm 840 
imaging station (Amersham Biosciences). 
3.2.3.2 In the Presence of Malonyl-CoA and Hexanoyl-CoA 
Reactions were conducted using 20 mM HEPES [pH 7.0] at 20°C for 60 min. Extracts were 
dried under vacuum and then resuspended in 20 µL of resuspension solution. Assays were 
performed in triplicate. 
3.2.3.3 In the Presence of Different Buffers and ph 
Reactions used 20 µg of TKS and were conducted for 30 min at 25°C in 20 mM buffer, 0.2 mM 
malonyl-CoA, 0.2 mM hexanoyl-CoA, and 5 mM DTT. Buffers included 20 mM MES [pH 5.5, 
6.0, 6.5], phosphate [pH 6.0, 6.5, 7.0, 7.5, 8.0], HEPES [pH 7.0, 7.5, 8.0], and TRIS [pH 7.0, 7.5, 
8.0, 8.5, 9.0]. Assays were performed in triplicate and analyzed by HPLC. 
3.2.3.4 In the Presence of N-(2-acetamido)iminodiacetic acid (ADA) Buffer 
Reactions used 100 pmol (~5 µg) of TKS and were conducted in 20 mM ADA buffers [pH 5.7, 
6.0, 6.2, 6.4, 6.6, 6.8, 7.0, 7.2, 7.4, 7.6, 7.8]. Due to the large number of samples, reaction times 
were extended to 90 min at 20°C to ensure that there was time enough to start/stop samples. 
Extracts were resuspended in 20 µL resuspension solution and used 5 µL injections during 
LCMS analysis. Assays were performed in triplicate. 
  
  
44 
 
3.2.3.5 With Variable Temperatures 
TKS temperature assays used 20 µg TKS and were conducted in 50 mM HEPES [pH 7.5], 0.2 
mM malonyl-CoA, and 0.2 mM hexanoyl-CoA. Reactions were incubated for 30 min at 10, 20, 
30, 40, or 50°C. Reactions were performed in triplicate and were analyzed by HPLC. 
3.2.3.6 With Variable Substrate Concentrations 
Assays were performed in 100 mM HEPES [pH 7.5] containing 5 mM DTT, and either 0.2 mM 
hexanoyl-CoA and 0.1, 0.2, 0.5 or 1.0 mM malonyl-CoA, or 0.2 mM malonyl-CoA and 0.1, 0.2, 
0.5, or 1.0 mM hexanoyl-CoA. Reactions were performed at 40°C for 30 min in triplicate and 
were analyzed by HPLC. 
3.2.3.7 In the Presence of DTT 
Two sources of TKS were used in assays, both of which were derived from the same culture. 
Following the expression of TKS, 472-28A strains were divided into two portions so to purify 
proteins in either the presence or absence of β-mercaptoethanol (βME) and DTT in purification 
buffers. TKS purified in the presence or absence of reducing agents was used to assay the effect 
of DTT in assays. Reactions contained 100 mM HEPES [pH 7.5], 0.2 mM malonyl-CoA, 0.2 
mM hexanoyl-CoA, and either 0, 5, 10, 20, or 100 mM DTT. Reactions proceeded for 90 min at 
40°C before being extracted twice with 200 µL of ethyl acetate. Reactions were performed in 
triplicate and were analyzed by HPLC. 
3.2.4 Cannabis Trichome Preparation and Trichome Extract Assays 
Two different trichome extracts were used during assays; one derived from non drug-type 
cannabis (USO-31 hemp), and the other from drug-type cannabis. TRICHOME EXTRACTION 
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BUFFER consisted of 100 mM HEPES [pH 7.5], 3 mM EDTA, 500 mM sucrose, 10 mM DTT, 
and 1,000x diluted protease inhibitor mixture set III (Calbiochem). 
3.2.4.1 Trichome Isolation 
Female cannabis plants provided by Dr. Page had been grown in a controlled environment 
chamber at 18 h day lengths. Flowering bracts (60 g) were removed from the plants and 
dissected before soaking them for 1 h in ice water. Trichome separation was achieved using an 
adapted Beadbeater method (Gershenzon et al., 1992). The flowering material was moved to a 
950 mL vessel (BeadBeater, BioSpec Products) containing 120 mL of 0.5 mm glass beads, 35 g 
XAD-4 and 700 mL of TRICHOME ISOLATION BUFFER (25 mM HEPES pH 7.0, 200 mM 
sorbitol, 10 mM sucrose, 0.6% (w/v) methylcellulose and 1% (w/v) polyvinylpyrrolidone 
(40,000 g/mol) (PVPP)). The mixture was agitated using a teflon rotor for 1 min before filtering 
it through a 350 µ mesh. The tissue was then washed with 250 mL of trichome isolation buffer 
which did not contain methyl cellulose or PVPP. All filtrates were combined and run through a 
105 m mesh, and then again through a 20 m mesh filter prior to trichome collection. The 
trichome cells were rinsed using trichome isolation buffer and dried using a Kimwipe (Kimberly-
Clark). Trichomes were stored at -80°C. Yield was ca. 0.9 g from 60 g of flowers. 
3.2.4.2 Cannabis Trichome Extracts 
A 100 mg sample of isolated drug-type trichomes was homogenized in the presence of 10 mg 
PVPP and 200 µL trichome extraction buffer on ice, followed by a 20 min centrifugation at 
15,000 g at 4°C. The supernatant was removed, and trichomes were extracted again using 
another 200 µL of extraction buffer. Protein extracts were combined and desalted using a 2 mL 
Zeba desalting spin column (Thermo Scientific) equilibrated with 100 mM HEPES [pH 7.5]. 
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Protein concentration of the extracts was determined using an RC/DC protein assay as directed 
by the manufacturer (Bio-Rad). Protein extracts were assayed using 25 µg (ca. 45 µL) of protein 
for 30 min at 40°C in a final volume of 55 µL containing 0.4 mM hexanoyl-CoA and 0.4 mM 
malonyl-CoA or simply 0.4 mM hexanoyl-CoA and water (no malonyl-CoA negative control). 
Samples were prepared for HPLC analysis as described in Section 3.1.3. Injections of 20 µL 
were analyzed by HPLC.  
Scaled-up USO-31 hemp trichome assays used 195 µg of protein (ca. 350 µL) from 
protein extracts prepared as described above. Extracts were incubated in the presence of 0.25 
mM malonyl-CoA and 0.25 mM hexanoyl-CoA for 2 h at 40°C. The 400 µL solution was 
extracted twice using 2 x 1 mL ethyl acetate. A single 20 µL injection was performed during 
HPLC analysis.  
3.2.4.3 The Effect of Recombinant TKS on Trichome Extract Activity 
Trichome extracts were prepared as described in Section 3.1.4.2. A total of five reactions were 
conducted including 1) recombinant TKS (rTKS), 2) trichome extract, 3) trichome extract in the 
presence of rTKS 4) trichome extract lacking hexanoyl-CoA (negative control), and 5) rTKS 
lacking hexanoyl-CoA (negative control). The 55 µL TKS reaction was conducted by incubating 
50 µg of rTKS in the presence of 80 mM HEPES [pH 7.5], 0.4 mM malonyl-CoA, and 0.4 mM 
hexanoyl-CoA. The trichome extracts were assayed by incubating 200 µg of protein from 
trichome extract in the presence of 0.5 mM malonyl-CoA and 0.25 mM hexanoyl-CoA. A 
negative control for this reaction replaced hexanoyl-CoA with water. The TKS/trichome assay 
included 50 µg of TKS with 200 µg protein from trichome extracts. Reactions were incubated for 
2 h at 40°C before being extracted using five volumes of ethyl acetate. Samples were prepared 
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for HPLC analysis as previously described (Section 3.1.3) and used 20 µL injections during 
analysis. 
3.2.4.4 Rabbit Antibodies Directed Against TKS  
Antibodies were prepared by the National Research Council Canada, Biotechnology Research 
Institute (NRC-BRI) using their standard immunization protocols for the development of 
polyclonal antibodies, which required the inoculation of two rabbits each with 350 µg of purified 
recombinant TKS. Recombinant TKS was prepared and purified as outlined in Section 3.1.1. See 
Appendix B for details on rabbit injections and bleed times. 
3.2.4.5 Ammonium Sulfate Precipitation of Trichome Proteins 
Trichome extracts were prepared as previously described in Section 3.1.4.2. A saturated 
ammonium sulfate solution was prepared by stirring 7.5 g of ammonium sulfate in 10 mL of 
water. A 1 mL aliquot of extract was tumbled in the presence of 20% ammonium sulfate for 1 h 
at 4°C, followed by centrifugation at 15,000 g for 20 min. The supernatant was removed and the 
20% ammonium sulfate pellet was stored at -20°C. The supernatant was then tumbled in 40% 
ammonium sulfate for 1 h at 4°C, centrifuged at 15,000 g for 20 min, the supernatant removed, 
and the pellet stored at -20°C. In a similar fashion, the remaining supernatant was precipitated 
using 60% and 80% ammonium sulfate. The remaining supernatant (i.e. post-80% ammonium 
sulfate treatment) was desalted using a 5 mL PD10 column (GE Healthcare Biosciences) and 
stored at -20°C. Pellets were later thawed on ice and resuspended in 100 µL of 100 mM HEPES 
[pH 7.5]. Since there was some difficulty in reconstituting the 20% pellet in this volume, an 
additional 100 µL of buffer was used (total 200 µL). Solutions were concentrated using a YM10 
concentrator to ca. 150 µL. An aliquot of 3 µL from each solution was added to 2 µL SAMPLE 
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LOADING BUFFER (50 mM TRIS [6.8], 2% SDS (w/v), 10% glycerol (v/v), 1% βME (v/v), 
0.02% bromophenol blue (w/v)) and incubated for 5 min at 95°C before being analyzed by SDS-
PAGE and Western blotting using 10% gels run at 200 V for 45 min. One gel was stained in Bio-
Safe Coomassie stain for 1 h, and destained overnight in dH2O. The other gel was 
electrotransferred to a PVDF membrane using 15 V for 30 min. The transferred PVDF 
membrane was blocked with a 10% BSA/phosphate buffered saline (PBS) (Sigma-Aldrich) 
solution for 1 h and washed twice in PBS for 10 min, then 2 more times each time for 10 min in 
PBS containing 0.1% Tween 20. A 1:1,000 primary antibody solution was prepared by adding 20 
µL of rabbit antibodies (see Section 3.1.4.5) to 20 mL of 1% BSA in PBS, which was used to 
treat the PVDF membrane on an orbital shaker for 1 h. A 1:20,000 secondary antibody (goat 
anti-rabbit conjugated with alkaline phosphatase) was prepared in 1% BSA/PBS and allowed to 
react with the membrane for 40 min on an orbital shaker. The membrane was washed as above 
and investigated by chemiluminescence using 1 mL of substrate from the Immun-Star goat anti-
rabbit IgG (H + L) Detection Kit (Bio-Rad). A 30 s exposure on Kodak Biomax XAR film 
(Sigma-Aldrich) was used to detect anti-TKS antibodies in protein extract solutions. 
3.2.4.6 Activity of Ammonium Sulfate Trichome Protein Fractions 
Trichome protein extracts were assayed by incubating 50 µL of the resuspended solutions (0%, 
20%, 40%, 60%, 80%, and remaining supernatant) with 0.3 mM malonyl-CoA and 0.3 mM 
hexanoyl-CoA. A TKS positive control was used by assaying 25 µg of TKS in the presence of 
0.2 mM malonyl-CoA and 0.2 mM hexanoyl-CoA. A 50 µL aliquot from the 20% fraction was 
assayed in the absence of hexanoyl-CoA and used as a negative control. Reactions were started 
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by adding the appropriate fraction (or TKS), and proceeded for 60 min at 40°C. Reaction 
mixtures were prepared for HPLC as described in Section 3.1.3. 
3.2.4.7 Co-Immunoprecipitation of TKS 
Experiments were conducted with a Co-immunoprecipitation Kit (ThermoScientific) using 4 mL 
of rabbit anti-TKS antibodies (see Section 3.1.4.5) purified as directed by the manufacturer. 
Purified IgG was desalted using two 5 mL D-Salt Excellulose Desalting Columns equilibrated 
with 100 mM PBS [pH 7.3]. Purified antibodies were bound to a Cyanogen Bromide-Activated 
Sepharose 4B (CNBR) column. Purified IgG (50 µg) was used during column preparation. Two 
other columns were also prepared but did not include the use of antibodies, and were used as 1) a 
negative control, 2) a pre-binding column to minimize binding that could result from non-
specific interactions between the resin and the sample. Resin and antibodies were incubated for 
90 min at RT on an orbital shaker. The resin columns were washed six times, and rinsed once 
with 1x coupling buffer. Columns were washed three more times using 200 µL of wash buffer 
before further use. Initially, the columns were tested for their efficiency in binding recombinant 
TKS. Two samples of crudely purified TKS (100 µg) were used to determine the specificity of 
the prepared columns. The 0.5 µL samples were diluted to 400x (200 µL) before applying them 
to either column 1) containing control resin, or 2) pre-bind column. Following centrifugation, the 
flow-through was either 1) saved for further analysis in the case of the negative control, or 2) 
passed through the column containing IgG-bound resin which was incubated 2 h on a shaker at 
RT. All columns were washed four times with wash buffer, followed by three elutions using 20 
µL of elution buffer. All fractions were saved for analysis by SDS-PAGE. 20 µL from each 
fraction were incubated for 3 min at 98°C in the presence of 5 µL of the provided SDS-PAGE 
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loading buffer. Samples from each column were loaded onto separate 10% acrylamide gels and 
subjected to electrophoresis for 30 min at 200 V. Gels were stained using BioSafe coomassie 
blue (Bio-Rad) for 1 h, and washed overnight using dH20.  
Trichome extracts were prepared as previously described in Section 3.1.4.2. A total of 
500 µL of trichome extract was divided into two equal portions and applied to either 1) negative 
control IP column, or 2) pre-bind IP column. The pre-bind sample was incubated for 60 min at 
4°C upright on a shaker, and then centrifuged at 1,500 g for 90 s. The flow-through was 
collected. The pre-bind column was washed four times, then eluted using 3 x 1 mL elution 
buffer. Flow-through from the pre-bind column was applied to the antibody-bound resin IP 
column and allowed to incubate overnight at 4°C alongside the negative control upright on a 
shaker. Columns were later washed four times using 200 µL of IP wash/lysis buffer, followed by 
centrifugation of 1,500 g for 90 s after each wash. A 30 µL volume of elution buffer was added 
to each column, and after 5 min columns were centrifuged at 1,500 g for 5 min.  Two more 
elutions using 20 µL elution buffer were performed, before columns were washed and placed in 
1x coupling buffer for storage at 4°C. A total of 20 µL from each column fraction (flow-through, 
washes, and eluted fractions) were heated with 5 µL of sample loading buffer for 5 min at 98°C. 
Samples were analyzed by SDS-PAGE as described in Section 3.1.4.5.  
3.2.4.8 Protein Pull-Downs of Trichome Protein Extracts 
This experiment used bacterial lysate that had already undergone TKS purification as previously 
described (Section 3.1.1.). A second round of TKS purification was performed using the lysate, 
which was tumbled with 1 mL Talon beads at 4°C for 40 min. The beads were washed five times 
using 10 mL wash buffer and transferred to a 10 mL gravity flow column. A 200 µL aliquot of 
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trichome extract that had been previously prepared (Section 3.1.4.2) was thawed, transferred to 
the 10 mL gravity flow column and shaken for 1 h at RT. The gravity flow column was washed 
three times using 10 mL wash buffer each time. Proteins were eluted using 10 mL elution buffer. 
The solutions were concentrated to a 200 µL volume using a YM10 centrifugal filter device 
(Millipore), and desalted by resuspending the solution in 3 mL of 100 mM HEPES [pH 7.5], and 
then concentrating to a 200 µL volume. Eluted proteins were compared by SDS-PAGE to a 
sample of purified TKS obtained from the first round of purification, and to untreated trichome 
extracts. Samples included (separate) 2 µg TKS, 3 µg of eluted proteins, 6 µg of eluted proteins, 
1 µg of trichome protein, and 2 µg of trichome protein, which were each heated to 95°C for 5 
min in the presence of sample loading buffer prior to loading them onto a 10% acrylamide gel. 
Proteins were analyzed by SDS-PAGE as previously described in Section 3.1.4.5.  
3.2.5 Cloning and Assaying of Candidate Cyclases 
3.2.5.1 Cloning and Expression of Candidate Cyclases 
Chi-like, mlp-like, and oac (Table 3.1) were PCR-amplified using the primers described in Table 
3.2 and conditions outlined in Table 3.3. Whereas chi and mlp were cloned using Phusion High 
Fidelity DNA Polymerase (Finnzymes), each oac construct was amplified using Pfu Ultra II 
DNA Polymerase (Stratagene). Amplicons were A-tailed by incubating with Taq polymerase 
(Invitrogen) in the presence of 5 mM dATP for 30 min at 72°C and purified using a QIAquick 
Spin PCR Purification Kit (Qiagen). Following electrophoresis in 0.8% agarose, single bands 
were excised and cleaned using a MinElute PCR Purification Kit (Qiagen) before being either 
ligated into the linear pCR8GW entry vector (Invitrogen) or, in the case of OAC, cloned directly 
into pET100 (see Table 3.3). Plasmids were used to transform E. coli One Shot Top10 
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Table 3.2 Primers used during cloning of CHI-like, MLP-like, and OAC constructs 
Gene Forward Primer Reverse Primer 
chi-like ATGGCAACCTCAGATGGAAGC TTAGAAGAGAGAAAGCATGGA 
mlp-like ATGGGTGTTTTCACTTACG TTAGTTGTAAGCTTCAGGGTG 
oac/DABB1 CACCATGGCAGTGAAGCATTTGATTGTATTG CTTTCGTGGTGTGTAGTCAAAAATGAGAAG 
oac/DABB2 ATGGCAGTGAAGCATTTGATT CTACTTTCGTGGTGTGTAGTC 
1 - Original pET100 based OAC construct. 
2 - pHIS8GW based OAC construct. 
 
 
Table 3.3 Details regarding the creation of CHI-like, MLP-like, and OAC constructs 
Gene Template Melting1 Annealing1 Elongation1 Destination Selection2 
chi-like CL8contig1
3 98°C/30s 60°C/10s 78°C/15s pHIS8GW KanR 
mlp-like pJS16
3,4 98°C/30s 55°C/30s 72°C/30s pDEST17 AmpR 
oac/DABB5 CL2contig13 95°C/20s 55°C/20s 72°C/60s pET100 AmpR 
oac/DABB6 pET100-OAC 95°C/20s 50°C/20s 72°C/18s pHIS8GW KanR 
1 - The reactions were cycled 30-35 times before ending with 7 min at 72°C. 
2 - Antibiotic resistance markers include Kanamycin (Kan
R
) and Ampicillin (Amp
R
). 
3 - Originally derived from cDNA 
4 - An out-of-frame mlp-like construct originally cloned by Jake Stout from trichome cDNA template. 
5 - Original pET100 based OAC construct. 
6 - pHIS8GW based OAC construct 
 
Competent Cells (Invitrogen), and transformants were plated onto LB containing 50 µg/mL 
spectinomycin (or 100 µg/mL ampicillin for pET100 construct), and grown overnight at 37°C. 
Colonies were selected for each construct and grown overnight under selective pressure at 37°C. 
Plasmids were isolated and sequenced as previously described (Section 3.1.1). Following 
sequence confirmation, genes were transferred from the entry vector into the appropriate 
destination vector by LR reaction following the manufacturer’s directions (Invitrogen) (see Table 
3.3), and the resulting plasmids transformed into E. coli Rosetta2 BL21(DE3)pLysS Competent 
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Cells (Novagen Biosciences). Transformants were cultured with the appropriate antibiotic, 
cultures were induced, and proteins purified as previously described (Section 3.1.1). 
3.2.5.2 Assaying TKS in the Presence of Candidate Cyclases 
Reactions used 100 pmol of TKS (ca. 5 µg) and either 500 pmol of CHI-like, MLP-like, OAC, or 
in the case of negative controls, no protein, and were conducted for 1 h at 30°C. Samples were 
prepared and analyzed by LCMS in triplicate as described in Section 3.1.3. 
 
3.3 Results 
3.3.1 Tetraketide Synthase (TKS) 
TKS contains 385 amino acids (AAs) and is a 43 kDa protein with a 6.04 pI (47 kDa and 6.58 pI 
with histidine tag). A BLASTP homology search of the NCBI non-redundant database reveals 
TKS to be 100% identical to PKSG4 (annotated ACD76855) (Flores-Sanchez et al., 2010), and 
similar to several Cannabis homologs, including OLS (annotated BAG14339; 385 AAs; 99% 
identity to TKS in 385 AA overlap). These enzymes belong to a superfamily of condensing 
enzymes (cl09938) that contain a conserved CHS-like domain (cd00831) attributed to plant 
specific type III PKSs. TKS belongs to a subset of type III PKSs that do not produce chalcone 
and are markedly different than other cannabis CHSs previously reported in the literature 
(annotated AAL92879; 389 AA; 68.9% identity over a 379 AA subset with TKS)  (Raharjo et 
al., 2004b), (annotated ACT10338; 392 AA; 66.0% identity in 377 AA overlap with TKS) 
(Marks et al., 2009). An alignment of known cannabis type III PKSs highlights differences in 
their amino acid sequence (Figure 3.1).   
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TKS        1 ---------MNHLRAEGPASVLAIGTANPENILIQDEFPDYYFRVTKSEHMTQLKEKFRK 
PKSG4      1 ---------MNHLRAEGPASVLAIGTANPENILIQDEFPDYYFRVTKSEHMTQLKEKFRK 
PKSG1      1 ---------MNHLRAEGPASVLAIGTANPENILIQDEFPDYYFRVTKSEHMTQLKEKFRK 
PKSG5      1 ---------MNHLRAEGPASVLAIGTANPENILIQDEFPDYYFRVTKSEHMTQLKEKFRK 
PKSG2      1 ---------MNHLRAEGPASVLAIGTANPENILIQDEFPDYYFRVTKSEHMTQLKEKFRK 
PKSF3      1 ---------MNHLRAEGPASVLAIGTANPENILIQDEFPDYYFRVTKSEHMTQLKEKFRK 
OLS        1 ---------MNHLRAEGPASVLAIGTANPENILLQDEFPDYYFRVTKSEHMTQLKEKFRK 
CAN383     1 MASISVDQIRKAQRANGPATVLAIGTANPPTSFYQADYPDFYFRVTKNQHMTELKDKFKR 
CHS2004    1 --MVTVEEFRKAQRAEGPATIMAIGTATPANCVLQSEYPDYYFRITNSEHKTELKEKFKR 
 
TKS       52 ICDKSMIRKRNCFLNEEHLKQNPRLVEHEMQTLDARQDMLVVEVPKLGKDACAKAIKEWG 
PKSG4     52 ICDKSMIRKRNCFLNEEHLKQNPRLVEHEMQTLDARQDMLVVEVPKLGKDACAKAIKEWG 
PKSG1     52 ICDKSMIRKRNIFLNEEHLKQNPKLVEHDVQTLDARQDMLVVEVPKLGKDACAKAIKEWG 
PKSG5     52 ICDKSMIRKRNCFLNEEHLKQNPRLVEHEMQTLDARQDMLVVEVPKLGKDACAKAIKEWG 
PKSG2     52 ICDKSMIRKRNCFLNEEHLKQNPRLVEHEMQTLDARQDMLVVEVPKLGKDACAKAIKEWG 
PKSF3     52 ICDKSMIRKRNCFLNEEHLKQNPRLVEHEMQTLDARQDMLVVEVPKLGKDACAKAIKEWG 
OLS       52 ICDKSMIRKRNCFLNEEHLKQNPRLVEHEMQTLDARQDMLVVEVPKLGKDACAKAIKEWG 
CAN383    61 ICEKTTIKKRHLYLTEDRLNQHPNLLEYMAPSLNTRQDMLVVEIPKLGKEAAMKAIKEWG 
CHS2004   59 MCDKSMIRKRYMHLTEEILKENPNLCAYEAPSLDARQDMVVVEVPKLGKEAATKAIKEWG 
 
TKS      112 QPKSKITHLIFTSASTTDMPGADYHCAKLLGLSPSVKRVMMYQLGCYGGGTVLRIAKDIA 
PKSG4    112 QPKSKITHLIFTSASTTDMPGADYHCAKLLGLSPSVKRVMMYQLGCYGGGTVLRIAKDIA 
PKSG1    112 QPKSKITHLIFTSASTTDMPGADYHCAKLLGLSPSVKRVMMYQLGCYGGGTVLRIAKDIA 
PKSG5    112 QPKSKITHLIFTSASTTDMPGADYHCAKLLGLSPSVKRVMMYQLGCYGGGTVLRIAKDIA 
PKSG2    112 QPKSKITHLIFTSASTTDMPGADYHCAKLLGLSPSVKRVMMYQLGCYGGGTVLRIAKDIA 
PKSF3    112 QPKSKITHLIFTSASTTDMPGADYHCAKLLGLSPSVKRVMMYQLGCYGGGTVLRIAKDIA 
OLS      112 QPKSKITHLIFTSASTTDMPGADYHCAKLLGLSPSVKRVMMYQLGCYGGGTVLRIAKDIA 
CAN383   121 QPKSRITHLIFCSTNGVDMPGADYECAKLLGLSSSVKRVMLYQQGCHAGGSVLRIAKDLA 
CHS2004  119 QPKSKITHLVFCTTSGVDMPGADYQLTKLLGLRPSVKRLMMYQQGCFAGGTVLRLAKDLA 
 
 
TKS      172 ENNKGARVLAVCCDIMACLFRGPSDSDLELLVGQAIFGDGAAAVIVGAEPDESVGERPIF 
PKSG4    172 ENNKGARVLAVCCDIMACLFRGPSDSDLELLVGQAIFGDGAAAVIVGAEPDESVGERPIF 
PKSG1    172 ENNKGARVLAVCCDIMACLFRGPSDSDLELLVGQAIFGDGAAAVIVGAEPDESVGERPIF 
PKSG5    172 ENNKGARVLAVCCDIMACLFRGPSDSDLELLVGQAIFGDGAAAVIVGAEPDESVGERPIF 
PKSG2    172 ENNKGARVLAVCCDMTACLFRGPSDSNLELLVGQAIFGDGAAAVIVGAEPDESVGERPIF 
PKSF3    172 ENNKGARVLAVCCDIMACLFRGPSDSDLELLVGQAIFGDGAAAVIVGAEPDESVGERPIF 
OLS      172 ENNKGARVLAVCCDIMACLFRGPSESDLELLVGQAIFGDGAAAVIVGAEPDESVGERPIF 
CAN383   181 ENNKGARILTINSEITIGIFHSPDETYFDGMVGQALFGDGASATIVGADPDKEIGERPVF 
CHS2004  179 ENNKGARVLVVCSEITAVTFRGPNDTHLDSLVGQALFGDGSAALIVGSDPIPEV-EKPIF 
 
TKS      232 ELVSTGQTILPNSEGTIGGHIREAGLIFDLHKDVPMLISNNIEKCLIEAFTPIGISDWNS 
PKSG4    232 ELVSTGQTILPNSEGTIGGHIREAGLIFDLHKDVPMLISNNIEKCLIEAFTPIGISDWNS 
PKSG1    232 ELVSTGQTILPNSEGTIGGHIREAGLIFDLHKDVPMLISNNIEKCLIEAFTPIGISDWNS 
PKSG5    232 ELVSTGQTILPNSEGTIGGHIREAGLIFDLHKDVPMLISNNIEKCLIEAFTPIGISDWNS 
PKSG2    232 ELVSTGQTFLPNSEGTIGGHIREAGLMFDLHKDVPMLISNNIEKCLIEAFTPIGISDWNS 
PKSF3    232 ELVSTGQTILPNSEGTIGGHIREAGLIFDLHKDVPMLISNNIEKCLIEAFTPIGISDWNS 
OLS      232 ELVSTGQTILPNSEGTIGGHIREAGLIFDLHKDVPMLISNNIEKCLIEAFTPIGISDWNS 
CAN383   241 EMVSAAQEFIPNSDGAVDGHLTEAGLVYHIHKDVPGLISKNIEKSLVEALNPIGISDWNS 
CHS2004  238 ELVSAAQTILPDSDGAIDGHLREVGLTFHLLKDVPGLISKNIEKSLNEAFKPLGISDWNS 
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TKS      292 IFWITHPGGKAILDKVEEKLDLKKEKFVDSRHVLSEHGNMSSSTVLFVMDELRKRSLEEG 
PKSG4    292 IFWITHPGGKAILDKVEEKLDLKKEKFVDSRHVLSEHGNMSSSTVLFVMDELRKRSLEEG 
PKSG1    292 IFWITHPGGKAILDKVEEKLHLKSDKFVDSRHVLSEHGNMSSSTVLFVMDELRKRSLEEG 
PKSG5    292 IFWITHPGGKAILDKVEEKLHLKKEKFVDSRHVLSEHGNMSSSTVLFVMDELRKRSLEEG 
PKSG2    292 IFWITHPGGKAILDKVEEKLHLKSDKFVDSRHVLSEHGNMSSSTVLFVMDELRKRSLEEG 
PKSF3    292 IFWITHPGGKAILDKVEEKLHLKSDKFVDSRHVLSEHGNMSSSTVLFVMDELRKRSLEEG 
OLS      292 IFWITHPGGKAILDKVEEKLHLKSDKFVDSRHVLSEHGNMSSSTVLFVMDELRKRSLEEG 
CAN383   301 LFWIVHPGGPAILNAVEAKLHLKKEKMADTRHVLSEYGNMSSVSIFFIMDKLRKRSLEEG 
CHS2004  298 LFWIAHPGGPAILDQVESKLALKTEKLRATRHVLSEYGNMSSACVLFILDEMRRKCVEDG 
 
TKS      352 KSTTGDGFEWGVLFGFGPGLTVERVVVRSVPIKY 
PKSG4    352 KSTTGDGFEWGVLFGFGPGLTVERVVVRSVPIKY 
PKSG1    352 KSTTGDGFEWGVLFGFGPGLTVERVVVRSVPIKY 
PKSG5    352 KSTTGDGFEWGVLFGFGPGLTVETVVLRSVPINY 
PKSG2    352 KSTTGDGFEWGVLFGFGPGLTVERVVLRSVPINY 
PKSF3    352 KSTTGDGFEWGVLFGFGPGLTVERVVVRSVPIKY 
OLS      352 KSTTGDGFEWGVLFGFGPGLTVERVVVRSVPIKY 
CAN383   361 KSTTGDGFEWGVLFGFGPGLTVETIVLHSLAN-- 
CHS2004  358 LNTTGEGLEWGVLFGFGPGLTVETVVLHSVAI— 
 
Figure 3.1  Alignment of TKS and other cannabis PKS homologs. 
TKS was aligned with other reported cannabis PKSs using Clustal Omega (Sievers et al., 2011) 
and Boxshade software. The alignment members are PKSG1 (annotated ACD76853), PKSG2 
(annotated ACD76854), PKSF3 (annotated ACD76852), PKSG4 (annotated ACD76855), 
PKSG5 (annotated ACD76856) (Flores-Sanchez et al., 2010), OLS (annotated BAG14339) 
(Taura et al., 2009), CAN383 (annotated ACT10338) (Marks et al., 2009), and CHS2004 
(annotated ACT10338) (Raharjo et al., 2004b). Residues which differ from the consensus are 
depicted in blue if they share similarity with the consensus; residues that do not share similarity 
are depicted in red. TKS and PKSG4 share 100% identity. 
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3.3.2 Expression and Purification of TKS 
TKS was purified to near homogeneity by exploiting a poly-histidine tag by IMAC using Talon. 
The expression and purification of TKS gave yields typically reaching 20 mg/L. Purified TKS 
was visualized by SDS-PAGE on a 10% acrylamide gel (Figure 3.2). 
 
Figure 3.2  Expression and purification of TKS. 
The SDS-PAGE analysis of a (MW) BioRad Dual Color protein marker and samples taken 
during the pre-induction (pre) and post-induction (post) stages of E. coli BL21 cell cultures 
harboring CsTks, and from 1 mL eluents of IMAC purified TKS from Talon resin (lanes 1 to 7). 
Purified TKS migrated at its estimated 46.5 kDa size. 
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3.3.3 TKS produces HTAL, PDAL, and olivetol 
Different analytical methods were explored to determine which could best detect TKS assay 
products including the use of radio-labeled 
14
C-malonyl-CoA and reverse-phase thin-layer 
chromatography (Figure 3.3). The analysis of assay products by reverse-phase thin-layer 
chromatography indicated the production of three compounds assumed to be HTAL, PDAL, and 
olivetol, although it was determined that the use of an HPLC, and later LCMS, proved a better 
option for analysis since it is capable of superior product resolution, quantification, and mass 
confirmation (Figure 3.4). The use of authentic standards (Sigma) allowed for the identification 
and quantification of the three compounds produced during TKS assays: hexanoyl triacetic acid 
lactone (HTAL), pentyl-diacetic acid lactone (PDAL), and olivetol, but no OA was produced 
(Figure 3.4). These results confirm that olivetol synthase activity as reported by Taura et al., 
(2009) and Marks et al., (2009) is also present in TKS.  Standard and product LCMS traces, 
along with their UV spectra and masses are shown in Figure 3.4. The MS characteristics of 
HTAL, PDAL, OA, and olivetol were also analyzed by SIR is ES
+
 mode (Section 3.1.3 for 
details) (Figure 3.5). Note that the results shown in Figures 3.4 and 3.5 are from assays 
conducted once LCMS methods were well developed, and earlier results (such as seen in Figures 
3.13and 3.15), which were based only on HPLC analysis, have product retention times that 
slightly differ from later LCMS analysis. TKS assays accumulated PDAL, olivetol and HTAL in 
a ratio of 10:5:1, respectively. Although the ratio of triketide:tetraketide production varied during 
the intial characterization of TKS, the production of PDAL was always greater through all 
experiments performed. 
  
  
58 
 
 
Figure 3.3  Reverse phase radio TLC analysis of TKS assay products. 
Reverse-phase thin layer chromatography (TLC) was used to separate TKS assay products 
(HTAL, PDAL, and olivetol) which were analyzed by (A) phosphorimaging and (B) radioactive 
scanning. Products detected are assumed to be (1) HTAL, (2) PDAL, and (3) olivetol, where (0) 
is the origin. Further developments of these methods were abandoned for HPLC and LCMS 
methods which led to a better resolution of the products. 
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Figure 3.4  LCMS analysis of standards and TKS products. 
(A) LC chromatograms for TKS assay products (black) and standards (red) are overlayed to 
emphasize the similarity in retention times, except for OA which was absent in TKS assays. (B) 
An LCMS chromatogram of the standards used in this study indicate the retention times, UV 
spectra and extracted ion profiles for HTAL (5.2 min; UVmax 285 nm; m/z 225), PDAL (5.6 min; 
UVmax 287 nm; m/z 183), OA (9.0 min; UVmax 263 nm; m/z 225.), and olivetol (10.2 min; UVmax 
276 nm; m/z 181) and used to confirm the identities of (C) TKS assay products shown in a 
similar LCMS trace. 
0.00 
0.02 
0.04 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
ab
so
rb
an
ce
 a
t 
2
7
0
 n
m
 
time (min) 
A TKS standards 
HTAL PDAL 
olivetolic acid 
olivetol 
0.005 
0.015 
0.025 
0.035 
0.045 
4 5 6 7 8 9 10 11 12 
ab
so
rb
an
ce
 a
t 
2
7
0
 n
m
 
time (min) 
B 
200       600      1000 
225.05 
200       300        400 
285.8 
5.3 min   HTAL 
nm 
m/z 
6.0 min   PDAL 
287.0 
200       300        400 
nm 
183.01 
200       600      1000 
m/z 
200       300        400 
nm 
200       600      1000 
m/z 
9.0 min OA 
225.2 
263.3 
200       300        400 
nm 
10.2 min olivetol 
276.3 
200       600      1000 
m/z 
180.99 
0 
0.02 
0.04 
0.06 
4 5 6 7 8 9 10 11 12 
ab
so
rb
an
ce
  
at
 2
7
0
 n
m
 
time (min) 
C 
225.05 
200      600      1000 
200        300         400 
284.6 
5.2 min   HTAL 
nm 
m/z 
182.96 
287.0 
5.9 min   PDAL 
200       600      1000 
m/z 
10.2 min  olivetol 
180.99 
276.3 
200       600      1000 
m/z 
200        300         400 
nm 
200        300         400 
nm 
  
60 
 
 
Figure 3.5  Selected ion monitoring of TKS assay products. 
LCMS was used to confirm the identity of HTAL, PDAL and olivetol produced during TKS 
assays. (A) PDA results align well with selected ion monitoring in ES
+
 mode which was capable 
of detecting (B) olivetol (10.2 min; m/z 180.91), (C) PDAL (5.9 min; m/z 182.96), and (D) 
HTAL (5.2 min; m/z 224.95). Another peak (5.9 min) detected during (D) selected ion 
monitoring at 224.95 m/z is attributed to acetonitrile:PDAL adduct formation. 
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3.3.3.1 Quantification of TKS products 
Quantification of TKS reactions products (HTAL, PDAL, OA, and olivetol) was performed 
using the standard curves presented in Appendix A.  These standard curves were used to 
determine product yields (pmol) from assays conducted throughout this study. 
3.3.3.2 Buffers and pH 
The effect of buffering agents and pH on TKS activity was examined by assaying TKS in a 
series of buffers that overlapped in pH ranges (Figure 3.6). Assay results indicate that although 
olivetol production increases at a lower pH (ca. 6.0) in phosphate and MES buffers, similar 
results could be obtained by using HEPES at pH 7.0. The pH optimum for product formation was 
also analyzed by surveying TKS activity in ADA buffer between pH 5.7 – 7.8 allowing for a 
better pH range using only one buffer. The maximum production of tetraketides (HTAL and 
olivetol) occurred at a pH 6.4, whereas maximum PDAL production was at pH 7.3 (Figure 3.7). 
No OA production was observed. 
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Figure 3.6  TKS products in different pH and buffers. 
TKS product formation was first assessed in a pH range of 6.5 – 9.0 using a variety of buffers. 
HEPES [pH 7.0] was determined to be the most stable buffer with respect to TKS activity based 
on this data set. Error bars represent SD where n=3. 
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Figure 3.7  TKS product formation in ADA buffer. 
The accumulation of TKS products was monitored between pH 5.7 and 7.8 in 20 mM ADA 
buffer. Product analysis for (A) HTAL, (B) PDAL, and (C) olivetol are shown in the 
corresponding panel. Error bars represent SD where n=3. 
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3.3.3.3 Temperature 
To determine the effect temperature had on TKS activity, assays were performed between 10°C 
and 50°C in 100 mM HEPES buffer at pH 7.5. This pH was chosen since it corresponded to the 
maximum tetraketide production. Olivetol production appeared static until 40°C, but decreased 
at 50°C (Figure 3.8). Comparatively, HTAL and PDAL synthase activity appeared to increase 
until 40°C. PDAL production was slightly reduced 50°C, whereas HTAL production was 
approximately the same as seen in assays conducted at 40°C. 
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Figure 3.8  Temperature affects TKS product formation. 
The accumulation of TKS products HTAL (red), PDAL (blue) and olivetol (green) was 
determined between 10 to 50°C. Assays were conducted in 100 mM HEPES [pH 7.5] in the 
presence of 0.2 mM malonyl-CoA and 0.2 mM hexanoyl-CoA. Vertical axis is split to show 
smaller amounts of product accumulation. Error bars represent the SD where n=3. 
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3.3.3.4 Substrate Availabilty 
TKS was also assayed in the presence of 0.10 to 1.0 mM malonyl-CoA while 0.2 mM hexanoyl-
CoA was maintained, and similarly in the presence of 0.10 – 1.0 mM hexanoyl-CoA while 0.2 
mM malonyl-CoA was maintained. The concentration of both malonyl-CoA and hexanoyl-CoA 
affected the chemoselectivity of the TKS reaction. No product was detected when 0.10 mM 
malonyl-CoA was used in assays, but an increase in malonyl-CoA concentration correlated with 
an increase in product formation, except for PDAL which slightly decreased when 1.0 mM 
malonyl-CoA was used (Figure 3.9). Maximum PDAL production (938 ± 123 pmol) was 
detected when TKS was assayed with of 0.5 mM malonyl-CoA and 0.2 mM hexanoyl-CoA. 
Both HTAL (54 ± 8.4 pmol) and olivetol (79.0 ± 26.5 pmol) production were increased when 
TKS was assayed with 1.0 mM malonyl-CoA.  
The availability of hexanoyl-CoA also affected TKS product formation (Figure 3.10). 
Olivetol accumulated to greater amounts as hexanoyl-CoA increased, whereas HTAL and PDAL 
production peaked at 0.2 mM hexanoyl-CoA.  
Product ratios used to assess TKS triketide:tetraketide chemoselectivity indicate PDAL is 
preferentially formed when TKS was assayed with 0.1 mM hexanoyl-CoA and 0.2 mM malonyl-
CoA (Table 3.4). Conversely, increasing either malonyl-CoA or hexanoyl-CoA concentrations to 
1.0 mM resulted in the increased synthesis of tetraketides. Product ratios were also used to 
evaluate HTAL:olivetol chemoselectivity, which clearly reflect the preferential production of 
olivetol when hexanoyl-CoA concentrations were raised (Table 3.4). The triketide:tetraketide 
ratio represents total PDAL divided by the sum of HTAL and olivetol. 
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Figure 3.9  TKS product formation in varying malonyl-CoA concentrations. 
The amount of TKS products HTAL (red), PDAL (blue), and olivetol (green) were determined 
after TKS was assayed in the presence of 0.2 mM hexanoyl-CoA and 0.1 to 1.0 mM malonyl-
CoA. Vertical axis is split to show smaller amounts of product. Error bars are the SD where n=3. 
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Figure 3.10 TKS product formation in varying hexanoyl-CoA concentrations. 
The amount of TKS products HTAL (red), PDAL (blue), and olivetol (green) were determined 
after TKS was assayed in the presence of 0.2 mM malonyl-CoA and 0.1 to 1.0 mM hexanoyl-
CoA. Vertical axis is split to show smaller amounts of product. Error bars are the SD where n=3. 
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Table 3.4 Ratios of product formed during TKS assays. 
 
triketide : tetraketide* HTAL : olivetol 
0.1 mM malonyl-CoA nd nd 
0.2 mM malonyl-CoA 11.4 0.31 
0.5 mM malonyl-CoA 11.6 0.59 
1.0 mM malonyl-CoA 6.2 0.68 
   0.1 mM hexanoyl-CoA 13.2 0.42 
0.2 mM hexanoyl-CoA 11.4 0.31 
0.5 mM hexanoyl-CoA 9.3 0.20 
1.0 mM hexanoyl-CoA 7.1 0.11 
* Ratios for triketide/tetraketide were determined by comparing the amount of PDAL by the sum 
amount of HTAL and olivetol derived from Figure 3.9 and 3.10. 
nd = not detected. 
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3.3.3.5 TKS Activity in the Presence of DTT 
The use of dithiothreitol (DTT) and β-mercaptoethanol (βME) during protein purification, as 
well as the use of DTT in TKS assays, required an analysis of the potential deleterious effects 
caused by these strong reducing agents. Two solutions of TKS derived from the same culture 
were purified in tandem; one in the presence of reducing agents (DTT and βME), the other in 
their absence. Both protein solutions (± DTT/ βME) were assayed in increasing concentrations of 
DTT and product formation was monitored. TKS purified in the absence of DTT and βME 
possessed < 70% activity of TKS purified in the presence of DTT and βME (Figure 3.11). The 
addition of 5 mM DTT to TKS assays increased HTAL and PDAL production by 69% and 56%, 
respectively, although olivetol formation decreased by 10%. TKS activity was reduced when 
DTT concentrations exceeded 5 mM, and resulted in the least amount of product when TKS was 
assayed in the presence of 100 mM DTT. 
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Figure 3.11 TKS in the presence and absence of DTT and βME during purification. 
Two different preparations of recombinant TKS were assayed; one purified with DTT and βME 
(black), the other purified without DTT and βME (grey). Assays were conducted in increasing 
concentrations of DTT (0 to 100 mM) to determine if TKS product formation would be affected. 
Panels show the production of (A) HTAL, (B) PDAL, and (C) olivetol. Error bars are the SD 
where n=3.  
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3.3.4 OA Production by Trichome Protein Extracts 
Protein extracts from isolated trichomes obtained from drug-type and USO-31 hemp plants were 
separately assayed. Trace amounts of OA were detected in both samples by HPLC analysis 
implying OA synthase activity (Figure 3.12). Whereas USO-31 hemp trichome extracts 
accumulated HTAL, PDAL, OA and olivetol, no olivetol was detected in drug-type trichome 
extracts. In an attempt to increase the synthesis of assay products, trichome protein extracts 
obtained from USO-31 hemp were assayed in a scaled-up reaction using ten times more the 
starting materials than previous assays (Figure 3.12). In this larger reaction, HTAL, PDAL, OA, 
and olivetol accumulated to a ratio of 1:4:1:2, respectively. Absolute amounts were determined 
to be 167 pmol HTAL, 658 pmol PDAL, 161 pmol OA, and 318 pmol of olivetol.  
Drug-type trichome activity was further investigated in the presence and absence of 
recombinant TKS. Reactions used the same amount of TKS and/or trichome extracts in each 
assay. Trichome extracts, when assayed in the presence of TKS, produced 638% more OA than 
trichome extracts alone (Figure 3.13). HTAL and olivetol yields were also greater in the 
combined assays than in assays performed using only trichome protein (858% and 616%, 
respectively) or recombinant TKS (209% and 180%, respectively). The ratio of 
triketides/tetraketides formed was also markedly different when TKS was assayed alone (ratio 
8:1), than when trichome extracts were assayed in the absence or presence of TKS (ratio 1:4 and 
1:0, respectively). The HTAL:PDAL:OA:olivetol product ratio for: recombinant TKS assays was 
1:45:0:4; trichome protein extracts was 1:7:2:5; for trichome protein extracts in the presence of 
recombinant TKS was 1:9:2:4. 
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Figure 3.12 Assays of cannabis trichome protein extracts 
(A) HPLC chromatograms of products formed during cannabis trichome extract assays indicate 
the accumulation of OA when compared to an OA standard, except for trichomes assayed in the 
absence of malonyl-CoA (negative control). (B) An LC chromatogram of products formed 
during a larger USO-31 hemp trichome extract assay clearly detected HTAL, PDAL, olivetol, 
and OA. 
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Figure 3.13 Drug-type trichome extracts assayed with recombinant TKS. 
Product yields obtained when TKS and trichome extracts were assayed together or alone indicate 
the amount of HTAL (red), PDAL (blue), OA (purple), and olivetol (green) detected. Vertical 
axis is split to show smaller amounts of product accumulation. 
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3.3.4.1 Ammonium Sulfate Precipitation of Drug-Type Trichome Protein Extracts 
Once it was determined that trichomes possess OA synthase activity (Figure 3.12), ammonium 
sulfate was used to precipitate trichome proteins, which might have been able to separate olivetol 
and OA synthase activity, thus implying that separate proteins are required during OA 
biosynthesis. A protein solution obtained from isolated trichomes was precipitated using 
increasing amounts of ammonium sulfate (20%, 40%, 60%, and 80% w/v) followed by 
centrifugation. The precipitates were resuspended in 100 mM HEPES buffer [pH 7.5]. An aliquot 
from each fraction, along with a sample of the remaining supernatant was separated by 
electrophoresis before being transferred to a PVDF membrane (Figure 3.14A and 3.14B). A 
Western blot was then performed using polyclonal αTKS antibodies, and showed that the 
greatest accumulation of TKS occurred in the 80% cut (Figure 3.14). Polyclonal αTKS 
antibodies also detected impurities in recombinant TKS samples, and to a lesser degree, in each 
of the precipitated fractions.  
The precipitated protein fractions, along with the remaining unprecipitated supernatant 
and a positive TKS control, were separately assayed in the presence of hexanoyl-CoA and 
malonyl-CoA to determine if any of the precipitated protein fractions retained OA synthase 
activity. Resuspended protein derived from the 80% salt cut had OA synthase activity, but other 
fractions, including the supernatant, had neither TKS nor OA synthase activity, except for what 
appeared to be a trace amount of OA detected in the 0% fraction (Figure 3.14).  
Due to the lack of PDAL, HTAL, and olivetol, the appearance of what appears to be OA 
in 0% ammonium sulfate fractions is believed to be a contaminant. 
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Figure 3.14 Activity of trichome protein extracts in ammonium sulfate. 
(A) 10% SDS-PAGE of equal volume of trichome protein precipitates occurring at 0%, 20%, 
40%, 60%, and 80% ammonium sulfate fractions were run with Protein Ladder (MW), 1 µg of 
recombinant TKS (TKS), and an aliquot of unprecipitated supernatant obtained from post 80% 
ammonium sulfate treatments (S). TKS is circled in red. (B) A Western blot obtained after 
transferring proteins from (A) to a PVDF membrane indicates the majority of TKS is detected in 
80% ammonium sulfate fractions. (C) HPLC traces of assay products produced from 
recombinant TKS and trichome extracts obtained from the ammonium sulfate precipitates are 
offset for comparison. 
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3.3.4.2 The Co-Immunoprecipitation of Trichome Protein Extracts 
Polyclonal αTKS antibodies were used in co-immunoprecipitation experiments designed to 
retrieve TKS and potentially interacting proteins from drug-type trichome protein extracts. 
Purified rabbit IgG anti-TKS antibody-linked resin were incubated with either 1) a crude 
recombinant TKS solution, or 2) a protein solution extracted from isolated trichomes. Control 
resin was also used to determine non-specific protein binding to the resin. The antibody-linked 
resin was capable of successfully binding TKS from solutions, as seen when SDS-PAGE with 
Coomassie stain was used to visualize proteins (Figure 3.15). Another protein of (ca.) 60 kDa 
was also purified from both recombinant and trichome extracts, and sent to the PBI mass 
spectrometry lab for Q-TOF MS/MS analysis. The unknown protein(s) was identified as an A. 
thaliana chaperonin homolog (annotated NP_175945) (Appendix C). Chaperonins are highly 
conserved proteins involved in the proper folding of other proteins (Walter and Buchner, 2002). 
The presence of TKS was also confirmed by Q-TOF MS/MS analysis (Appendix D). 
 
Figure 3.15 Co-immunoprecipitation of TKS and trichome protein extracts 
Co-immunoprecipitation was conducted on (A) recombinant TKS and (B) trichome protein 
extracts using polyclonal αTKS antibody-coupled resin. The resin was capable of binding 
recombinant TKS (A; lane 7; 45 kDa) and an unknown protein (A; lane 7; ca. 60 kDa), as well as 
TKS found in trichome extracts (B; lane 7; 42 kDa) and another protein (B; lane 7; ca. 60 KDa). 
Lanes contained (1) Protein Ladder (numbered in kDa), and 20 µL of (2) flowthrough from resin 
columns, (3) first wash, (4) second wash, (5) third wash, (6) fourth wash, (7) first elution, (8) 
second elution, and (9) third elution. Drawn circles show the eluted proteins.  
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3.3.4.3 Protein Pull-Down Assays of Trichome Protein Extracts 
Recombinant TKS was bound to Talon beads and incubated with trichome protein extracts in an 
attempt to capture proteins that interact with TKS. Results from this experiment did indicate the 
presence of a ca. 30 kDa protein (Figure 3.16A; lanes 3 and 4) that was not present in a fresh 
TKS control (Figure 3.16A; lane 2). Although dilute, trichome extracts did not show this band 
(Figure 3.16A; lane 5 and 6). The unknown protein is assumed to be degraded and fragmented 
TKS as it was also detected in older TKS-only preparations (Figure 3.16B). 
 
Figure 3.16 Protein pulldown using TKS and cannabis drug-type trichome extracts. 
(A) SDS-PAGE of proteins used in an attempt to pull down potentially interacting proteins from 
trichome extracts. Lanes contained (1) 10 µL Protein ladder (numbered in kDa), (2) 2 µg 
recombinant TKS, (3) 3 µg recombinant TKS following incubation with trichome extracts, (4) 6 
µg recombinant TKS following incubation with trichome extracts, (5) 1 µg trichome extract, (6) 
2 µg trichome extract. (B) A 10% acrylamide gel containing (1) 10 µL Fermentas Prestained 
Protein ladder, and (2) 1 µg recombinant TKS. Although a new band appears in (A) lanes 3 and 
4 at ca. 30 kDa, this was presumed to be a TKS degradation product after it was also observed in 
(B) a TKS-only sample electrophoresed two days later. 
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3.3.5 The Analysis of cDNA Cyclase Candidates 
The goal of experiments was to identify, clone and express trichome-specific proteins that were 
potentially involved in the synthesis of OA. Candidate transcripts that were both highly abundant 
in the cDNA library and showed similarity to proteins with cyclase or cyclase-like activity were 
sub-cloned, expressed and purified before being assayed in the presence and absence of TKS 
(Figure 3.17). Candidate proteins included a putative chalcone isomerase (CHI; annotated 
Q6V7U9), a Betv1-like protein (pathogenesis related protein PR10; annotated B5KVN9) and a 
DABB protein (probable protein Pop3; annotated Q9LUV2) (Table 3.1). The inclusion of CHI 
was based on it constituting 0.52% of the total transcripts in trichome ESTs and its relationship 
with CHS in other plants, where CHI is capable of cyclizing chalcone to chalcone naringenin 
(Gensheimer and Mushegian, 2004; Jez et al., 2001). The Betv1-like protein (also known as 
major latex protein/MLP) constituted 0.25% of the total trichome ESTs, and shares structural 
similarity to Streptomyces TcmN ARO/CYC, a PKC involved in the biosynthesis of 
tetracenomycin (Ames et al., 2008). The DABB protein is also well represented in the trichome 
ESTs, representing 0.45% of the total library, and is structurally similar to Streptomyces TcmI, a 
cyclase also involved in the biosynthesis of tetracenomycin (Thompson et al., 2004).  
Candidate proteins were assayed in the presence and absence of TKS to determine if they 
produced OA at a ratio of 100 pmol TKS (ca. 2 µg) to 500 pmol of candidate protein (ca. 20 µg). 
Assays were performed in triplicate and their products analyzed by HPLC (Figure 3.18). HPLC 
chromatograms clearly show that, when TKS is assayed in the presence of the DABB candidate 
cyclase, OA is detectable, along with HTAL, PDAL, and olivetol. No OA accumulated when 
TKS was assayed alone, or in the presence of MLP or CHI, although the other TKS products (i.e. 
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PDAL, HTAL, and olivetol) were detected. The accumulation of TKS products also varied 
between samples (Figure 3.19). The amount of PDAL appeared invariable amongst the samples 
tested, with an average of 2357 ±SE 45.6 pmol produced (where n = 3). The amount of HTAL 
produced appeared static when TKS was assayed alone, or with the DABB protein, or CHI, with 
an average of 193 ±SE 4.3 pmol; less was produced when TKS was assayed in the presence of 
MLP (119 ±SD 10 pmol). The production of olivetol was the most varied between samples, with 
an average of 389 ±SE 20 pmol when TKS was assayed alone or in the presence of CHI, but less 
when TKS was assayed with the DABB protein or with MLP, producing 166 ±SD 32 pmol and 
228 ±SD 27 pmol of olivetol respectively. The ratio of HTAL to olivetol produced when TKS 
was assayed in the presence of the DABB protein is 1.2, whereas it was 0.5 when TKS was 
assayed in the presence or absence of CHI or MLP. 
 
Figure 3.17 SDS-PAGE of TKS and candidate cyclases. 
SDS-PAGE was used to analyze recombinant TKS (TKS; 44.5 kDa), and putative tetraketide 
cyclases including a DABB protein (18.7 kDa), Betv1-like protein (MLP; 20.7 kDa), and a 
chalcone isomerase-like protein (CHI; 27.6 kDa). Each IMAC-purified protein was loaded onto 
the 12% acrylamide gel using (first lane) 1.25 µg and (second lane) 3.75 µg of protein and were 
run next to a molecular weight marker (MW). 
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Figure 3.18 TKS activity in the presence of candidate cyclases. 
HPLC traces of the products formed when TKS was assayed (A) alone, or with (B) MLP-like, 
(C) CHI-like, or (D) DABB proteins are overlayed. Whereas HTAL (RT ca. 5.0 min), PDAL 
(RT ca. 5.5 min), and olivetol (RT ca. 9.5 min) were detected in all assays, OA (RT ca. 8.3 min) 
was only detected when TKS was assayed in the presence of the DABB protein. Standards used 
during HPLC analysis are overlayed (red trace). 
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Figure 3.19 TKS assays products when assayed in with putative cyclases. 
The absolute pmol amount of TKS products detected when TKS was assayed in the presence and 
absence of CHI, MLP, and DABB proteins is shown. OA was only detected when TKS was 
assayed in the presence of the DABB candidate. Vertical axis is split to show smaller amounts of 
product accumulation. Error bars are the SD where n=3. 
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3.4 Discussion 
Cannabis contains many secondary metabolites, including cannabinoids, stilbenes, anthocyanins, 
flavonoids, and spirans, that are synthesized by different PKSs (Flores-Sanchez and Verpoorte, 
2008b). The biosynthesis of these compounds requires type III PKSs that accept different starting 
substrates and vary in their chain lengthening activity and cyclization modes. The first cannabis 
CHS reported in the literature was identified using degenerate primers based on the sequences of 
the H. lupulus CHS and phlorisovalerophenone synthase (VPS). This cannabis CHS was 
described as a CHS and VPS (Raharjo et al., 2004b). It is capable of accepting p-coumaroyl-CoA 
as a reaction initiator, but fails to use hexanoyl-CoA as a substrate, making it incapable of 
producing OA. The subsequent identification of different PKSs in cannabis revealed an 
evolutionary divergence between PKSs that cluster either with known CHSs, such as the H. 
lupulus CHS/VPS (annotated CAC19808), or with CHS-like sequences, which are not involved 
with the biosynthesis of naringenin chalcone (Flores-Sanchez et al., 2010).  TKS shares 100% 
amino acid identity with PKSG4, a CHS-like paralog that has only been characterized using in 
silico methods (Flores-Sanchez et al., 2010). TKS also shares 98.7% amino acid identity with 
another CHS-like homolog, OLS, which has been biochemically characterized and has had its 
crystal structure solved (Taguchi et al., 2008; Taura et al., 2009). Although the characterization 
of OLS has been conducted, the discovery of TKS occurred at approximately the same time. The 
partial characterization of TKS which is described in this chapter indicates that TKS has similar 
activity as OLS. Amino acid differences between OLS and TKS do not appear to affect olivetol 
synthase activity, although a future study could investigate all known TKS homologs for further 
robust analysis. 
  
82 
 
 The characterization of TKS in this study was not conducted under the same conditions 
as used for OLS (Taura et al., 2009). In the present work, a variety of buffers were used to 
determine the optimum for the production of tetraketides, and although TKS assays conducted in 
ADA buffer showed an increased tetraketide production at pH 6.4, a greater absolute amount of 
tetraketides, as well as a lower triketide:tetraketide ratio resulted when TKS was assayed in 
HEPES buffer at pH 7.0, and therefore further assays were conducted using HEPES. The 
observed changes in TKS activity when assayed in different buffers may be attributed to the 
enzyme’s conformational stability (Ugwu and Apte, 2004). All in vitro assays resulted in PDAL 
and HTAL production, which are suspected to be early derailment products resulting from 
artificial in vitro conditions (Austin and Noel, 2003). It is not known if the biosynthesis of 
pyrones by TKS has a specific biological function, or if they are even produced in the plant, 
although the expression of Arabidopsis CHS-like LAP5 and LAP6, which also produce alkyl 
pyrones during in vitro assays, have been shown to be required for pollen exine development 
which plays a crucial role in plant reproduction (Dobritsa et al., 2010). Early characterization 
work continued using HEPES buffer at pH 7.5, since a greater amount of tetraketides were 
produced. Contrastingly, Taura et al. (2009) assayed OLS in citrate buffer at a pH 5.5. TKS and 
OAC assays with citrate buffers are shown in Chapter 4. 
 The temperature at which assays were conducted in earlier work was determined to be 
optimum at 40°C based on the overall amount of products formed (Figure 3.8). At 50°C, both 
olivetol and PDAL accumulated to a lesser degree than at lower temperatures, whereas the 
production of HTAL was slightly increased. An increase in HTAL production, coupled to a 
decreased accumulation of PDAL and olivetol, suggest that the overall enzyme activity is 
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decreased at > 40°C. Furthermore, the increase of HTAL at higher temperatures coupled to a loss 
of olivetol suggests that HTAL and olivetol share a common tetraketide intermediate pre-cursor. 
The lactonization of a tetraketide intermediate to HTAL may be a spontaneous and 
thermodynamically-favored process compared to olivetol cyclization, which may require a 
slower step so to achieve cyclization. Alternatively, enzyme stability is compromised at 
temperatures > 40°C, leading to an increase in enzyme derailment products. 
 Substrate availability assays indicate that increased malonyl-CoA concentrations result in 
a lower triketide:tetraketide ratio (Figure 3.9 and Table 3.4). This intuitively seems correct, since 
a growing polyketide chain that is attached to a PKS active site requires malonyl-CoA to produce 
a final, longer product, and that a (shorter) derailment product (i.e. triketide leading to PDAL) 
would result if less malonyl-CoA was available. Although a greater malonyl-CoA concentration 
favors the production of tetraketides, HTAL production is also favored over the production of 
olivetol under these conditions. An increase in the availability of hexanoyl-CoA also decreased 
the triketide:tetraketide product ratio, but a greater amount of olivetol was synthesized under 
these conditions instead of HTAL (Figure 3.10 and Table 3.4). These results show that TKS 
chemoselectivity can be altered by varying substrate concentration and suggest that excess 
malonyl-CoA, or possibly its breakdown product, acetyl-CoA, either destabilize an enzyme-
tethered tetraketide intermediate causing its early release and cyclization to HTAL, or influences 
the cyclization of a linear tetraketide intermediate that has already been released by TKS, to 
favor HTAL production. The use of a malonyl-CoA:hexanoyl-CoA substrate ratio of 3:1 in 
subsequent assays was used based on the stoichiometry of tetraketide biosynthesis. 
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 DTT is a strong reducing agent routinely added to buffers used during the purification 
and assaying of enzymes. DTT is used to prevent cysteine residues from forming disulfide 
linkages within and between proteins, and to assure the reduction of the cysteine residue in the 
TKS active site. Although DTT has been used extensively, there was concern regarding the 
potential interfering effects which could present themselves as a problem in TKS reactions. Type 
III PKS activity is dependent on the modification of thiol bonds involving CoA esters (Austin 
and Noel, 2003). Since a similar reaction mechanism is involved between type III PKSs and 
DTT through the use of sulfhydryl bonds, the additive and deleterious effects of DTT were 
examined in TKS assays. Results indicate that the addition of DTT and βME in purification 
buffers has a beneficial effect on TKS activity, although the use of DTT in enzyme assays 
increases the production of pyrones, but not olivetol, at lower concentrations, and negatively 
affects all TKS activity at concentrations > 5 mM. The use of DTT in enzyme assays was 
deemed beneficial at concentrations of 5 mM.  
 The assaying of trichome-derived protein solutions provided direct evidence of OA 
synthase activity in cannabis (Figure 3.12). Earlier studies that attempted to detect OAS activity 
from cannabis tissues were unable to detect OA, and reported the production of olivetol instead 
(Flores-Sanchez and Verpoorte, 2008a; Raharjo et al., 2004a). In this study, when a USO-31 
hemp trichome protein solution was assayed, HTAL, PDAL, OA and olivetol were detected, 
whereas only HTAL, PDAL, and OA were detected when a drug-type trichome protein solution 
was assayed. The small amount of drug-type trichomes that were used may have not been 
enough for the production of olivetol in detectable amounts. The availability of drug-type 
trichomes restricted further analysis. Protein extract assays strongly suggest that TKS is involved 
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in the biosynthesis of OA since the addition of TKS to protein extract assays resulted in a 5-fold 
increase of OA (Figure 3.13). Assays confirmed that cannabis trichomes possess OA synthase 
activity, and led to further attempts at identifying other proteins required for the proper 
cyclization of tetraketide products. The analysis of trichome extracts following treatments with 
ammonium sulfate show that the OA synthase activity is retained in the 80% ammonium sulfate 
precipitate, indicating that a protein and not a co-factor is involved. Furthermore, the isolation of 
the OA synthase activity along with the majority of TKS in the same fraction suggested the 
possibility that a physical interaction existed with TKS and the unknown protein. This instigated 
a search for potential TKS interaction partners using co-immunoprecipitation and protein pull-
down methods. 
 Co-immunoprecipitation experiments used αTKS polyclonal antibodies that were bound 
to a solid-support agarose matrix. The finding of a chaperonin homolog was most likely due to 
the cross-reactivity of polyclonal antibodies that were generated using TKS contaminated with 
an E.coli chaperonin homolog (Figure 3.15). These experiments were unable to detect any 
protein that physically interacts with TKS. In another effort to discover a TKS-interacting 
protein, affinity chromatography (i.e. protein pull-down) was attempted after incubating 
trichome extracts in the presence of recombinant TKS, then purifying TKS and any interacting 
proteins using IMAC.  An additional protein was detected during protein pull-down experiments, 
but it was concluded to be a TKS degradation product after a similar protein band was detected 
following the SDS-PAGE of TKS-only controls (Figure 3.16). Neither co-immunoprecipitation 
nor protein pull-down methods were either capable of retrieving any TKS-interacting proteins 
from trichome extracts, suggesting that no such protein exists, or that these methods were 
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incapable of detection. Experiments designed to isolate trichome proteins using chromatography 
had been planned, and attempts to tease out an accessory protein from trichome extracts were 
already underway, but were not continued since TKS assays conducted in the presence of 
potential cyclases meanwhile led to the discovery of OAC. 
 An analysis of the trichome-specific cDNA library resulted in the identification of several 
putative polyketide cyclases that could be involved in the biosynthesis of OA (Table 3.1). 
Another cannabis cDNA library prepared from isolated trichomes had also been published at the 
time of this study by Marks et al. (2009). TKS and its homolog (CAN24/OLS) in the Marks et al. 
(2009) library were highly expressed in EST libraries, where TKS is the most abundant transcript 
in the Stout et al. (2012) trichome cDNA library and CAN24 is the eighth most abundant 
transcript in the Marks et al. (2009) library. Similarly, the DABB protein (homologous to A. 
thaliana heat stable 1 protein; annotated   NP_566569) chosen as a potential cyclase was also 
detected as a highly abundant transcript in both cDNA libraries, where it is the 15
th
-most 
abundant transcript in the Stout et al. (2012) trichome cDNA library and the fifth-highest in the 
Marks et al. (2009) library. The MLP-like and CHI-like transcripts were the 34
th
- and 9
th
-most 
abundant transcripts detected in the trichome cDNA library published by Stout et al. (2012) 
(Table 3.1), whereas they were the 10
th
- and 108
th
-most abundant in the Marks et al. (2009) 
library, respectively.  
 Assays containing TKS and the DABB candidate led to the production of OA, whereas 
TKS assays with the other candidate cyclases did not (Figure 3.18). Early TKS assays performed 
in the presence of DABB protein produced an equimolar amount of tetraketides, with an 
HTAL:PDAL:OA:olivetol ratio of approximately 1:10:1:1 (Figure 3.19). TKS assays preformed 
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in the absence of DABB protein produced an HTAL:PDAL:olivetol ratio of approximately 
1:10:2, indicating a proportional two-fold increase in olivetol when compared to TKS assays 
conduced in the presence of DABB protein. This observation indicates that 1) HTAL production 
is static in all TKS assays performed, and that 2) OA and olivetol are synthesized using the same 
TKS-produced intermediate. The discovery of the DABB protein’s cyclase activity prompted the 
naming of this protein to olivetolic acid cyclase (OAC), the enzyme that is the focus of the next 
chapter. 
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4. THE CHARACTERIZATION OF OAC 
 
4.1 Introduction 
Many polyketide cyclases have been reported in actinomycetes species, and are required during 
the biosynthesis of antibiotics and pigments (Ames et al., 2011; Shen and Hutchinson, 1993b; 
Sultana et al., 2004; Thompson et al., 2004). These cyclases are involved in the modification of 
products derived from type II polyketide synthases, which do not occur in plants, although 
structurally similar proteins possessing either the Betv1 or DABB motifs have been identified 
(Bingman et al., 2004; Radauer et al., 2008). These motifs were identified in trichome proteins, 
and due to their structural relationship with bacterial polyketide cyclases, I initiated an 
investigation into their putative cyclase activity during the biosynthesis of OA. These 
experiments led to the discovery of OAC, a DABB protein capable of producing OA when 
assayed together with TKS (Gagne et al., 2012). The discovery of OAC warranted further 
investigation of this protein. This chapter describes OAC sequence and phylogenetic analysis, 
the identification of assay products by LCMS, and experiments designed to characterize OAC. 
Since type III PKSs are known to exhibit flexibility in substrate specificity, TKS and OAC were 
also assayed with alternative starter compounds to determine if TKS and OAC could produce 
alternative resorcylic acids (Wakimoto et al., 2012). Lastly, an addition to the TKS/OAC assays 
was made by adding recombinant malonyl-CoA synthetase (MCS) derived from Rhizobium 
leguminosarum in hope of augmenting OA biosynthesis (Zhang and Tang, 2009). In summary, 
the experiments presented in this chapter have helped optimize the TKS/OAC reaction, and 
provide valuable insight into the biosynthesis of OA by the TKS/OAC reaction.  
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4.2 Materials and Methods 
4.2.1 Phylogenetic Analysis of OAC 
The nucleic acid sequence (derived from sequencing) of OAC and its deduced protein sequence 
were used to conduct eight blast searches against a number of plant protein databases (described 
in Section 4.3.2). Initially > 150 protein sequences were obtained, but a third of the sequences 
were discarded since a limit of four representatives from any one species was applied. 
Representative sequences were arbitrarily chosen. A total of 93 OAC-like sequences (including 
OAC) were aligned using ClustalW provided in Mega5 (Tamura et al., 2011) with parameters as 
described in Appendix E. A Maximum Likelihood Phylogenic Tree was constructed using the 
Mega5 software and alignment file using the settings described in Appendix E. A thousand 
bootstraps were performed during the analysis.  
4.2.2 Biochemical Characterization of OAC 
Assays were performed using 100 pmol TKS and 1,000 pmol OAC in 50 µL volumes containing 
0.2 mM hexanoyl-CoA, 0.6 mM malonyl-CoA, 50 mM HEPES [pH 7.0], and 5 mM DTT. 
Reactions were maintained at 30°C for 60 min before being extracted and analyzed by LCMS as 
described in Section 3.3.1. The following subsections note differences in these methods. All 
reactions were performed in triplicate. 
4.2.2.1 TKS/OAC Ratios 
Assays used 10 mM DTT and a range of 250 to 12,500 pmol OAC. Reactions were maintained at 
37°C for 60 min. Reactions were analyzed by HPLC as described in Section 3.3.1. 
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4.2.2.2 Temperature 
Assays used 0.5 mM malonyl-CoA. Mixtures were maintained at 10, 15, 20, 25 or 30°C for 5 
min before starting the reaction. Reactions were held at the appropriate temperature for 60 min.  
4.2.2.3 Buffers 
Reactions were conducted in 50 mM buffers including HEPES, TRIS, sodium phosphate, and 
PIPES. Reactions were incubated for 60 min at 10°C.  
4.2.2.4 Concentration of Buffer 
The concentration of HEPES used was 12.5, 25, 50, and 100 mM HEPES [pH 7.0]. 
4.2.2.5 pH 
Assays were conducted in: HEPES pH [6.8 to 8.2]; phosphate pH [6.0 to 7.5] which used 0.5 
mM malonyl-CoA and were conducted at 10°C; ADA pH [5.7 to 7.8] as described in Section 
3.1.3.4 except for the addition of 1000 pmol OAC; and citrate pH [5.0 to 6.0] which used 20 mM 
buffer. Assays conducted in citrate were run in parallel to reaction performed in 20 mM HEPES 
pH [7.0] and 20 mM MOPSO pH [7.0]. Citrate buffers were prepared according to (Gomori, 
1955).  
4.2.2.6 Metals 
Reactions were performed in 20 mM HEPES [pH 7.0], and 5 mM of MgCl2, MnCl2, ZnCl2, 
FeCl2, CoCl2, CaCl2, CuCl2, or water. All metal solutions were freshly prepared from 50 mM 
stock solutions. Analysis was performed by HPLC as described in Section 3.3.1. 
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4.2.2.7 EDTA 
Reactions were performed in 20 mM HEPES [pH 7.0] in the presence or absence of 10 mM 
EDTA. Reactions used 200 pmol TKS and 200 pmol OAC, and were maintained at 20°C for 1 h. 
4.2.2.8 Malonyl-CoA Synthetase 
A 1 mL aliquot of Talon-purified recombinant malonyl-CoA synthetase (MCS) (10 mg/mL) was 
provided by Mr. Enwu Liu (Zhang and Tang, 2009). Assays using MCS were conducted in 50 
µL containing 20 mM HEPES [pH 7.0], 0.2 mM CoA, 0.4 mM ATP, 2.5 mM MgCl2, 8 mM 
sodium malonate, 5 mM DTT, and 0.2 mM hexanoyl-CoA. Assays were started by adding the 
appropriate mixture of 5 µg TKS, 10 µg MCS, and 5 µg OAC. Reactions that did not use MCS 
were conducted using 20 mM HEPES [pH 7.0] as described in Section 4.2.2. Assays were 
performed at 20°C and were analyzed by LCMS as described in Section 3.3.1.  
4.2.2.9 Alternative Substrate Assays 
4.2.2.9.1 Free CoA 
Assays used 0, 0.25, 0.50, 0.75, or 1.0 mM excess CoA esters. Reactions were started by adding 
a mixture of 200 pmol TKS and 1,000 pmol OAC and were incubated at 37°C for 1 h. 
4.2.2.9.2 TKS products 
Assays were performed using 1.0 nmol of OAC in 50 mM HEPES [pH 7.0] and either 1 mM 
HTAL, 1 mM PDAL, 1 mM olivetol, or 1 mM HTAL + 1 mM CoA and proceeded for 1 h at RT.  
4.2.2.9.3 Butyryl-CoA, Octanoyl-CoA, and Acetyl-CoA  
Assays used 0.2 mM butyryl-CoA, octanoyl-CoA, or acetyl-CoA instead of hexanoyl-CoA as a 
starter molecule. Reactions also used 200 pmol TKS, ±1,000 pmol OAC, 0.6 mM malonyl-CoA, 
and 20 mM HEPES [pH 7.0] and were incubated for 30 min at 30°C. Reactions were prepared 
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for LCMS analysis as described in Section 3.3.1. Assays using butyryl-CoA were separated over 
a 30 min gradient run that started with (v/v) 90% water, 10% acetonitrile, and 0.05% formic acid 
and ended with (v/v) 80% water, 20% acetonitrile and 0.05% formic acid. Assays using 
octanoyl-CoA were separated over a 25 min run that started with (v/v) 98% water, 2% 
acetonitrile, and 0.05% formic acid and ended with (v/v) 2% water, 98% acetonitrile and 0.05% 
formic acid. Assays using acetyl-CoA were analyzed by LCMS as described in Section 3.3.1. All 
flow rates were maintained at 0.2 mL/min with a 30°C column temperature. Products were 
monitored at 270 nm and were analyzed using the Empower2 software suite. SIR was conducted 
as described in Section 3.1.3; SIR m/z values are described in Section 4.3.10. 
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4.3 Results 
4.3.1 Olivetolic Acid Cyclase 
OAC is a 101 amino acid protein with a predicted molecular weight of 12 kDa. OAC was 
initially identified in the CL2contig1 ORF of the CSATR1JP unigenes library previously 
described by Stout et al. (2012), and cloned into the pET-100 vector resulting in a new construct 
with a calculated molecular weight of 18.7 kDa.  At the amino acid level, OAC shares 48% 
identity with a heat stable protein from Arabidopsis thaliana named AtHS1 (annotated 
NP_566569), and 38% identity to Populus tremula PtSP1 (annotated CAC34953), which is 
upregulated during stress responses (Park et al., 2007). The crystal structure for AtHS1 has been 
solved and confirms the presence of dimeric α + β barrel domains (Bingman et al., 2004). 
Although AtHS1 was shown to possess antifungal and antibacterial activity, no specific 
physiological function has been attributed to this protein (Park et al., 2007). Similarly, it is not 
known why the heat-stable SP1 is upregulated during heat, salt and stress responses, yet A. 
thaliana plants expressing transgenic SP1 have been shown to be heat-tolerant (Zhu et al., 2008). 
Structurally, the OAC protein sequence was used to query the Interpro web resource, revealing a 
plethora of DABB proteins with many different functions. Of specific relevance is the TcmI 
protein from Streptomyces glaucescens (annotated AAA67513), which assists in the cyclization 
of TcmF2 to TcmF1 during the biosynthesis of tetracenomycin C, an antitumor/antibiotic 
aromatic polyketide (Thompson et al., 2004). The TcmI DABB domain belongs to a superfamily 
of actinobacterial proteins known as the PKCs (Interpro IPR006765; CDD cl04663). It was 
partially this structural relationship that initially implicated OAC as a candidate polyketide 
cyclase. Structurally, the OAC DABB domain belongs to a different family of proteins than 
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TcmI, called the stress-responsive alpha beta barrel (SRABB) proteins by Interpro (IPR013097), 
or simply as DABB proteins by the CDD (cl15807). Conversely, DABB proteins are recognized 
by Interpro as a superfamily of structurally similar proteins (IPR011008) which include SRABBs 
and PKCs, as well as many other structurally similar protein families.  
4.3.1.1 Expression and Purification of OAC 
Originally, OAC was cloned in the pET100 vector, expressed in E. coli BL21, and purified using 
IMAC. Although this produced active protein to be processed, low amounts of impure protein 
were obtained. The low expression of OAC in the pET100 vector led to the construction of the  
pHIS8-OAC plasmid, but this change did not substantially increase protein yields, which were 
only between 1-2 mg/L culture. Furthermore, the expression and purification of OAC from the 
pHIS8-OAC vector resulted in protein fragmentation attributed to OAC degradation. During 
SDS-PAGE, IMAC-purified OAC migrates as a (ca.) 19 kDa band next to a less intense 17 kDa 
band (Figure 4.1). Both bands were analyzed by MS/MS, with results indicating that both bands 
correspond to OAC, suggesting that the 17 kDa contaminant was degraded OAC. Various 
attempts to further purify OAC using chromatographic techniques including size exclusion, ion 
exchange and hydrophobic interaction chromatography had little success in removing the 
degradation product. Assays that were performed throughout this chapter used OAC that was 
purified using minimal amounts of Talon and, with the exception of the degradation product, 
resulted in a purified active product (Figure 4.1). 
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Figure 4.1  SDS-PAGE of Talon purified TKS and OAC. 
A 15% polyacrylamide gel was used to resolve 1.25 µg TKS (lane 3), 3.75 µg of TKS (lane 5), 
1.25 µg OAC (lane 7) and 3.75 µg OAC (lane 9) next to 10 µL Prestained Protein ladder (lane 1) 
at 200V for 45 min. OAC did show a contaminating band at (ca.) 17 kDa as seen in lanes 7 and 
9. Numbers on the left of the gel are the corresponding protein masses (kDa). 
 
4.3.2 The Evolutionary Relationship of OAC 
A search for OAC homologs was conducted using the OAC protein sequence during a variety of 
blast queries in a number of plant sequence databases, namely the NCBI Transcriptome Shotgun 
Assembly Sequence Database (Benson et al., 2000), the Cannabis Genome database (Van Bakel 
et al., 2011), TIGR Plant Transcript Assemblies (Childs et al., 2007), the Solanum lycopersicum 
project (Tomato Genome Consortium, 2012), GreenPhylDB (Conte et al., 2008), and Phytozome 
(Goodstein et al., 2012). A total of 93 protein sequences with an expected threshold <1x10
-10
 
were aligned using MEGA5 software’s ClustalW implementation, and then used to construct a 
Maximum Likelihood phylogenetic tree (Tamura et al., 2011) (Figure 4.2). Names of sequences 
are included in Appendix F. A limit of four homologs from any given species to be included in 
the alignment was applied when too many sequences from one species were detected. Sequences 
used in the alignment were obtained from BLAST searches against higher plant genomes, but 
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also included Cyanidioschyzon merolae, Chlamydomonas reinhardtii, and Ostreococcus tauri 
genomes, although no OAC homolog within an expected threshold of 1x10
-2
 could be detected 
within these algal genomes. Phylogenic analysis indicates that OAC homologs form two distinct 
clades that further subdivide into monocot and dicot lineages (Figure 4.3 and 4.4). Broader 
searches for OAC homologs against GenBank non-redundant sequences clearly detected their 
existence in a variety of bacteria including Proteobacteria, Firmicutes, Enterobacteriaceae, and 
Sphingobacteria with E-values less than 1x10
-14
.  
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Figure 4.2  Phylogenetic relationship of plant OAC homologs. 
The evolutionary history was inferred using the Maximum Likelihood method based on the JTT 
matrix-based model (Jones et al., 1992). The bootstrap consensus tree inferred from 1,000 
replicates represents the phylogenetic relationship of OAC (Felsenstein, 1985). Bootstrap values 
are shown along branch lengths. The analysis involved 93 amino acid sequences (Appendix F). 
There were a total of 58 positions in the final dataset. Analyses were conducted in MEGA5 
(Tamura et al., 2011). Two distinct clades (A and B) divide the homologs, which can be further 
divided into eudicot and monocot groups. The scale bar indicates the genetic distance of 0.2 
substitution/site. 
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Figure 4.3  Phylogenetic relationship of OAC plant homologs in Clade A. 
Plant OAC homologs found in clade A are shown. The scale bar indicates the genetic distance of 
0.05 substitution/site.  
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Figure 4.4  Phylogenetic relationship of OAC plant homologs in Clade B. 
OAC homologs that form the ‘B’ clade division are shown. These homologs can be further 
subdivided into monocot and eudicot classifications. The scale bar indicates the genetic distance 
of 0.2 substitution/site. 
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4.3.3 The TKS/OAC Reaction Produces Olivetolic Acid 
TKS assays conducted in the presence of OAC produced four compounds identifiable by 
comparing their retention times, UV spectra, and masses to authentic standards during LCMS 
analysis (Figure 4.5). The four products included HTAL, PDAL, olivetol, and OA, which were 
also confirmed by single ion monitoring in electrospray positive ion mode at 224.95 m/z for 
HTAL and OA, 182.96 m/z for PDAL, and 180.91 m/z for olivetol (Figure 4.6). Product ratios 
(i.e. chemoselectivity) were affected by assay conditions including temperature, pH, and 
substrate concentrations and are discussed in the appropriate Sections. Product ratios generally 
mirrored product accumulation of TKS assays performed in the absence of OAC, with the 
exception of olivetol which accumulated to a lesser degree in TKS assays performed in the 
presence of OAC, and of course OA which does not accumulate when TKS is assayed alone 
(Figure 4.7). Typically, product ratios of HTAL:PDAL:OA:olivetol were in circa 1:10:1:1 
throughout this work, but these values did fluctuate dramatically. Once reaction conditions were 
optimized for OA production, a product ratio of 1:7:2:1 was obtained. 
The LCMS chromatograms of standards and the TKS/OAC assay presented in Figures 
4.5 and 4.6 can be directly compared to the chromatograms presented in Chapter 3 (Figure 3.4 
and 3.5); they were obtained from experiments conducted in parallel. Note that the 
chromatograms shown are derived from reactions conducted once optimized reaction conditions 
were determined. 
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Figure 4.5  LCMS of standards and TKS/OAC assay products. 
(A) Overlayed LC chromatograms for TKS/OAC assay products (black) and standards (red) 
indicate the similarity in product retention times. (B) An LCMS chromatogram of the standards 
used in this study indicate the retention times, UV spectra and extracted ion profiles for HTAL 
(5.2 min; UVmax 285 nm; m/z 225), PDAL (5.6 min; UVmax 287 nm; m/z 183), OA (9.0 min; 
UVmax 263 nm; m/z 225.), and olivetol (10.2 min; UVmax 276 nm; m/z 181) and were used to 
confirm the identities of (C) TKS/OAC assay products shown in a similar LCMS trace. 
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Figure 4.6  Selected ion monitoring of TKS/OAC assay products. 
LCMS was used to confirm the identity of HTAL, PDAL and olivetol produced during TKS 
assays. (A) PDA results align well with selected ion monitoring in ES
+
 mode which was capable 
of detecting (B) olivetol (10.2 min; m/z 180.91), (C) PDAL (6.0 min; m/z 182.96), (D) HTAL 
(5.2 min; m/z 224.95) as well as olivetolic acid (9.0 min; m/z 224.95). Another peak (6.0 min) 
detected during (D) selected ion monitoring at 224.95 m/z is attributed to acetonitrile:PDAL 
adduct formation. 
0 
0.02 
0.04 
0.06 
4 5 6 7 8 9 10 11 12 
a
b
so
rb
a
n
ce
 a
t 
2
7
0
 n
m
 
time (min) 
A PDA 270 
0.0E+00 
2.0E+04 
4.0E+04 
6.0E+04 
4 5 6 7 8 9 10 11 12 
io
n
 c
o
u
n
t 
time (min) 
B ES+ 180.91 
0.0E+00 
1.0E+07 
2.0E+07 
3.0E+07 
4.0E+07 
4 5 6 7 8 9 10 11 12 
io
n
 c
o
u
n
t 
time (min) 
C ES+ 182.96 
0.0E+00 
5.0E+05 
1.0E+06 
1.5E+06 
2.0E+06 
4 5 6 7 8 9 10 11 12 
io
n
 c
o
u
n
t 
time (min) 
D ES+ 224.95 
acetonitrile:PDAL adduct 
  
103 
 
 
Figure 4.7  A comparison of TKS and TKS/OAC assay products. 
TKS assayed in the presence of OAC resulted in the accumulation of OA apparently at the cost 
of olivetol accumulation. Error bars are the SD where n=3. 
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4.3.4 Optimum Ratio of TKS and OAC  
Experiments were conducted to establish the ratio of TKS to OAC required to optimize the 
production of OA. Additionally, this work tested if a stoichiometric relationship exists between 
TKS and OAC, which could suggest if a physical interaction occurs between these enzymes. The 
optimum amount of starting enzyme was determined by assaying 200 pmol (ca. 10 µg) TKS in 
the presence of 250 to 12,500 pmol (ca. 230 µg) of OAC (Figure 4.8). The largest amount of OA 
accumulation (538 pmol) during these assays was observed when 200 pmol TKS was assayed in 
the presence of 7,500 pmol (ca. 140 µg) OAC. OAC activity appears to level off when amounts 
greater than 7,500 pmol of OAC was assayed. The accumulation of OA is inversely proportional 
to the accumulation of olivetol, and has a correlation coefficient of -0.978 (P value of 0.00001). 
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Figure 4.8  TKS assays conducted with variable amounts of OAC. 
Product accumulation during TKS/OAC assays was affected by the concentration of OAC. 
Constant amounts of 200 pmol TKS were assayed in the presence of 250 to 12,500 pmol OAC. 
Error bars are the SD where n=3. Vertical axis is split to show smaller amounts of products.  
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4.3.5 OAC Activity as a Function of Temperature 
These experiments were conducted to examine the effect temperature has on the TKS/OAC 
reaction and to determine the optimum temperature at which OA production occurs. Temperature 
influenced both the product ratios and total amounts of products from TKS/OAC assays. Results 
indicate that OA production increases at lower (10 to 20°C) temperatures, while HTAL, PDAL 
and olivetol production decreased (Figure 4.9). Although previous TKS assays indicated an 
increase in product formation at (ca.) 40°C (Figure 3.9), the largest amount of OA detected in 
TKS/OAC assays occurred at 15°C and was not significant at 10°C (z for 95% CI= 1.96). 
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Figure 4.9  The activity of TKS/OAC as a function of temperature. 
(A) As temperature is increased, so is the production of HTAL, PDAL, and olivetol. Conversely, 
OAC activity increases at lower (10 to 20°C) temperatures. Vertical axis is split to show smaller 
amounts of products. (B) The total amount of products is increased at temperatures of 20 to 30°C 
compared to lower temperatures. Error bars are the SD where n=3.   
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4.3.6 OAC Activity in Different Buffer Systems  
The activity of both TKS and OAC was strongly influenced by the buffer in which assays were 
conducted. Assays were performed in triplicate using (final) concentrations of 50 mM HEPES, 
TRIS, phosphate, or PIPES at pH 7.0, and product accumulation was compared (Figure 4.10). 
HEPES appears a better buffer than TRIS, phosphate, or PIPES, and was capable of reducing the 
amount of PDAL production while increasing overall tetraketide (HTAL, OA, and olivetol) 
production. Assays conducted in the presence of HEPES buffer compared to other buffering 
systems accumulated more than two times the amount of OA (1,100 pmol), and more than three 
times the amounts of HTAL (569 pmol) and olivetol (1,061 pmol). 
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Figure 4.10 TKS/OAC assays conducted in different buffers. 
When TKS and OAC were assayed in HEPES, an increase in tetraketide (HTAL, olivetol, OA)  
production was observed compared to assays conducted in TRIS, phosphate or PIPES buffer. All 
assays were conducted in the presence of 50 mM buffer [pH 7.0]. Vertical axis is split to show 
smaller amounts of products. Error bars are the SD where n=3.   
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4.3.6.1 OAC Activity in Varying Concentration of HEPES pH 7.0 
Product accumulation from TKS/OAC assays was also investigated using different molarities of 
HEPES buffer, where final concentration of HEPES at pH 7.0 were 12.5, 25, 50, and 100 mM 
(Figure 4.11A). This experiment was conducted to determine if HEPES concentration affected 
OA production. The largest amounts of tetraketides were detected in assays that used 12.5 mM 
HEPES including HTAL (573 pmol), OA (621 pmol), and olivetol (574 pmol). Total polyketide 
production was unaffected by the HEPES concentrations used (Figure 4.11B) 
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Figure 4.11 Activity of TKS/OAC in variable concentrations of HEPES. 
(A) A comparison of product accumulation during TKS and OAC assays conducted in the 
presence of 12.5 – 100 mM HEPES buffer at pH 7.0. (B) The total amount of PDAL (triketide) is 
compared to the sum of tetraketides (HTAL, OA, and olivetol). Vertical axis is split to show 
smaller amounts of products. Error bars are the SD where n=3.  
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4.3.7 OAC Activity as a Function of pH 
The accumulation of TKS/OAC assay products was monitored over a pH range in a variety of 
buffers including HEPES, phosphate, ADA, and citrate. Given that a marked increase in 
tetraketide production was observed in assays conducted in HEPES buffer, product accumulation 
at different pHs was analyzed using this buffer. Unfortunately, the effective pH range of HEPES 
is too narrow (6.8 to 8.2) to accomodate for more acidic environments. Monitoring of reaction 
products at pH lower than 6.8 was later achieved using ADA and phosphate as buffering agents. 
Taura et al. (2009) used citrate [pH 5.5] as a buffer for OLS, and this led to the further analysis 
of TKS/OAC products in this buffer, which was directly compared to TKS/OAC assays 
conducted in HEPES and MOPSO buffers. 
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4.3.7.1 OAC Activity in HEPES pH 6.8 to 8.2 
Assays conducted in HEPES buffers within its full pH range indicate that maximal production of 
OA, as well as HTAL and olivetol occurs at a lower pH than HEPES could accommodate 
(Figure 4.12). The largest amount of OA (704 pmol) was detected in assays conducted at pH 6.8. 
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Figure 4.12 Activity of TKS/OAC in HEPES buffer pH 6.8 to 8.2. 
A pH profile using 50 mM HEPES was developed by assaying 100 pmol TKS and 1,000 pmol 
OAC over the full buffering range of HEPES (6.8 to 8.2). Vertical axis is split to show smaller 
amounts of products. Error bars are the SD where n=3.  
  
110 
 
4.3.7.2 OAC Activity in Phosphate Buffer pH 6.0 to 8.0 
Although it was previously shown that phosphate decreases TKS and OAC activity (Figure 
4.10), the buffering range of phosphate allowed for a broader examination of pH and its effect on 
activity (Figure 4.13). These assays suggest an optimum pH 6.5 for the production of OA (442 
pmol) and HTAL (173 pmol), pH 7.5 for the production of PDAL (2650 pmol), and pH 6.0 for 
olivetol (704 pmol). The lower pH at which olivetol production is increased suggests that 
olivetol production could be augmented at an even lower pH. 
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Figure 4.13 Activity of TKS/OAC in phosphate buffer pH 6.0 to 8.0. 
A pH profile using 50 mM phosphate was obtained by assaying 100 pmol TKS and 1,000 pmol 
OAC in the presence of malonyl-CoA and hexanoyl-CoA over a broad pH range (6.0 to 8.0). 
Vertical axis is split to show smaller amounts of products. Error bars are the SD where n=3.  
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4.3.7.3 in ADA Buffer pH 5.7 to 7.8 
The activity of TKS and OAC were also examined using ADA buffer at pH intervals of 0.2 
between the range of 5.7 to 7.8 (Figure 4.14). This pH profile is the most comprehensive of all 
pH curves obtained for TKS/OAC assays and indicates a similar trend as the other pH profiles. 
Maximal HTAL (153 pmol) and OA (550 pmol) production occurred at pH 6.4, whereas olivetol 
(83 pmol) accumulation was highest at pH 6.0, and that of PDAL (pmol 1,361) was at pH 7.2. 
These ADA pH profiles were obtained during experiments conducted in parallel with those 
presented in Section 3.2.2.1, where TKS was assayed alone.  
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Figure 4.14 Activity of TKS/OAC in ADA buffer pH 5.7 to 7.8. 
A pH profile using 50 mM ADA was obtained by assaying 100 pmol TKS and 1,000 pmol OAC 
in the presence of malonyl-CoA and hexanoyl-CoA over a broad pH range (5.7 to 7.8). Vertical 
axis is split to show smaller amounts of products. Error bars are the SD where n=3.  
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4.3.7.4 in Citrate Buffer pH 5.0 to 6.0 
TKS and OAC were assayed in the presence of 20 mM citrate at pH 5.0, 5.25, 5.5, 5.75, and 6.0 
and product accumulation was directly compared to assays conducted in 20 mM HEPES at pH 
7.0 and in 20 mM MOPSO at pH 7.0 (Figure 4.15). The largest amount of OA was detected from 
assays performed in MOPSO at pH 7.0, where OA accumulated to 754 pmol. The second largest 
OA accumulation was from assays conducted in HEPES at pH 7.0 where OA accumulated to 605 
pmol. The largest amounts of olivetol (1,508 pmol) and HTAL (523 pmol) were detected in 
assays conducted in citrate buffer at pH 5.75, although assays conducted in citrate generated the 
least amount of OA (456 pmol), which was maximally produced in citrate at pH 6.0. 
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Figure 4.15 Activity of TKS/OAC in citrate buffer pH 5.0 to 6.0. 
A pH curve using 20 mM citrate was obtained by assaying 100 pmol TKS and 1,000 pmol OAC 
in a pH range of 5.0 to 6.0 and is directly compared to assays conducted in HEPES [pH 7.0] and 
MOPSO [pH 7.0]. Vertical axis is split to show smaller amounts of products. Error bars are the 
SD where n=3. 
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4.3.8 OAC Activity in the Presence of Metals 
These experiments were conducted to determine if metals had an effect on TKS and OAC 
activity. The effect that metals have on OAC activity was determined by assaying the enzymes in 
the presence of Mg
2+
, Ca
2+
, Mn
2+
, Fe
2+
, Co
2+
, Cu
2+
 and Zn
2+
 (Figure 4.16). Whereas alkaline 
earth metals had a relatively small effect on TKS/OAC activity, the transition metals strongly 
affected the product profile of the TKS/OAC reaction. Notably, Fe
2+
, Co
2+
, Zn
2+
 and Cu
2+
 
reduced the amount of HTAL, PDAL, and OA to an average of 38%, 20%, and 23%, 
respectively when compared to TKS/OAC reactions without metals. These same metals also 
increased the amount of olivetol by an average of 84% when compared to the amount of olivetol 
produced in TKS/OAC reactions without metals. The largest amount of OA was observed in the 
absence of metals. 
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Figure 4.16 The effect of metal on the TKS/OAC reaction. 
This figure compares product accumulation in TKS/OAC reactions conducted in the presence 
and absence of selected metals. Vertical axis is split to show smaller amounts of products. Error 
bars are the SD where n=3. 
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4.3.8.1 TKS/OAC Activity in the Presence of EDTA 
In addition to surveying OAC activity in the presence of metals, TKS and TKS/OAC were also 
assayed in the presence and absence of 10 mM EDTA, a hexadentate chelating agent capable of 
sequestering metal ions (Figure 4.17). These experiments were conducted to examine TKS/OAC 
activity in the absence of metals. The addition of EDTA to TKS and TKS/OAC assays increased 
the production of PDAL by about 30%, whereas the production of HTAL and olivetol dropped 
by 40% and 25%, respectively, when compared to assays performed in the absence of EDTA. 
The production of OA also diminished in TKS/OAC assays conducted in the presence of EDTA, 
but only by 8% when compared to similar assays performed in the absence of EDTA. 
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Figure 4.17 EDTA affects the synthesis of TKS/OAC products. 
A comparison of reaction products that accumulated during TKS and TKS/OAC assays in the 
presence and absence of EDTA show a reduction in tetraketide production and an increase in 
PDAL production in EDTA containing reactions. Error bars are the SD where n=3. 
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4.3.9 TKS/OAC Activity in the Presence of MCS 
Malonyl-CoA synthetase (MCS) was used to produce malonyl-CoA in vitro alongside TKS/OAC 
assays. These assays were performed to compare the activity of TKS and TKS/OAC in the 
presence and absence of MCS. Although the inclusion of MCS in assays allowed for the 
production of malonyl-CoA, the reaction required the addition of free CoA, ATP, MgCl2 and 
sodium malonate. Assays which did not include MCS required malonyl-CoA, but not free CoA, 
ATP, MgCl2 and sodium malonate. In experiments conducted in parallel, TKS assays that used 
malonyl-CoA produced an average 32% more HTAL, PDAL and olivetol than TKS assays using 
MCS (Figure 4.18). Similarly, TKS/OAC assays that used malonyl-CoA showed increases of 
53% HTAL, 36% PDAL, 9% olivetol, and 40% OA when compared to TKS/OAC assays that 
employed MCS.  
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Figure 4.18 TKS/OAC assays conducted in presence and absence of MCS. 
TKS and TKS/OAC assays were performed with and without MCS allowing for the comparison 
of product accumulation. Vertical axis is split to show smaller amounts of products. Error bars 
are the SD where n=3. 
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4.3.10 Substrate Utilization in the TKS/OAC Reaction 
These experiments were conducted to determine if TKS assay products were suitable substrates 
for OAC. Free CoA was added to the TKS/OAC reaction to determine if it influenced OA 
production, and to determine if free CoA could be involved in the acquisition and use of HTAL 
as a substrate by OAC. OAC was assayed without TKS in the presence of the polyketide 
products themselves, which included HTAL, PDAL, and olivetol, to determine if OAC was 
capable of using these compounds as substrates for the production of OA. Additionally, to 
explore TKS promiscuity, enzyme assays were performed using starter molecules other than 
hexanoyl-CoA, which included octanoyl-CoA, butyryl-CoA, and acetyl-CoA. TKS assays were 
conducted with and without OAC using alternative starter compounds and product accumulation 
was compared.  
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4.3.10.1 The Effect of Free CoA on TKS/OAC Activity 
TKS/OAC assays were conducted in the presence and absence of free CoA and product 
accumulation was compared (Figure 4.19). When the concentration of free CoA was increased, 
PDAL production also appeared to increase, but the amount of HTAL, olivetol and OA was 
diminished. The maximal amount of OA (159 pmol) was produced by TKS/OAC assayed 
without CoA, whereas the smallest amount of OA (23 pmol) was recovered when TKS/OAC was 
assayed in the presence of 0.75 mM CoA, resulting in an 85% reduction in OA production. 
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Figure 4.19 TKS/OAC product accumulation in the presence of free CoA. 
An increase in PDAL and a decrease in HTAL, OA, and olivetol were detected when TKS/OAC 
was assayed in the presence of free CoA, when compared to assays conducted in the absence of 
free CoA. Vertical axis is split to show smaller amounts of products. Error bars are the SD where 
n=3. 
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4.3.10.2 TKS Products as Substrates for OAC 
The TKS/OAC reaction clearly leads to the production of OA, but the question as to which 
substrate OAC cyclizes remains unanswered. The unidentified substrate could be a linear 
tetraketide that spontaneously cyclizes to either HTAL or olivetol in solution, or as a release 
mechanism from TKS, but studies that have tried to produce reactive triketo acids have failed to 
report the production of lactones from the cyclization of free acids (Harris and Carney, 1966; 
Harris and Carney, 1967; Staunton and Weissman, 2001). The existence of linear polyketide 
intermediates has also been questioned during substrate channeling between CHS and 
downstream enzymes, such as chalcone reductases (CHRs); whether or not these substrates are 
enzyme-bound or exist as free intermediates remains unknown (Austin and Noel, 2003). To 
address the issue of OAC substrate utilization, OAC was assayed in the presence of isolated TKS 
products (HTAL, PDAL, and olivetol), which could act as substrates if OAC possesses ring-
opening activity. Additionally, OAC was assayed with 0.5 mM HTAL and either 1) 0.5 mM free 
CoA, or 2) 200 pmol TKS. The addition of free CoA to these assays was investigated since ring-
opening activity could require a cofactor which was present when TKS products are generated in 
vitro. The addition of TKS to assays allowed the investigation as to whether or not TKS could 
itself be responsible for the potential ring-opening of HTAL, resulting in the production of 
triketo acid intermediates. When OAC was assayed with either PDAL or olivetol, no other 
compound could be recovered (traces not shown). OAC assays performed in the presence of 1.0 
mM HTAL resulted in the detection of trace amounts of OA during LCMS analysis (Figure 
4.20). The addition of free CoA or TKS to OAC assays did not lead to an increase of OA. 
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Figure 4.20 LCMS of OAC assays conducted with HTAL. 
The LCMS analysis of products generated when OAC was assayed with 0.5 mM HTAL. (A) 
PDA trace clearly indicates the elution of HTAL at 5.2 min, although no OA is observable at this 
scale. The UV spectrum for HTAL is shown to the right. (B) Trace amounts of OA are detectable 
at a UV absorbance scale of 0.005 at 8.9 min. The UV spectrum for OA is shown to the right. (C) 
Analysis by SIR at m/z of 224.95 in ES
+
 mode was capable of detecting HTAL at 5.2 min, as 
well as trace amounts of OA at 8.9 min. 
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4.3.10.3 With Butyryl-CoA 
TKS was assayed in the presence and absence of OAC using butyryl-CoA as a starter molecule. 
These assays employed MCS and its necessary substrates instead of using malonyl-CoA (see 
Section 4.2.9). Reaction products were analyzed by LCMS with selected ion monitoring in ES
+
 
mode at m/z values of 153.19 corresponding to 5-propylbenzene-1,3-diol (divarin; an olivetol 
propyl analog), 155.16 corresponding to 4-hydroxy-6-propyl-pyran-2-one (butyryl diacetic acid 
lactone (BDAL); a PDAL analog), and 197.20 corresponding to both 2-hydroxy-6-(2-
oxopentyl)pyran-4-one (butyryl triacetic acid lactone (BTAL); an HTAL analog), and 2,4-
dihydroxy-6-propylbenzoic acid (divarinic acid; an OA analog) (Figure 4.21). When TKS was 
assayed in the absence of OAC, compounds were detected at 7.4 min (BDAL), 9.0 min (BTAL), 
and at 16.9 min (divarin). When TKS and OAC were assayed together, in addition to those peaks 
previously mentioned, another peak at 18.0 min was detected which corresponded exactly with 
SIR at 197.20 m/z  (divarinic acid). An unknown compound eluting at 16.1 min was also 
detected by PDA and SIR at m/z 153.19; this peak is not seen when TKS was assayed alone. 
4.3.10.4 With Octanoyl-CoA 
TKS was assayed in the presence and absence of OAC using octanoyl-CoA as a starter molecule. 
These assays also used MCS and its required components instead of malonyl-CoA (See Section 
4.2.9). Reaction products were analyzed by LCMS using selected ion monitoring in ES
+
 mode at 
m/z values of 209.30 corresponding to 5-heptylbenzene-1,3-diol (heptylresorcinol; an olivetol 
heptyl analog), 211.27 corresponding to 6-heptyl-4-hydroxypyran-2-one (heptyl diacetic acid 
lactone (HDAL); a PDAL analog), and 253.31 corresponding to both 4-hydroxy-6-(2-
oxononyl)pyran-2-one (octanoyl triacetic acid lactone (OTAL); an HTAL analog), and 2-heptyl-
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4,6-dihydroxybenzoic acid (heptylresorcinolic acid; an OA heptyl analog) (Figure 4.22). When 
TKS was assayed in the absence of OAC, compounds were detected at 6.7 min (HDAL), 7.8 min 
(OTAL), 9.5 min (unknown), and at 10.6 min (heptylresorcinol). The unknown compound 
observed during PDA analysis eluting at 9.5 min is not detectable by SIR at 253.31; this 
compound is not heptylresorcinolic acid. The same compounds were detected when TKS and 
OAC were assayed, in addition to another compound, seen as a larger peak eluting at 9.4 min 
during PDA analysis; this compound (heptylresorcinolic acid) is clearly detectable by SIR at m/z 
253.31 (Figure 4.22). 
4.3.10.5 With Acetyl-CoA 
TKS was assayed in the presence and absence of OAC using acetyl-CoA as a starter molecule. 
These assays used MCS and its required components instead of malonyl-CoA (Section 4.2.9). 
Reaction products were analyzed by LCMS using selected ion monitoring in ES
+
 mode at m/z 
values of 125.14 corresponding to 5-methyl-1,3-benzenediol (orcinol; an olivetol methyl analog), 
127.11 corresponding to 6-methyl-4-hydroxypyran-2-one (triacetic acid lactone (TAL); a PDAL 
analog), and 169.15 corresponding to both 2-acetonyl-6-hydroxy-pyran-4-one (tetra acetic acid 
lactone (TTAL); an HTAL analog), and 2,4-dihydroxy-6-methylbenzoic acid (orsellinic acid; an 
OA methyl analog) (Figure 4.23). Whether TKS was assayed with or without OAC, the assumed 
compounds were detected at 4.0 min (TAL), 4.8 min (TTAL), 8.1 min (orcinol), and at 10.1 min 
(orsellinic acid). An unknown compound was also observed during PDA analysis at 270 nm 
eluting at 3.5 min, which is also detectable by SIR at m/z 169.15 (Figure 4.23). There is little 
difference between assays conducted with or without OAC suggesting that shorter alkyl 
tetraketides may spontaneously cyclize to orsellinic acid.  
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Figure 4.21 LCMS of TKS/OAC assays conducted with butyryl-CoA. 
LCMS chromatograms from TKS assays performed in the presence (red) and absence (black) of 
OAC are overlaid. (A) LC traces align well with selected ion monitoring in ES
+
 mode capable of 
detecting (B) divarin (16.9 min; m/z 153.19), (C) BDAL (9.0 min; m/z 155.16), (D) BTAL (7.4 
min; m/z 197.20) and divarinic acid (18.0 min; m/z 197.20). An unknown compound was also 
detected using PDA monitoring at 16.1 min (A) and SIR monitoring at m/z of 153.19 (B). No 
divarinic acid was detected when TKS was assayed in the absence of OAC. 
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Figure 4.22 LCMS of TKS/OAC assays conducted with octanoyl-CoA. 
LCMS chromatograms from TKS assays performed in the presence (red) and absence (black) of 
OAC are overlaid. (A) LC traces align well with selected ion monitoring in ES
+
 mode capable of 
detecting (B) heptylresorcinol (10.6 min; m/z 209.30), (C) HDAL (7.8 min; m/z 211.27), (D) 
OTAL (6.7 min; m/z 253.31) and heptylresorcinolic acid (9.4 min; m/z 253.31). The detection of 
heptylresorcinolic acid is confirmed by its appearance at 9.4 min during PDA analysis (A) and its 
corresponding peak during SIR at m/z 253.31 (D), which was not detected when TKS was 
assayed in the absence of OAC.   
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Figure 4.23 LCMS of TKS/OAC assays conducted with acetyl-CoA. 
LCMS chromatograms from TKS assays performed in the presence (red) and absence (black) of 
OAC. (A) LC and MS ES
+
 results are aligned and capable of detecting what is assumed to be (B) 
orcinol (8.1 min; m/z 125.14), (C) TAL (4.0 min; m/z 127.11), (D) TTAL (4.8 min; m/z 169.15) 
and orsellinic acid (10.1 min; m/z 169.15), which were detected in all assays performed. 
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4.4 Discussion 
TKS assays conducted in the presence of candidate polyketide cyclases led to the discovery of 
OAC, an enzyme capable of modifying TKS product formation resulting in the synthesis of OA 
(Gagne et al., 2012). This discovery warranted the biochemical characterization of OAC, the 
main focus of this chapter. 
4.4.1 Phylogenetic Relationship of OAC 
Blast searches for OAC homologs indicate that similar proteins are ubiquitous in plants. Their 
strong conservation indicates a beneficial property in plants, probably related to salt and heat 
stress responses, as their family name suggests (i.e. SRABBs). The occurrence of similar 
sequences to OAC in bacterial genomes (namely Rhizobium) is an indicator that they may 
originate from ancestral prokaryotes, and may have been introduced to plants by early horizontal 
gene transfer events, as it has been hypothesized to occur in Nicotiana (Intrieri and Buiatti, 
2001). Phylogenetic analysis divides the OAC homologs into two specific clades suggesting that 
a primary OAC homolog (clade A) is conserved, and may have duplicated so to form a clade of 
paralogs (clade B). The relationship OAC shares with these clades A and B appears remote, 
having formed its own branch with clade A, but includes homologs from Mimulus guttatus 
(common monkey-flower), and Populus trichocharpa (poplar).  
4.4.2 The Optimum TKS/OAC Ratio 
Ratio experiments were designed to determine the amount of OAC required for maximal OA 
production. The amount of enzyme used in these assays reported values in pmol instead of µg 
values to determine if a stoichiometric relationship existed between TKS and OAC; results 
suggest that no such relationship exists and that maximal OA production occurred when 
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OAC:TKS ratios were approximately 40:1. The largest amount of OA production was observed 
when 140 µg of OAC (i.e. 7,500 pmol) was assayed with 9 µg of TKS (200 pmol). Larger 
amounts (>7,500 pmol) of OAC did not increase OA production, indicating that peak OAC 
activity had been achieved, or that self-inhibition of OAC (and/or possibly TKS inhibition) was 
occurring due to its increased concentration. Based on its structural classification, it is presumed 
that OAC exists as a dimer in solution and that at greater concentrations a higher ordered 
oligomer could exist, as it does with the OAC homolog, Populus tremula SP1, which is capable 
of forming dodecameric quaternary structures (Dgany et al., 2004). This potential 
oligomerization could lead to structural changes that result in self-inhibition, which is known to 
occur in other enzymes such as 12-oxophytodienoate reductase from Lycopersicon esculentum 
(tomato), which exhibit a weak tendency for dimerization correlating with a loss of activity 
(Breithaupt et al., 2006). Results themselves do not suggest a loss of activity, and may instead 
indicate a maximum limit of products being reached, and that the effects seen when >7500 pmol 
OAC were used is simply a leveling-off of OA production. Results suggest that 100 pmol of 
TKS should be assayed with 3,500 pmol of OAC for optimum OA production, but further 
analyses were conducted using a TKS:OAC ratio of 100:1,000 pmol due to the huge amounts of 
recombinant OAC that would otherwise be required (where 1,000 pmol of OAC is approximately 
19 µg of enzyme). 
4.4.3 The Optimum Temperature for In Vitro OA Production 
Assays designed to determine the optimum temperature for OA production gave insights about 
the TKS/OAC reaction. The results from TKS assays conducted in the absence of OAC indicate 
that maximal product formation occurred at ca. 40°C. When TKS was assayed in the presence of 
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OAC, the largest amount of OA was produced at a lower temperature of 15°C, and OA 
production was reduced at temperatures exceeding 25°C. These results suggest that an unstable 
intermediate is produced by TKS, which undergoes a spontaneous decarboxylative cyclization at 
higher temperatures resulting in the formation of olivetol. Conversely, at lower temperatures the 
tetraketide intermediate is stabilized, allowing it to reach OAC, where it is cyclized to OA before 
any thermo-dependent spontaneous cyclization occurs. Based on these data, future assays 
optimized for OA production were conducted at 20°C. 
4.4.4 The Optimum Buffer and pH for OAC 
The choice of buffering agents also played a key role in determining the optimum for OA 
production. Results from combinatorial assays performed in the presence of sodium phosphate, 
PIPES, HEPES, TRIS, and citrate were directly compared and results indicate that HEPES is the 
best buffering system for OA production. Furthermore, a lower concentration of HEPES was 
deemed beneficial for tetraketide production, and a 20 mM HEPES buffering solution was used 
in subsequent assays. The activity of OAC was also compared over a wide pH range using a 
number of buffers due to the limited effective pH range of HEPES. Combined results indicate 
that maximal OAC activity occurs at a pH of 6.4, but this pH is not possible with HEPES. 
Nevertheless, the amounts of OA detected from assays conducted in HEPES buffer at pH 7.0 
were greater than those amounting when assays were conducted in phosphate, TRIS, or PIPES at 
pH 6.4. It was decided that future assays would use HEPES at pH 7.0. At a later date, citrate and 
MOPSO buffer systems were also compared to HEPES, and showed that MOPSO was as good 
as HEPES as a buffering agent, if not superior. In retrospect, the use of MOPSO would have 
been beneficial during all work that continued, since its pH range is 6.2 to 7.6, and an optimum 
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pH of 6.4 could have been achieved. However, the MOPSO/HEPES buffer comparison was 
tested after many assays had already been performed, and in the interest of time and resources, 
the use of HEPES as a buffer continued throughout this study. The cause for the differences in 
TKS and OAC activity in the various buffer systems is not known.  
4.4.5 OAC Does Not Require a Metal for Activity 
The TKS/OAC reaction was assayed in the presence of metals to determine if they would affect 
TKS and OAC activity, potentially leading to an augmentation in OA production. Additionally, 
the possibility that OAC employs a type II aldol mechanism to achieve OA cyclization, which 
would require the participation of a metal ion, was also explored (Silverman, 2002). It was also 
reasonable to suspect that OAC required a metal, since Mg
2+
 has been identified in the AtHS1 
crystal structure (Bingman et al., 2004). Results clearly indicate that no metal tested could 
increase OAC activity. The effect that some transition metals have on the TKS/OAC product 
profile is difficult to explain without further experimentation, but the observation that Fe
2+
, Co
2+
, 
Zn
2+
 and Cu
2+
 affect polyketide chemoselectivity is intriguing enough to warrant a directed study 
in the future.  It is easy enough to explain a loss of activity when OAC is assayed in the presence 
of these metals, but the amplification of olivetol production to levels that are three times the 
amounts observed in assays conducted in the absence of metals, coupled to a reduction of PDAL 
derailment products suggests a possible route to stabilizing TKS, and putatively other type III 
PKS in vitro reactions. These findings indicate that there is no metal requirement for OAC. 
Future experiments that would examine this chemoselectivity phenomenon should include a 
broader spectrum of metals to test and vary the concentrations of these metals when being 
assayed with TKS.  
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In support of the notion that neither TKS nor OAC requires any metal for their activity 
are the results from assays conducted in the presence of EDTA. The results showed that, 
although TKS product accumulation is decreased when TKS and OAC are assayed with EDTA, 
enzyme activity is not abolished, and OA accumulation is hardly affected (Figure 4.17). The 
findings discount the metal-catalyzed aldol condensation as a plausible mechanism for OAC. 
Likewise, no other bacterial cyclase involved with type II PKSs has been reported to require a 
metal (Schneider, 2005). 
The inclusion of EDTA also caused an increase in PDAL production, suggesting EDTA 
destabilizes the TKS reaction by causing the premature release of nascent polyketide 
intermediates, although notably, OAC activity remained unaffected. The effects caused by 
EDTA and metals may be due to direct interaction on the enzymes themselves, but may also 
have been caused by their reactivity to a yet unidentified labile polyketide intermediate that 
remains in solution until it cyclizes. 
4.4.6 The use of MCS in assays abolishes the need for malonyl-CoA 
Assays that utilized MCS bypassed the requirement of malonyl-CoA in TKS/OAC assays, but 
required the inclusion of sodium malonate, ATP, Mg
2+
, and free CoA instead. These assays were 
primarily conducted to determine if MCS could augment OA production during TKS/OAC 
assays. Assays performed in the presence of MCS were capable of successfully generating 
malonyl-CoA required by TKS, although a reduction in product accumulation was observed. 
This reduction in overall TKS/OAC activity could be due to the addition of Mg
2+
 and/or free 
CoA, which have each been shown to be destabilizing agents. It should be noted that the 
optimization of the MCS reaction with TKS and OAC has not been conducted, and that future 
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work employing MCS could benefit if this were to take place, which would most likely lead to 
an increase in product yield. Nevertheless, the inclusion of MCS in the TKS/OAC reaction was 
successful in that these reactions could be conducted without exogenous malonyl-CoA. Assays 
were also conducted with free CoA to determine how well this compound could be tolerated. As 
previously mentioned, a decrease in the overall TKS/OAC reaction output is correlated to the 
concentrations of free CoA in enzyme assays, but the concentration of free CoA used in later 
analyses (0.20 mM CoA) did not interfere with the quantification of assay products. 
4.4.7 Neither HTAL, PDAL, nor olivetol are substrates for OAC 
The possibility that OAC acts directly on TKS products was explored by assaying OAC in the 
presence of HTAL, PDAL, and olivetol, but no significant OA production was detected. Trace 
amounts of OA were detectable when 1 mM HTAL was incubated with OAC, although this 
small amount was almost negligible (20 pmol), since typically TKS reaction generates much 
smaller amount of HTAL than the amounts used in these assays. If OAC was capable of opening 
and re-cyclizing HTAL into OA, it would be anticipated that OA accumulation would be 
comparable to a typical TKS/OAC reaction, where OA accumulated to approximately 500 pmol. 
It is noted that OA was detected when OAC was assayed with 1 mM HTAL, but that the minute 
amount may have been produced following spontaneous HTAL ring opening followed by 
spontaneous or possibly OAC-catalyzed cyclization to form OA. The spontaneous opening and 
closing of lactones which results in the formation of resorcylates has been previously reported 
with starter-chain homologs (i.e. TTAL) (Guilford et al., 1968). I propose that a similar reaction 
also occurs, although at a slower rate, with HTAL. The potential involvement of TKS during 
HTAL ring opening was also assessed by including TKS during OAC assays performed in the 
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presence of HTAL, but no OA was detected, conclusively discounting this possibility. Similarly, 
the putative involvement of free CoA as a cofactor was also investigated during OAC/HTAL 
assays, but no OA was detected during LCMS analysis.  
4.4.8 Polyketide Analogs are Cyclized to their Respective Resorcylic Acid by OAC 
TKS/OAC assays were also performed using alternative CoA-esters besides hexanoyl-CoA, 
which included butyryl-CoA, octanoyl-CoA, and acetyl-CoA. Although no standards were used, 
the detection of polyketide analogs was made possible by comparing product UV spectra 
produced in these assays with those from standard TKS/OAC assay products that used hexanoyl-
CoA as a starter. Additionally, the use of LCMS SIR for masses of the theoretical products was 
also capable of confirming the identities of the polyketide analogs produced (Figures 4.21, 4.22, 
and 4.23). Acetyl-CoA, butyryl-CoA and octanoyl-CoA were each accepted as starter 
compounds by TKS, and appeared to be successfully incorporated into triketide and tetraketide 
products, which included PDAL, HTAL, and olivetol analogs. In addition to these analogs, TKS 
assays conducted in the presence of OAC were also capable of producing divarinic acid and 
heptylresorcylic acid, when butyryl-CoA and octanoyl-CoA were used as alternative starter 
compounds, respectively. These results contradict previous reports that TKS cannot produce 
HTAL analogs when either butyryl-CoA or octanoyl-CoA replaces hexanoyl-CoA as starter CoA 
ester, and that TKS cannot produce heptylresorcylic acid when octanoyl-CoA is used (Taura et 
al., 2009). The lack of polyketide analogs in assays conducted by others may be due to 
differences in buffering system, the lower pH employed, or subtle differences between TKS and 
OLS. 
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Findings also show that TKS is capable of using acetyl-CoA as a starter molecule, and 
results in the production of TAL, TTAL, orcinol, and orsellinic acid (Figure 4.23). These assays 
differ from assays using butyryl-CoA or octanoyl-CoA, in that TKS assays that use acetyl-CoA 
are capable of accumulating a resorcylic acid analog (orsellinic acid in this case) whether they 
are performed in the presence or absence of OAC. When butyryl-CoA or octanoyl-CoA were 
used as priming agents, the accumulation of their resorcylic acid analogs was only produced 
when OAC was present. This difference in the cyclization can be attributed to the variability in 
length and bulkiness of the primer’s alkyl groups, and the propensity of the synthesized 
tetraketide’s lactone ring to open and close in solution. The ability of TTAL to spontaneously 
and easily reform into orcinol and orsellinic acid has been previously reported (Bentley and 
Zwitkowits, 1967; Guilford et al., 1968). Guilford et al. (1968) have also demonstrated that 
phenacylpyrone, a TTAL lactone analog attached to a bulky phenyl group, is a moderately stable 
lactone capable of withstanding ring opening and subsequent conversion to its 
recorcylate/resorcinol analog, whereas TTAL, which contains only a methyl group instead of a 
phenyl ring, can open easily. Therefore, it is not surprising to discover orsellinic acid is a product 
of TKS assays that use acetyl-CoA when conducted in the absence of OAC. 
The ability of TKS and OAC to synthesize different resorcylic acids by using different 
starting molecules is in agreement with the occurrence of cannabinoid analogs observed in 
nature. These analogs replace the otherwise normal pentyl side chain of cannabinoids with 
methyl (Vreet et al., 1972), propyl (Merkus, 1971), butyl (Harvey, 1976), and possibly even 
heptyl side chains (Isbell, 1973). The biosynthesis of these cannabinoid analogs would proceed 
through the prenylation of short-chain (1-8 carbon) resorcylic acids which would have been 
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generated by TKS and OAC. The plasticity observed in TKS is reminiscent of GCHS2, a non-
CHS type III PKS from Gerbera hybrida also capable of accepting acetyl-CoA as a starter 
molecule (Eckermann et al., 1998). Unlike the traditional CHSs that synthesize naringenin 
chalcone from phenylpropanoid CoA esters, GCHS2 is a pyrone synthase that synthesizes TAL 
after two condensations with acetyl-CoA. GCHS2 is also capable of using only malonyl-CoA as 
a primer following decarboxylation to acetyl-CoA. Similar activity was not observed with TKS. 
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5. ANALYSIS OF PHYSICAL INTERACTION BETWEEN TKS AND OAC 
 
5.1 Introduction 
This chapter focuses on experiments designed to examine the physical relationship between TKS 
and OAC, which may also provide insight into the mechanism of OA biosynthesis. Despite the 
biochemical evidence presented in Chapter 4, showing that TKS and OAC function together to 
produce OA, fundamental questions about to the mechanism of OA biosynthesis still need to be 
addressed. One issue was whether these enzymes exist in the same cellular compartment, for if 
they do not, it would be difficult to suggest that they participate together in an enzymatic 
reaction. The possibility that TKS and OAC physically interact is reasonable, given that OAC 
resembles a type II cyclase, and that type II polyketide biosynthesis is accomplished by 
multienzyme complexes (Staunton and Weissman, 2001). Multienzyme complexes (metabolons) 
have also been shown to exist in plants, as in Calvin cycle complexes (Suss et al., 1993), serine 
and cysteine biosynthesis enzyme complexes (Prabhu et al., 1996; Saito et al., 1995), and the 
oxidative pentose phosphate metabolon (Debnam et al., 1997). Winkel-Shirley (1999) suggests 
that metabolons frequently occur in the cell and constitute a structured organization of cellular 
components instead of loosely associated soluble enzymes (Winkel-Shirley, 1999). This makes 
sense, considering that cellular activities could be more tightly regulated in this way, as well as 
increasing metabolic efficiency, increasing local substrate concentrations, and partitioning 
metabolites to similar branching pathways. Earlier reports from Stafford (1974) also suggest that 
enzyme complexes exist so to facilitate the biosynthesis of products that are localized in specific 
subcellular compartments (Stafford, 1974). Interestingly, enzymes from both the 
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phenylpropanoid and flavonoid biosynthesis pathways have been shown to interact. Winkel-
Shirley’s (1999) review on enzyme complex association in the phenylpropanoid and flavonoid 
biosynthesis pathways suggests that: 1) metabolites are channelled from one enzyme to another 
as in the case of phenylalanine ammonia-lyase (PAL) and cinnamate 4-hydroxylase (C4H), 
where 
3
H-phenylalanine is preferentially used as a substrate instead of 
14
C-cinnamic acid in the 
production of labelled p-coumaric acid (Czichi and Kindl, 1977); 2) enzymes are co-localized at 
microsomal and endoplasmic reticulum sites, as is evident by cell fractionation experiments 
conducted by Grisebach and Fritsch (1975), and similarly Hrazdina et al. (1978) who showed 
that CHS pellets with the microsomal fraction of Tulipa and Hippeastrum tissues, and later by 
Wagner and Hrazdina (1984), who demonstrated that PAL, C4H, and CHS all co-fractionated 
with NADPH:Cyt c reductase, an endoplasmic reticulum marker; 3) enzymes involved in the 
phenylpropanoid/flavonoid biosynthesis pathway are induced in a co-ordinate manner, which has 
led to the classification of early and late genes associated with the synthesis of flavonoids, and 
the later synthesis of proanthocyanidins, anthocyanidins and flavonols (Pelletier et al., 1997); 4) 
direct protein-protein interactions do occur, as reported by Burbulis et al. (1999), who used a 
yeast two-hybrid (Y2H) system to show direct interaction between A. thaliana CHS, chalcone 
isomerase (CHI) and dihydroflavonol 4-reductase (D4R), and used polyclonal antibodies 
generated against CHI to co-immunoprecipitate CHS and D4R. 
To determine if TKS and OAC co-localize in vivo, the subcellular localization of 
fluorescent tagged TKS and OAC was performed. This allowed the visualization of these 
proteins in planta using confocal microscopy following agroinfiltration in Nicotiana 
benthamiana leaves. Once the co-localization of the enzymes was confirmed, a Y2H assay was 
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performed to determine if TKS and OAC physically interact. If a physical interaction existed, it 
would imply that TKS physically directs a transient intermediate to OAC, as in the case of PAL 
and C4H (Czichi and Kindl, 1977), or possibly that TKS activity is modified by OAC through an 
allosteric mechanism that alters the TKS active site. 
Further experiments attempted to determine if TKS produces and subsequently releases a 
polyketide intermediate, which is then bound and cyclized by OAC. TKS/OAC reactions were 
conducted by exploiting the poly-histidine tag in recombinant TKS using magnetic Talon beads, 
allowing TKS to be removed during enzyme assays and then observing whether or not OA could 
be produced in the absence of TKS.  
Similar assays, designed to assess the enzymes’ ability to function independently, were 
performed using a microdialysis apparatus which separated TKS and OAC. These experiments 
have provided important insights into the physical relationship between TKS and OAC, as well 
as providing valuable evidence that supports the notion of a linear polyketide intermediate being 
produced and released from TKS before it is acquired and cyclized by OAC. 
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5.2 Materials and Methods 
5.2.1 Subcellular Localization of TKS and OAC 
The TKS-cyan fluorescent fusion protein (TKS:CFP) and OAC-yellow fluorescent fusion protein 
(OAC:YFP) constructs were generated by amplifying TKS and OAC without C-terminal stop 
codons using Pfu Ultra II DNA Polymerase (Stratagene) and the primers and cycling conditions 
shown in Tables 5.1 and 5.2. PCR products were A-tailed by incubation at 72°C for 15 min 
along with 50 U of Taq polymerase (Invitrogen) and 0.10 mM dATP before purification using a 
Minelute PCR kit (Qiagen). PCR products were ligated into the pCR8/GW/topo entry vector 
(Invitrogen), resulting in the pSG054 and pSG055 plasmids harboring TKS and OAC without 
stop codons, respectively, that were separately used to transform E. coli DH5α competent cells 
(Invitrogen). Plasmids were isolated using a Qiaprep Spin Miniprep Kit (Qiagen) from DH5α 
cultures after they were grown in LB in the presence of 50 mg/mL spectinomycin overnight at 
37°C. Following sequence verification (PBI DNA Technologies Unit), pSG054 was subcloned 
into the pEARLEY102 (Invitrogen), resulting in the TKS:CFP construct. Similarly, pSG055 was 
subcloned into pEARLEY101 (Invitrogen), creating the OAC:YFP construct. Following LR 
recombination, constructs were sequenced to confirm orientation using the primers described in 
Table 5.2.  
Expression constructs were transformed by electoporation in competent Agrobacterium 
tumefaciens LBA4404 and plated onto selective LB in the presence of 10 µg/mL of rifampacin 
and 50 µg/mL of kanamycin (Weigel and Glazebrook, 2006). Freshly cultured transformants 
were grown to an OD600 of 0.2 and used to agroinfiltrate two-week old Nicotiana benthamiana 
leaves (Sparkes et al., 2006). Following a two-day incubation period, plant tissue near 
  
138 
 
agroinfiltration sites were cut into 1 x 1 cm squares and placed in dH2O on a microscope slide 
prior to being examined by confocal microscopy. A Zeiss LSM510 confocal microscope was 
used to visualize the TKS:CFP construct after excitation with a diode laser set to 458 nm and to 
capture images using a 475-525 nm bandpass filter. The OAC:YFP construct was visualized by 
setting the diode laser to 514 nm and using a 530-600 nm bandpass filter. Images were processed 
using the Zen software suite (Carl Zeiss Microscopy). 
Table 5.1 Primers used during the creation of TKS:CFP and OAC:YFP 
Name Forward Primer Reverse Primer 
TKS:CFP ATGAATCATCTTCGTGCTGAG ATATTTGATGGGAACACTACG 
OAC:YFP ATGGCAGTGAAGCATTTGATT CTACTTTCGTGGTGTGTAGTC 
TKS:CFP sequencing ATGAATCATCTTCGTGCTGAG CTTTCGTGGTGTGTAGTC 
OAC:YFP sequencing ATGGCAGTGAAGCATTTGATT CTTTCGTGGTGTGTAGTC 
 
Table 5.2 Details regarding the creation TKS:CFP and OAC:YFP constructs 
Name Template Melting
1
 Annealing
1
 Elongation
1
 Destination Selection
2
 
TKS:CFP pHIS8-TKS 95°C/20s 50°C/20s 72°C/18s pEARLEY102 Kan
R
 
OAC:YFP pET100-OAC 98°C/20s 55°C/20s 72°C/18s pEARLEY101 Kan
R
 
1 - The reactions were cycled 30-35 times before ending with 7 min at 72°C. 
2 - Kanamycin resistance (Kan
R
). 
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5.2.2 Yeast Two-Hybrid Methods 
Experiments used a ProQuest Two-Hybrid System (Invitrogen). The system uses two specialized 
Gateway plasmids, pDest32 and pDest22, for rapid cloning, expression and analysis of proteins 
of interest. The pDest32 plasmid contains a GAL4 DNA-binding domain (DBD), one of two 
domains derived from the GAL4 transcription factor, and is responsible for binding an upstream 
operator sequence. Proteins of interest fused to this domain are collectively known as bait 
protein. The activating domain (AD) is the other half of the GAL4 transcription factor and is 
harbored by the pDest22 plasmid. Proteins of interest fused to this domain are referred to as prey 
proteins. β-galactosidase assays of fusion proteins allowed for blue/white screening using 5-
bromo-4-chloro-3-indolyl- beta-D-galactopyranoside (X-gal) as a substrate. If an interaction 
existed between bait and prey fusion proteins, X-gal would be cleaved, resulting in an insoluble 
blue 5, 5'-dibromo-4,4'-dichloro-indigo which acts as an colorimetric indicator. 
A number of plasmids were required for these experiments, necessitating the cloning of 
TKS and OAC into the pDest32 and pDest22 vectors. Furthermore, a combination of plasmids 
were used to transform the Saccharomyces cerevisiae strain MaV203, resulting in a collection of 
different transformants (results Section 5.3.2). Plasmids used in this work are summarized in 
Table 5.3.  
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Table 5.3 Plasmids used to transform MaV203 yeast used in Y2H experiments 
Name Function Derived from Selection
1
 
pDEST32 Bait vector n/a LEU2 and Gen
R
 
pDEST22 Prey vector n/a TRP1 and Amp
R
 
pEXP32/Krev1 Control bait  pDEST32 LEU2 and Gen
R
 
pEXP22/RalGDS-wt Strong positive control  pDEST22 TRP1 and Amp
R
 
pEXP22/RalGDS-m1 Intermediate positive control  pDEST22 TRP1 and Amp
R
 
pEXP22/RalGDS-m2 Negative control pDEST22 TRP1 and Amp
R
 
pRT030 TKS (entry vector)  pCR8/GW/TOPO Spc
R
 
pSC033 OAC (entry vector)  pCR8/GW/TOPO Spc
R
 
pSG057 TKS in prey vector  pDEST22 + pRT030 TRP1 and Amp
R
 
pSG058 TKS in bait vector pDEST32 + pRT030 LEU2 and Gen
R
 
pSG059 OAC in prey vector pDEST22 + pSC033 TRP1 and Amp
R
 
pSG060 OAC in bait vector pDEST32 + pSC033 LEU2 and Gen
R
 
1 – Antibiotic resistance to gentamycin (GenR), ampicillin (AmpR), or spectinomycin (SpcR). 
5.2.3 Plasmid Construction 
Both Gateway-compatible TKS (pSC033) and OAC (pRT030) were subcloned into each 
pDEST22 and pDEST32 by LR recombination as directed by the manufacturer’s protocol. 
Reagents were supplied as part of the ProQuest Two-Hybrid System (Invitrogen). The reactions 
generated the pSG057, pSG058, pSG059, and pSG060 constructs (Table 5.3). Plasmids were 
transformed into E. coli Mach 1 cells (Invitrogen) and, following their culturing, were isolated 
using a QIAprep Spin Miniprep Kit (Qiagen) before being sequenced using the recommended 
ProQuest kit primers (Invitrogen) (Table 5.4). 
Table 5.4 Sequencing primers for pDEST22 and pDEST32 based vectors 
Function Sequence 
pDEST32 forward sequencing primer (23mer) AACCGAAGTGCGCCAAGTGTCTG 
pDEST22 forward sequencing primer (21mer) TATAACGCGTTTGGAATCACT 
pDEST32/22 reverse sequencing primer (23mer) AGCCGACAACCTTGATTGGAGAC 
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5.2.4 Yeast Transformants 
Once sequences were confirmed, Saccharomyces cerevisiae MaV203 competent cells were 
transformed with the generated plasmids (Table 5.3). MaV203 cells were made competent by 
initially inoculating 10 mL of liquid YPAD media (1% Bacto-yeast extract, 2% Bacto-peptone, 
2% glucose, 0.01% adenine sulfate [pH 6]) and culturing overnight at 30°C. The overnight 
culture was diluted to an OD600 of 0.4 in 50 mL of YPAD and incubated for an additional 4 h. 
The culture was centrifuged at 1,000 g and resuspended in 40 mL of sterile TE (10 mM TRIS-
HCl [pH 7.5], 1 mM EDTA). Cells were again centrifuged at 1,000 g (supernatant discarded) and 
resuspended in 2 mL of sterile 1 x LiAc/0.5x TE (100 mM LiAc, 5 mM TRIS-HCl [pH 7]). Cells 
were incubated in this solution for 10 min before proceeding to transformations. A total of 1 µg 
of DNA was used in each transformation, where 500 ng of DNA from each plasmid was used. 
An example of this is SG100, where 1 µL of 500 ng/µL pEXP32/Krev1 was used with 1 µL of 
500 ng/µL pEXP22/RalGDS-wt resulting in 1 µg of total DNA being used in this transformation. 
For each transformation 1 µg of DNA was added with 100 µg denatured sheared salmon sperm 
DNA to 100 µL of competent yeast cells. 700 µL of 1 x LiAc/40% PEG-3350/1x TE was then 
added and mixed. Reactions were incubated for 30 min at 30°C, followed by the addition of 88 
µL DMSO. Cells were then heat-shocked at 42°C for 7 min, followed by a 1,000 g centrifugation 
for 10 s. Supernatant was removed, and cells were resuspended in 1 mL of 1 x TE. Cells were 
again pelleted at 1,000 g for 10 s and resuspended in 100 µL TE, before being plated onto 
selective SC-Leu-Trp plates (0.67% Bacto-yeast nitrogen base without amino acids (Sigma), 2% 
glucose (w/v), 2% Bacto agar (w/v), 0.2% dropout mix (w/v) containing equal (w/w) proportions 
of adenine sulfate, alanine, arginine, aspartic acid, asparagine, cysteine, glutamic acid, 
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glutamine, glycine, isoleucine, lysine, methionine, phenylalanine, proline, serine, threonine, 
tyrosine, and valine [pH 5.9]). Plates were incubated for three days at 30°C. After three days 
colonies were selected and restreaked onto fresh SC-Leu-Trp plates and incubated for another 3 
days at 30°C. A negative control lacking plasmid was also set up, although no cells were found 
to grow.  
5.2.5 Confirmation of DNA Inserts 
Yeast DNA was prepared using a QIAprep Spin Miniprep Kit (Qiagen), and a protocol adapted 
by Jones (2000). MaV203 yeast transformants SG103, SG200, SG201, SG202, and SG203 were 
cultured for two days at 30°C. Cells were pelleted (5 min at 5,000 g) and resuspended in 250 mL 
P1 buffer  containing 0.1 mg/mL RNase A. Approximately 100 mL of acid-washed glass beads 
(Sigma) were used to rupture cells over 2 min in a minibeadbeater (Biospec). The remainder of 
the DNA extraction was conducted as directed by Jones (2000), although 25 mL of elution buffer 
(EB) was used in the final step instead of 50 mL. A 2 µL aliquot of purified DNA was used to 
individually transform 50 mL of E. coli Top 10’ electrocompetent cells (Invitrogen), which were 
plated onto LB + 100 µg/mL carbenicillin and LB + 10 µg/mL gentamycin and grown overnight 
at 37°C. Cultures were successfully transformed, except for SG103 and SG 200 which did not 
grow on LB + 10 µg/mL gentamycin. Single colonies were used to inoculate 5 mL liquid LB + 
10 µg/mL gentamycin or LB + 100 µg/mL carbenicillin and grown overnight at 37°C. DNA was 
purified using a QIAprep Spin Miniprep Kit (Qiagen), quantified using a NanoDrop 8000 
Spectrophotometer (Thermo Scientific) and sequenced using ProQuest-recommended 
sequencing primers (Invitrogen) (Table 5.4). Although SG200 did not grow on LB + 10 µg/mL 
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gentamycin, the TKS cassette was detected by direct sequencing using either the pDEST32 or 
pDEST22 forward sequencing primers. 
5.2.5.1 Determination of 3-AT Concentration used in Histidine Dropout Media 
Before proceeding with the full characterization of transformants, the amounts of 3-
aminotriazole (3-AT) needed to inhibit HIS3 self-activation were assessed. Yeast transformants 
SG100, SG101, SG102, SG200, SG201, and SG202 were grown overnight in 5 mL liquid SC-
Leu-Trp medium at 30°C. Cells were pelleted and resuspended in 1 mL sterile dH2O. Cells were 
again pelleted and resuspended in 1 mL sterile water. Cultures were diluted with sterile water 
until the OD600 of a 10x dilution (i.e. 100 µL of culture + 900 µL water) was 0.1 ± 0.01. This 
allowed the standardization of cultures with an estimated starting OD600 of 1.0 ± 10%. These 
cultures were serially diluted resulting in OD600 concentrations of 0.5, 0.25, 0.125, 0.0625, and 
0.03125 (based on original OD600). A 5 µL aliquot from each of these dilutions was spotted onto 
several SC-Leu-Trp-His plates containing either 10, 25, 50, or 100 mM 3-AT, and incubated at 
30°C for three days.  
5.2.5.2 Characterization of Transformants 
Two-day old starter cells that had been grown at 30°C were pelleted (5,000 g for 10 min), the 
supernatant was removed, and cells washed with 2 mL sterile H2O (this step removed excess 
amino acids). The cells were again pelleted and resuspended into 1 mL sterile water then diluted 
until an OD600 of 1.0 ± 0.1 was achieved. These cells were used to spot 5 µL aliquots of 1x, 2x 
and 10x dilutions onto SC –Leu –Trp –His + 50 mM 3-AT and onto YPAD plates covered with 
an 82 mm diameter nylon membrane specialized for colony and plaque hybridization (Roche). 
The SC –Leu –Trp –His + 3-AT plates were incubated for three days at 30°C and then observed 
  
144 
 
for colony formation. The YPAD + membrane plates were incubated for 24 h at 30°C. The nylon 
membrane was placed in liquid N2 for 1 min. The membrane was then thawed on two saturated 
150 mm diameter filter papers (Whatman) in a 150 mm petri dish. The filter papers were 
saturated with 8 mL X-gal solution (10 mg X-gal in 100 µL DMF + 60 µL 2-mercaptoethanol in 
10 mL (filter sterile) Z-buffer (0.06 M Na2HPO4-7H2O + 0.04 M NaH2PO4-H2O + 0.01 M KCl + 
0.001 M MgSO4-7H2O in H2O [pH 7]). Petri dishes were covered and incubated 24 h at 37°C. 
5.2.6 TKS Magnetic Pulldown Methods 
The poly-histidine tag in the pHIS8-TKS construct was exploited using Talon magnetic beads 
(Clontech) to remove TKS from solutions containing malonyl-CoA and hexanoyl-CoA. Reaction 
mixtures were allowed to incubate with TKS for a given time, after which the TKS was removed, 
and the supernatant was transferred to a new reaction vessel containing OAC. The accumulation 
of OA was then analyzed by LCMS. 
A new OAC construct that was codon-optimized for its expression in E. coli (pJE60174) 
was used during this work. The pJE60174 OAC construct was expressed, purified (as in Section 
3.1.1), and digested in the presence of Thrombin to remove its poly-histidine tag. Protein 
solution eluting from Talon beads was concentrated to a 1 mL solution using YM10 centrifugal 
filter device (Millipore) and rinsed using a 5 mL solution of 20 mM HEPES, 50 mM NaCl, and 5 
mM DTT before being concentrated again to 1 mL and transferred to a Spectra-Por Float-A-
Lyzer with a 5 kDa MWCO (Sigma).  A 10 U aliquot of high activity Thrombin (Millipore) was 
added to the dialysis tubing. The solution was allowed to digest and dialyze overnight at 4°C. 
The solution was removed from the dialysis tubing and incubated at 4°C for 1 h with 1 mL Talon 
(Clontech). The Talon was added to a gravity flow column and the wash-through was collected 
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and concentrated using a YM10 centrifugal filter device (Millipore). This solution contained the 
cleaved OAC without a His-tag.  
Reaction mixtures were incubated with TKS for a short time, after which the TKS was 
removed by magnetic aggregation and the supernatant was transferred to a new reaction vessel 
containing either OAC or water. The accumulation of OA was then analyzed by LCMS as 
described in Section 3.3.1. A flowchart for this experiment is illustrated in Figure 5.1. 
 
Figure 5.1  Flowchart for TKS pulldown assays. 
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5.2.6.1 Magnetic Talon Beads 
The binding capacity is 705 µg of protein for each 1 mL suspension of Talon beads, therefore 25 
µL of beads per 10 µg of TKS were used, although 25 µL of beads is capable of binding almost 
2x this amount of protein (i.e. 18.75 µg of protein). A total of 325 µL Talon suspension (12 
reactions) was pelleted (1,000 g for 1 min) and washed twice using 300 µL of 20 mM HEPES 
[pH 7.0] containing 5 mM DTT. A total of 25 µL of 5 mg/mL TKS was added to 275 µL of 20 
mM HEPES [pH 7.0] containing 5 mM DTT. This volume was added to the washed Talon beads 
and was allowed to tumble for 90 min at 4°C to assure proper binding. Beads were pelleted once 
more (1,000 g for 1 min) and the supernatant discarded. A fresh 300 µL of buffer was added to 
the Talon-TKS beads. This allowed for 10 µg of TKS per 25 µL volume. 
5.2.6.2 TKS Pulldown Reactions 
All experiments were conducted in triplicate. Reaction mixtures (100 µL) were derived from a 
master mix consisting of 0.2 mM hexanoyl-CoA, 0.6 mM malonyl-CoA, 5 mM DTT, and 20 
mM HEPES [pH 7.0]. Reactions were started by adding 25 µL of TKS-beads. Samples included: 
Sample 1 – TKS-beads alone. Incubated at 10°C for 30 min. This sample was a negative control. 
Sample 2 – TKS-beads + OAC. Incubated at 10°C for 30 min. This was a positive control. 
Sample 3 – TKS-beads alone at 10°C for 15 min. Beads were pulled down, the supernatant was 
transferred to a new reaction vessel containing OAC and allowed to react for an additional 15 
min at 10°C. This sample is the experimental sample.  
Sample 4 – TKS beads alone incubated at 10°C for 1 min. Beads were removed and supernatant 
was transferred to a new tube, then maintained at 10°C for 14 min. OAC was added to the 
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supernatant and allowed to react for an additional 15 min at 10°C. This sample was to assure no 
TKS was being released; it represents another negative control. 
Reactions were extracted twice using 500 µL ethyl acetate. Extracts were dried under vacuum 
then resuspended in 20 µL of resuspension solution. Injections of 10 µL were analyzed by 
LCMS as previously described (Section 3.1.1).  
5.2.7 Equilibrium Enzyme Assays 
Assays were performed using Fast Micro-Equilibrium Dialyzers with 100 µL chambers (Harvard 
Apparatus) (Figure 5.2). Each apparatus contained two chambers separated by a 5,000 Da 
MWCO cellulose acetate membrane that had been rinsed in dH20, and then equilibrated for 30 
min in 20 mM HEPES [pH 7.0]. Each chamber contained 100 µL reaction mixture consisting of 
20 mM HEPES [pH 7.0], 5 mM DTT, 200 µM hexanoyl-CoA, and 600 µM malonyl-CoA. 
Reactions were initiated by adding TKS (20 µg) into one of the chambers. Reactions included a 
negative TKS-only control, a positive TKS and OAC (10 µg) control containing both enzymes in 
one chamber, and a TKS and OAC sample containing 20 µg TKS and 10 µg OAC in separate 
chambers. After incubating the reactions for 2 h at 10°C, reactions were transferred to 1.5 mL 
tubes and extracted using 2 x 500 µL of ethyl acetate. Extracts were dried under vacuum and 
resuspended in 20 µL of resuspension solution. 10 µL aliquots were analyzed by LCMS as 
described in Section 3.1.1. 
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Figure 5.2  The Harvard Apparatus Dialyzer 
This dialyzer, which is similar to the one used during my experiments, separates two 100 µL 
chambers with a cellulose acetate membrane allowing for equilibrium to be reached between 
both chambers, while partitioning molecules > 5 kDa (i.e. TKS and OAC). 
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5.3 Results 
5.3.1 Sub-Cellular Localization of TKS and OAC 
To test whether both TKS and OAC co-localize in planta, fluorescent fusion constructs were 
made and used to infiltrate N. benthamiana plants where their location could be monitored by 
confocal microscopy. Specifically, TKS was subcloned without a stop codon into the Gateway-
compatible pEarley102 vector to generate a pTKS:CFP, and OAC was subcloned without a stop 
codon into the pEarley101 vector, resulting in the generation of pOAC:YFP (Earley et al., 2006). 
These two constructs were separately used to transform Agrobacterium tumefaciens, which 
subsequently were used to infiltrate N. benthamiana plants based on previously reported methods 
(Sparkes et al., 2006; Weigel and Glazebrook, 2006). After a two-day incubation period, 
epidermal cells were observed using confocal microscopy, where TKS:CFP and OAC:YFP were 
visualized following excitation with a diode laser at the appropriate wavelengths. Results 
indicate that both constructs co-localized to the same sub-cellular compartment, with some 
residual fluorescence detected in the nucleus (Figure 5.3).  
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Figure 5.3  Co-localization of TKS and OAC. 
The subcellular localization of (A) TKS:CFP and (C) OAC:YFP in N. benthamiana cells show 
both constructs co-localize as seen when images are (B) overlayed.  N. benthamiana epidermal 
cells were examined by confocal microscopy.  
5.3.2 Yeast Two-Hybrid Approach 
Once the subcellular co-localization of TKS and OAC was confirmed, Y2H experiments were 
carried out to determine if TKS and OAC physically interact. TKS and OAC were cloned into 
the pDest32 and pDest22 vectors. A combination of plasmids were then used to transform the 
Saccharomyces cerevisiae strain MaV203, resulting in a collection of different yeast 
transformants (Table 5.5). Before proceeding with the full characterization of transformants, it 
was required to assess the amounts of 3-aminotriazole (3-AT) needed to inhibit HIS3 self-
activation (Ausubel et al., 1994). Yeast transformants SG100, SG101, SG102, SG200, SG201, 
and SG202 with an OD600 equal to 0.1 ± 0.01 were diluted to concentrations of 0.5, 0.25, 0.125, 
0.0625, and 0.03125 (based on original OD600), before being spotted onto several SC-Leu-Trp-
His plates containing 10 mM, 25 mM, 50 mM or 100 mM 3-AT. Plates were incubated at 30°C 
for three days (Figure 5.4). A concentration of 50 mM 3-AT was found sufficient to inhibit HIS3 
self-activation. 
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Once the appropriate level of 3-AT was determined, MaV203 yeast transformants were 
spotted onto SC-Leu-Trp-His plates containing 50 mM 3-AT, and then grown for three days at 
30°C. Other than the positive controls, no other transformant was capable of growth (Figure 5.5). 
Additionally, the β-galactosidase activity of transformants was also assayed, yet only the yeast in 
positive controls were capable of cleaving X-gal, resulting in a characteristic blue color (Figure 
5.5). Collectively, these Y2H results indicate that OAC and TKS do not physically interact at the 
molecular level. 
Table 5.5 Yeast transformants used in Y2H experiments 
NAME BAIT VECTOR PREY VECTOR FUNCTION 
SG100 pEXP32/Krev1 pEXP22/RalGDS-wt strong positive control 
SG101 pEXP32/Krev1 pEXP22/RalGDS-m1 intermediate positive control 
SG102 pEXP32/Krev1 pEXP22/RalGDS-m2 negative control 
SG103 pDEST32 pDEST22 negative control 
SG104 pDEST32 pSG057 (TKS) negative control 
SG105 pDEST32 pSG059 (OAC) negative control 
SG106 pSG058 (TKS) pDEST22 negative control 
SG107 pSG060 (OAC) pDEST22 negative control 
SG200 pSG058 (TKS) pSG057 (TKS) negative control 
SG201 pSG058 (TKS) pSG059 (OAC) test sample 
SG202 pSG060 (OAC) pSG057 (TKS) test sample 
SG203 pSG060 (OAC) pSG059 (OAC) negative control 
 
 
Figure 5.4  Determining 3-AT concentrations used in Y2H assays. 
MaV203 yeast transformants SG100, SG101, SG102, SG200, SG201, and SG202 were spotted 
onto SC-Leu-Trp-His plates containing varying concentrations of 3-amino-1,2,4-triazole (3-AT).  
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Figure 5.5  Histidine biosynthesis and β-Galactosidase activity in Y2H screens. 
Yeast two-hybrid assays included strong (SG100) and intermediate (SG101) positive controls, 
and a negative (SG102) control. Colonies spotted on Histidine drop-out medium are shown in 
left  panels, whereas colonies transferred to assess β-galactosidase activity are shown on the 
right. Numbers below the panels represent the MaV203 yeast transformant tested. Note that 
SG101 did appear faint blue, but the color is not clelarly visible in this photo.  
5.3.3 The Expression and Purification of OAC in pJE60174 
Due to the low expression of OAC in pHIS8 and pET100 vectors, OAC was codon-optimized for 
expression in E. coli using the pJexpress 411 vector (DNA2.0), resulting in the pJE60174 
construct. Following the transformation of Rosetta2 BL21(DE3) Competent Cells (Novagen) and 
the subsequent growth of a starter culture (100 mL LB + 50 µg/mL of kanamycin), 1 L cultures 
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were grown for 16 h in autoinduction medium containing 50 µg/mL of kanamycin at either 25 or 
37°C. Cultures were started using 50 mL starter cultures, from which a pre-induction sample for 
SDS-PAGE was taken (Figure 5.6). The variation in temperature during culturing was performed 
to determine the optimal temperature for the expression of OAC. Post-induction samples were 
also collected prior to purification for SDS-PAGE analysis (Figure 5.6). OAC was purified by 
IMAC using Talon as previously described (Section 3.1.1), resulting in ca. 1 mL protein 
solutions. A 5 µL aliquot of purified OAC from both 25°C and 37°C was used during SDS-
PAGE (Figure 5.6). Although the Talon purification of OAC used excessive amounts of Talon to 
accommodate for excess protein that may or may not have been present, SDS-PAGE results 
indicate that the expression of OAC was increased when 25°C temperature was used instead of 
37°C (Figure 5.6). Expression of OAC at lower tempertatures resulted in ca. 8.5 mg of protein, 
whereas expression at 37°C yielded ca. 1.2 mg of OAC. Thrombin was also used to remove the 
poly-histidine tag from OAC (Figure 5.7).   
 One evident benefit of the inclusion of OAC in the pJexpress 411 vector was the loss of 
the dual band seen in previous OAC purifications derived from pHIS8 and pET100 vectors 
(Figure 4.1). The purification of OAC from pJexpress-based vectors resulted in the appearance 
of a single band during SDS-PAGE (Figure 5.7) 
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Figure 5.6  SDS-PAGE of OAC expressed from the pJexpress 411 vector. 
A 15% polyacrylamide gel was used to resolve 5.0 µL of pre-induced (PRE) and post-induced 
(POST) cultures expressing OAC, and Talon-purified OAC (PURE). Cultures were initiated 
using the same starter culture, but were then grown in parallel at either 25 or 37°C. Equal 
volumes were used to load the gel. Proteins were purified in the presence of excess Talon 
(Clontech) to ensure maximal amounts of protein were retained. OAC is evidently expressed, as 
is seen in the PURE 25°C lane at the 13 kDa mark. OAC is indicated by arrows. Numbers on the 
left of the gel correspond to the kDa of molecular weight markers (MW). 
 
Figure 5.7  SDS-PAGE of Thrombin cut OAC. 
IMAC purified OAC (PRE) was digested in the presence of Thrombin resulting in the loss of its 
polyhistidine tag. Digested OAC (CUT) was isolated by running the solution over Talon beads, 
which adhered to uncut OAC and other contaminants. The Talon-bound contaminants were also 
eluted and visualized on this gel (ELUTANT). The gel was overloaded in order to detect 
contaminating protein. Equal volumes of solution were used to load this gel. OAC is indicated by 
arrows. Numbers on the left correspond to the kDa of molecular weight markers (MW). 
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5.3.4 TKS Magnetic Pulldowns 
Experiments were designed to address whether or not OAC is capable of cyclizing TKS products 
in the absence of TKS. The experiment allowed TKS to catalyze polyketide synthesis for a brief 
time before being magnetically removed (pulled down), and removing the supernatant containing 
TKS products. The supernatant was then incubated with OAC or water, extracted, and analyzed 
by LCMS. Reactions included: 1) a negative control using only TKS-beads (B-TKS) that should 
be capable of producing HTAL, PDAL, and olivetol, but not OA; 2) a positive control that 
assayed TKS-beads in the presence of OAC and should be capable of producing OA; 3) an 
experimental sample that allowed TKS-beads to react for 15 min before using a magnet to pull 
the TKS-beads out of solution, then transferring the supernatant to a new reaction vessel 
containing OAC and incubating the solution for another 15 min, and 4) a TKS bead leak control 
that pulled down the TKS beads prior to transferring the solution to a reaction vessel containing 
malonyl-CoA, then allowing the reaction to proceed for another 15 min. These assays were also 
performed in parallel with assays that used soluble TKS (S-TKS) to compare the differences in 
product accumulation between assays. Initially, to determine the optimum temperature at which 
to conduct these experiments, the assays were performed at 10, 20, and 30°C (Figure 5.8). 
Results show that TKS-only negative controls only produced HTAL, PDAL, and olivetol, 
whereas TKS and OAC positive controls produced HTAL, PDAL, olivetol, and OA. A 
difference between S-TKS and B-TKS chemoselectivity was observed, where S-TKS produced 
almost an order of magnitude more HTAL and PDAL than did B-TKS, in the absence or 
presence of OAC and at all temperatures (Figures 5.8 and 5.9). Notably, the amounts of olivetol 
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Figure 5.8  Products accumulating during TKS pulldown assays. 
The product yields from soluble (S-TKS) and Talon-bound (B-TKS) TKS assays performed at 
10, 20, and 30°C in the presence or absence of OAC. Each panel corresponds to one reaction 
product, where the products were (A) HTAL, (B) PDAL, (C) OA, and (D) olivetol.  
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Figure 5.9  The production of OA by OAC following TKS pulldown. 
A comparison of soluble (S-TKS) and Talon-bound (B-TKS) TKS assays conducted in the 
presence and absence of OAC show product amounts obtained when B-TKS was pulled out of 
solution before adding OAC. All assays that included OAC successfully produced OA. Error 
bars are the SD where n=3. 
produced by S-TKS and B-TKS were approximately the same, which accumulated to ca. 1,800 
pmol when assayed in the absence of OAC, and to ca. 300 pmol when assayed in the presence of 
OAC (Figures 5.8 and 5.9). Similarly, OA production was also approximately the same when 
assaying S-TKS or B-TKS in the presence of OAC, where the amount of OA accumulated to ca. 
1800 pmol (Figures 5.8 and 5.9). Samples where B-TKS was removed prior to the addition of 
OAC did accumulate OA. These samples accumulated OA ca. four times less than B-TKS + 
OAC positive controls, accompanied by ca. 2.5 times more olivetol than seen in positive 
controls. Optimum temperature for OA production differed between S-TKS and B-TKS samples, 
where S-TKS showed increased OA activity at 20°C, and B-TKS showed optimum OA activity 
at 30°C. Samples that were designated as B-TKS leak controls did not show any activity. Once 
an optimal temperature of 20°C was determined (Figure 5.8), experiments were repeated to 
confirm results (Figure 5.9).  
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The hypothesis that TKS produces a soluble linear tetraketide intermediate was also 
explored by monitoring the TKS-B reactions over time (Figure 5.10). Reactions were incubated 
with TKS-B for 15 min before pulling down TKS and transferring the supernatant to a new 
reaction vessel. OAC was added to reactions immediately, or after 5, 10, 20 or 40 min had 
elapsed. OAC reactions were incubated 15 min before stopping and extracting the reactions. 
These reactions also used a negative control consisting of B-TKS only, and a positive control 
which assayed B-TKS in the presence of OAC; both assays were incubated for 30 min before 
stopping and extracting them, and were conducted in parallel with the other timed assays 
described. All assays were conducted in triplicate. The largest amount of OA (1,600 pmol) was 
detected in TKS and OAC positive controls, whereas no OA was detected in TKS-only negative 
controls. Pulldown assays that added OAC immediately following the removal of TKS produced 
the largest amount of OA (490 pmol), followed decreasingly by the 5, 10, 20, and 40 min timed 
samples, which accumulated 287, 256, 238 and 200 pmol of OA, respectively. OAC activity, or 
more correctly the substrate for OAC, was retained even after 40 min had elapsed between the 
time TKS was removed and the time OAC was added. Conversely, amongst the samples that 
were allowed to stand for a given time before OAC was added, the largest amount of olivetol 
(1,300 pmol) was detected in samples that stood for 40 min before the addition of OAC, and 
decreased as the sitting time before the addiction of OAC was shortened. Whereas HTAL 
amounts remained relatively static (41 to 56 pmol), the largest amount of PDAL (754 pmol) was 
detected in positive controls that assayed TKS in the presence of OAC. The accumulation of 
PDAL appeared to increase as sampling time increased, although the initial 0 min sample did 
contain an intermediate amount of PDAL (i.e. more than the 5 and 10 min samples, but less than 
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the 20 and 40 min samples). The least amount of PDAL and HTAL were detected in negative 
controls. 
 
Figure 5.10 Monitoring OAC substrate availability following TKS pulldowns. 
Talon bound TKS (B-TKS) was incubated for 15 min in a reaction mixture before being 
removed by magnetic pull-down. Following the transfer of the supernatant, OAC was added after 
a given time (0 to 40 min), and allowed to react for another 15 min. Error bars are the SD where 
n = 3. 
5.3.5 The TKS/OAC Dialysis Reaction 
To assess whether or not TKS and OAC can function independently, and if OAC’s substrate is a 
diffusible intermediate that is initially produced and released by TKS before being cyclized by 
OAC, dialysis experiments separated TKS and OAC enzymes using a 5 kDa membrane which 
allowed the diffusion of substrates and reaction products between chambers. A negative control 
incapable of OA production was accomplished by only adding TKS to one chamber, where the 
second chamber contained no enzyme. A positive control was produced by adding both TKS and 
OAC to one chamber, and not adding any enzyme to the second chamber. Experimental samples 
included TKS in one chamber and OAC in the other chamber. Following 1 h incubation, each 
chamber’s solution was separately extracted, and analyzed by LCMS. Whereas TKS-only 
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controls produced only HTAL, PDAL, and olivetol, positive controls and test samples were 
capable of producing OA in addition to the other TKS products (Figure 5.11).  
 
Figure 5.11 The micro-dialysis of TKS assay products. 
Chromatograms are results from HPLC sample analysis that were monitored at 270 nm. (A) The 
use of a micro-dialysis apparatus allowed TKS/OAC assays to be conducted while enzymes were 
physically separated by a 5 kDa membrane in two separate chambers. (B) Positive controls 
included both enzymes in one chamber and resulted in the production of HTAL, PDAL, OA, and 
olivetol. (C) Negative controls only used TKS in one chamber. The elution of OA is highlighted 
in pink across samples, whereas the elution of olivetol is highlighted in green. 
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5.4 Discussion 
A central focus of this work was to determine if TKS and OAC interact. Results from subcellular 
localization experiments indicate that both TKS and OAC co-localize in planta, and are not 
spatially constrained, indicating that both proteins could potentially participate in the in vivo 
production of OA (Figure 5.3). This observation raised the question as to whether or not TKS 
and OAC physically interact, conceivably modifying TKS activity by an allosteric mechanism, 
or possibly by directing a transfer of an unstable reaction intermediate. Y2H assays did not 
indicate that any physical interaction exists between TKS and OAC (Figure 5.5). The lack of 
physical interaction between these enzymes was also observed during i) TKS pulldown 
experiments, and ii) TKS/OAC dialysis assays, both of which physically separated TKS and 
OAC during assays, yet were capable of producing OA. Although these latter experiments 
cannot directly determine if TKS and OAC physically interact, they show that TKS products can 
be cyclized by OAC in the absence of TKS, which shows that these enzymes do not require 
physical interaction for OA production. These results also indicate that neither an allosteric 
mechanism nor the direct transfer of polyketide intermediates is required for OA biosynthesis. 
Instead, these results, along with the observation that neither PDAL, HTAL, nor olivetol are 
appropriate substrates for OAC (Section 4.2.10.2), and that OA production is augmented at 
colder temperatures (Section 4.2.5) suggest that a somewhat thermolabile tetraketide 
intermediate is released by TKS and is stable long enough for OAC to cyclize it. These findings 
challenge the current understanding of type III polyketide cyclization, which was understood to 
occur exclusively within the PKS active site itself (Austin and Noel, 2003). Namely, the Claisen 
condensation that occurs in CHS has been described as an intramolecular cyclization that results 
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in the release of the aromatic compound from either a conserved cysteine that tethers the nascent 
polyketide chain to the enzyme, or from CoA. Although the mechanism of polyketide release 
from the enzyme is currently unknown, the cyclization specificity of chalcone and stilbene 
synthases has been attributed to specific amino acid residues found within the type III PKS 
active site (Austin et al., 2004). There exists evidence in support of a short-lived polyketide 
intermediate, especially in type II PKSs, which produce irregular shunt products when they are 
assayed in the absence of the necessary polyketide cyclases (Shen and Hutchinson, 1996; Sultana 
et al., 2004). Since TKS does not cluster with traditional CHS or STS, and is instead related to 
unique non-chalcone synthase PKSs, it is likely that the mechanism of retention, release and 
cyclization of polyketide intermediates by TKS differs from traditional CHS/STS paradigms (a 
descriptive analysis of the phylogenetic relationship between PKSs  is shown in Appendix G 
(Schröder, 2010). 
The pathway for OA biosynthesis in cannabis requires the involvement of OAC, a unique 
polyketide cyclase, which has not been previously known to occur in plants. Instead, similar 
cyclases have been found in bacterial type II PKS systems, where multiple enzymes participate 
in the biosynthesis of polyketide products (Shen and Hutchinson, 1996). The involvement of 
OAC-like cyclases during polyketide cyclization may not be exclusive to cannabis; it is 
conceivable that similar cyclases are involved in other plants where the accumulation of 
carboxylated polyketides remains unclarified. Examples of resorcylic acid accumulation in plants 
include anacardic acids in cashew and stilbene carboxylates in Hydrangea (Gorham, 1995; 
Kozubek and Tyman, 1999), although it should be noted that type III PKSs capable of producing 
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long-chained alkylresorcylic acids without the requirement of a cyclase have been previously 
identified in rice and in the mold Neurospora crassa (Funa et al., 2007; Matsuzawa et al., 2010). 
An observation indirectly related to this project was the reduction of lactone products 
during assays performed using Talon-bound TKS. Assays that compared the activities of 
immobilized and soluble TKS showed a decrease in the production of lactone products (HTAL 
and PDAL) with almost no change to OA production when immobilized TKS was used (Section 
5.2.3). Similar results have also been reported for alfalfa CHS that had been immobilized onto 
Ni-NTA agarose, which, in addition to increased tetraketide:triketide yields, resulted in a bound 
enzyme with a much more effective half-life than soluble CHS (Kim et al., 2009).  Although the 
half-life of TKS was never explored in the current study, the observation that both immobilized 
PKSs produce higher tetraketide:triketide yields suggests that product derailment occurs easily in 
these enzymes, and that in vivo these enzymes may very well be anchored to a naturally-
occurring support matrix, as suggested for phenylpropanoid and flavonoid metabolism (Winkel-
Shirley, 1999). Recent studies have shown that resuspended type II minimal PKS involved in 
actinorhodin biosynthesis increases product yield when retained and stabilized within a dense 
coacervate matrix (Crosby et al., 2012). The authors attribute their findings to a crowding effect 
that allows for the direct transfer of PKS intermediates, but it may also be due to the stabilization 
of the PKS itself which leads to its increased efficiency. The matrix used by Crosby et al. (2012) 
is also reminiscent of the unique physiology of the trichome cell, which is dominated by 
spherical secretory bodies that could potentially be involved in anchoring TKS (Hammond and 
Mahlberg, 1978). The chemoselective adaptability observed in TKS could be of practical benefit 
in other type III PKS research that hopes to maximize enzyme efficiency. 
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6. THE STRUCTURE AND MECHANISM OF OAC 
 
6.1 Introduction 
In the previous chapter, experiments were conducted to examine the physical relationship shared 
between TKS and OAC. The observation that TKS and OAC contructs co-localize in vivo in N. 
benthamiana suggested that the proteins could potentially interact, which led to yeast two-hybrid 
experiments being performed to determine if physical interaction did occur. Yeast two-hybrid 
assays indicated that no physical interaction exists between TKS and OAC. In turn, this 
observation led to experiments that separated TKS and OAC, including the physical removal of 
TKS midway through a reaction by magnetic pull-down methods, as well as the use of a micro 
dialysis apparatus that allowed the enzymes to be separated by a permeable membrane. These 
experiments indicated that the enzymes perform separate reactions, wherein TKS synthesizes a 
theoretical soluble tetraketide intermediate, which is then independently cyclized to OA by OAC.  
The observations that TKS and OAC act separately has led to two related and important 
questions, which are; what is the mechanism of cyclization used by OAC, and what is the nature 
of the theoretical tetraketide intermediate? In the present chapter, experiments that were 
conducted to address the mechanism of OA cyclization and the nature of the intermediate are 
presented.  
The mechanism of chalcone and stilbene biosynthesis involves an intramolecular 
cyclization step that can be dramatically influenced by replacing several key amino acids located 
in the active site (Austin and Noel, 2003). Comparatively, TKS appears to behave as an STS 
when assayed alone. Similarly, during TKS and STS cyclizations, a carboxyl moiety is lost, 
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which suggests that an aldol reaction occurs during the production of olivetol as it does during 
the biosynthesis of stilbenes. This is contrasted by Claisen reactions that occur in CHSs, which 
retain all carbon moieties during the cyclization of final products. Yet, when TKS is assayed in 
the presence of OAC, the two enzymes together behave as an STCS capable of catalyzing an 
aldol C2  C7 cyclization while retaining its C1 carboxyl moiety (Figure 2.5). To better 
understand the mechanism of cyclization adopted by OAC, traditional aldolase mechanisms, 
which include class I and class II reactions, were considered (Gijsen et al., 1996). The role of a 
metal as a catalyst could have implicated a class II aldol mechanism in OAC, but this was 
dismissed since no metal is required for OA cyclization (Chapter 4), suggesting that a type I 
aldolase mechanism could be employed by OAC. It was a goal of this research to examine the 
lysine residues putatively involved in a type I aldolase mechanism in OAC, which were 
conserved by homologs that could share a similar function, but in addition to simply 
investigating conserved lysine residues, several AA residues that are conserved in OAC and its 
homologs were also investigated. 
The experiments in the present chapter use the primary and secondary structure of OAC 
to determine residues putatively involved with enzyme activity. The primary sequence of OAC 
was compared with twelve other SRABB proteins, and a homology-based model of OAC was 
developed. These analyses led to the identification of conserved AAs shared between SRABB 
homologs, some of which were subsequently targeted for alanine substitution. Additionally, to 
better understand the putative active site, the OAC structure was modeled using the crystal 
structures of A. thaliana HS1 (pdb 1Q53) and P. tremula SP1 (pdb 1TR0) as templates, allowing 
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the closer inspection of the enzyme’s three-dimensional strucutre and the positions of site-
directed mutatgenesis (SDM) sites. 
Since previous observations regarding TKS and OAC reactions imply the existence of a 
transient tetraketide intermediate, attempts to detect its existence were performed using highly 
sensitive analytical MS techniques. MS ion screens were performed during TKS and TKS/OAC 
reactions in order to detect CoA-linked compounds, with specific interest in a tetraketide-CoA 
intermediate that could exist transiently in solution. Due to the uncertainty about the reaction 
mechanism and in determining which intermediate is produced during a TKS reaction, these 
techniques were used to find ions possessing CoA fragments with a common positively charged 
fragment of 428 m/z (Figure 6.1). Similarly, neutral loss experiments were also used to detect a 
loss of 507 amu from CoA-containing molecules. 
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Figure 6.1 CoA fragmentation during MS analysis. 
(A) A proposed linear polyketide intermediate with a molecular weight of 992.8 screened for 
during MS analysis. (B) Sites of bond cleavage occur along the dashed lines in the CoA-portion 
of acyl-CoAs during MS analysis conducted in positive ion mode. Substituents (R) may include 
hexanoyl, acetyl, malonyl, and other products, such as seen in (A). 
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6.2 Materials and Methods 
6.2.1 Primary and Secondary Structure Analysis 
A BLASTP query using the OAC ORF was conducted against the NCBI non-redundant protein 
sequence database using a BLOSUM62 scoring matrix, a gap cost of 11 and extension cost of 1, 
using the conditional compositional score matrix adjustment  (Altschul et al., 1997). Highest-
ranking homologs with the lowest E-value were selected, although only one homolog from a 
species was selected. Sequences were aligned using ClustalW engine as previously described 
(Section 4.2.1). Analysis was conducted by querying the OAC sequence using the Swiss-Model 
Template Identifier (Arnold et al., 2006). The Interpro Domain Scan was conducted against the 
HMMPfam, HMMTigr, ProfileScan, SuperFamily, and BlastProDom databases using a gapped 
blast query with an E-value cutoff of 1.0E-6 and a BLOSUM62 matrix (Zdobnov and Apweiler, 
2001). Secondary Structure prediction and domain assignment were completed using the 
PSIPRED and DISOPRED engines provided by the domain annotation feature in the Swiss-
Model Workspace (Jones, 1999). The DISOPRED E-value cutoff was 2%. 
6.2.2 Cloning, Expression and Activity of OAC Mutants 
This work used an OAC construct (pJ60174) that was optimized for codon usage in E. coli and 
was commercially prepared in the pJE411 vector (DNA2.0). This OAC construct also contains 
an N-terminal polyhistidine tag for IMAC purification. In addition to the wild-type OAC 
(wtOAC), 12 constructs each containing a single point alanine substitution were also ordered 
(DNA2.0). Additional single point OAC mutants at K4A, K38A, and D45A were not 
commercially produced, but created by the site-directed mutagenesis (SDM) of pJ60174, and are 
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found in pJ60187, pJ60188, and pJ60189, respectively. Primers used during SDM are shown in 
Table 6.1. 
Table 6.1 Primers used for SDM and sequencing of pJR60174 
Name Sequence Function 
F-K4A GTAGCATGGCGGTGGCACACTTGATCGTG (F) primer for pJ60187 K4A 
R-K4A CACGATCAAGTGTGCCACCGCCATGCTAC (R) primer for pJ60187 K4A 
F-K38A CATTATTCCGGCGATGGCAGACGTTTATTGGGG (F) primer for pJ60188 K37A 
R-K38A CCCCAATAAACGTCTGCCATCGCCGGAATAATG (R) primer for pJ60188 K37A 
F-D45A GTTTATTGGGGCAAGGCTGTGACCCAGAAGAAC (F) primer for pJ60189 D44A 
R-D45A GTTCTTCTGGGTCACAGCCTTGCCCCAATAAAC (R) primer for pJ60189 D44A 
F-pJE CTCGAAAATAATAAAGGGAAAATCAG (F) primer for sequencing 
R-pJE TGGTAGTGTGGGGACTC (R) primer for sequencing  
 
6.2.3 Creation of K4A, K38A, and D45A by SDM 
Reactions (50 µL) were performed using 5 µL Pfu II Ultra HS 10x buffer, 1 µL of 50 ng/µL 
pJE60174 (template), 1 µL of 125 ng/µL forward (F) primer, 1 µL of 125 ng/µL reverse (R) 
primer, 0.5 µL 100 mM dNTP (25 mM of each), 40.5 µL water, 1 µL of 2 U/µL Pfu II ultra HS 
polymerase (Stratagene). Forward and reverse primers are described in Table 6.1. Thermocycling 
was performed in five steps, where steps 2 - 4 were repeated 16 times before ending with step 5: 
step 1 - 95°C for 1 min; step 2 - 95°C for 1 min; step 3 - 58°C for 1 min; step 4 - 68°C for 2 min; 
step 5 - 68°C for 3 min. Reactions were incubated at 37°C for 60 min in the presence of 1 µL of 
8 U/µL Dpn1 (Sigma). 
Plasmids from SDM reactions were isolated using a MinElute Reaction Cleanup Kit 
(Qiagen), and each used to transform separate E. coli One Shot BL21 (DE3) competent cells 
(Invitrogen). Transformants were plated onto LB + 50 µg/mL kanamycin and cultured overnight 
at 37°C. Six colonies from each transformation were selected and grown in 5 mL LB + 50 
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mg/mL kanamycin overnight at 37°C. Plasmids were purified using a QIAprep Spin Miniprep 
Kit (Qiagen) and sequenced (PBI DNA Technologies Unit) using the F-pJE and R-pJE 
oligonucleotides (Table 6.1) to confirm that the SDM reactions were successful. 
6.2.3.1 Expression and Purification of OAC and its Mutants 
Plasmids harboring wild-type OAC (wtOAC) and OAC mutants were individually used to 
transform E. coli Rosetta (DE3) competent cells (Novagen). Transformation reactions were 
plated on LB + 50 µg/mL kanamycin and grown overnight at 37°C. Single colonies were used to 
inoculate two 5 mL cultures of LB + kanamycin, where one solution was used as a starter culture 
and the other for i) -80°C stocks (as described in Section 3.1.2), and ii) plasmid isolation and 
sequencing as described in Section 6.2.3. A 0.5 mL aliquot of starter culture was used to 
inoculate 50 mL LB + 50 µg/mL kanamycin, which was grown overnight at 37°C with shaking 
(200 RPM). Cultures were used to inoculate 500 mL of LB + 50 µg/mL kanamycin, and grown 
to an OD600 = 0.8 before being induced using 0.5 mM IPTG. Cells were grown for an additional 
5 h at 37°C before being harvested by centrifugation at 20,000 g. Pellets were stored overnight at 
-80°C. 
Cell pellets were thawed on ice in the presence of 50 mL lysis buffer. The solution was 
divided into 25 mL aliquots and each sonicated for 3 min on ice. The solutions were then 
centrifuged for 20 min at 20,000 g at 4°C. The decanted lysates were tumbled in the presence of 
500 µL suspension volume of Talon (Clontech) for 40 min at 4°C. The resin was centrifuged (1 
min at 1,000 g) and the supernatant removed. The Talon beads were resuspended in 10 mL wash 
buffer and tumbled at 4°C for 10 min to wash away protein impurities. The washing step was 
conducted four more times before the Talon beads were rinsed in a gravity flow column with a 
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10 mL wash buffer. Each protein was eluted using 10 mL of elution buffer directly into separate 
Amicon Ultra 15 centrifugal concentrators (5,000 MWCO) (Millipore), which were later used to 
concentrate the solutions to 2.5 mL. The solutions were desalted using a PD10 column (GE 
Healthcare Biosciences) equilibrated with storage buffer (20 mM HEPES pH 7.0, 25 mM NaCl, 
10% glycerol, 5 mM DTT). The solutions were further concentrated to 100 µL using Microcon 
centrifugal filter devices (Millipore). These solutions were quantified using an RC/DC protein 
assay kit (Bio-Rad) as directed by the manufacturer. 
6.2.3.2 Enzyme Assays 
Separate 50 µL reactions containing a final concentration of 0.2 mM CoA, 0.4 mM ATP, 2.5 
mM MgCl2, 8 mM sodium malonate, 5 mM DTT, 20 mM HEPES [pH 7.0], and 0.2 mM 
hexanoyl-CoA were prepared using a master mix. Each reaction mixture contained 200 pmol of 
wtOAC or one of the single point OAC mutants. The first experiments (experiment A) did not 
include the K4A, K38A, or D45A mutants, whereas the second set of experiments (experiment 
B) did. Experiments A and B were conducted independently with slight differences described in 
the methods below. All reactions were conducted in triplicate. 
Experiment A 
Reactions were started by adding 2 µL of an enzyme cocktail containing 100 pmol TKS and 200 
pmol MCS. Reactions were incubated for 30 min at RT before being extracted twice using 250 
µL ethyl acetate. Extracts were dried under vacuum and analyzed by LCMS as previously 
described (Section 3.1.1).  
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Experiment B 
Reactions were started by adding an enzyme cocktail containing 200 pmol of TKS and 200 pmol 
of MCS, and were incubated at 20°C for 45 min before being extracted twice using 200 µL ethyl 
acetate. Extracts were dried under vacuum and stored overnight at 4°C. The extracts were 
resuspended in 20 µL of resuspension solution. 10 µL aliquots were analyzed by LCMS as 
previously described (Section 3.1.1). 
6.2.4 MS/MS Monitoring of the TKS/OAC Reaction 
Reaction mixtures of 50 µL were prepared with 0.6 mM malonyl-CoA, 0.2 mM hexanoyl-CoA, 
5 mg/mL enzyme (TKS and/or OAC) in 1 mM HEPES [pH 7.0] and 5 mM DDT, and were 
incubated for 1 h at 37°C, before being stored in the autosampler at 8°C. A control sample was 
also prepared without enzyme present. Reaction mixtures were diluted by a factor of ten with 1 
mM HEPES [pH 7.0] and injected to a stream of 50:50 ACN:H2O with 5 mM triethylamine 
(TEA) and 3 mM acetic acid (HOAc), using an Alliance 2695 HPLC coupled to a Quattro 
Ultima mass spectrometer (Waters Corporation). Signals were recorded in positive ion mode 
electrospray ionization with tandem MS scanning of selected reaction monitoring (SRM) for 
each of the acyl coenzyme-A compounds of interest; malonyl-CoA, acetyl-CoA, hexanoyl-CoA, 
free CoA, formyl-CoA, and a tetraketide intermediate-CoA (992 m/z) (de Hoffmann 1996). 
Since an intermediate was expected, an alternate mode of tandem MS precursor ion scanning 
was also used to monitor any possible acyl-CoA that might be produced during the reaction. 
Analyses were conducted by S. Ambrose (Applied Genomics and Analytical Technologies, 
NRC-PBI).  
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6.3 Results 
6.3.1 Primary and Secondary Structure Analysis 
Following a BLASTP query of the OAC protein sequence, 12 representative SRABB proteins 
were selected and aligned using ClustalW with the MEGA5 software suite (Figure 6.2). Most 
SRABB homologs used in this work are annotated in Genbank as POP3 proteins and include 
members from: Medicago truncatula (annotated XP_003609973.1), Vitis vinifera (annotated 
XP_002272048.1), Glycine max (annotated XP_003526484.1), Zea mays (annotated 
NP_001152608.1), Ricinus communis (annotated XP_002510283.1), A. thaliana (pdb 1Q53), P. 
trichocarpa (annotated ABK93400.1), Brachypodium distachyon (XP_003579052.1), Oryza 
sativa (annotated NP_001043194.1), Sorghum bicolor (annotated XP_002458107.1), 
Physcomitrella patens (annotated XP_001766578.1) and P. tremula (pdb 1TR0). A total of 19 of 
the 103 amino acids in OAC (i.e. 18%) are identical in all of the selected homologs, and another 
11 amino acids share similarity (Figure 6.2).  
Furthermore, the OAC protein sequence was analyzed using software provided by the 
Swiss Institute of Bioinformatics (Arnold et al., 2006). The secondary structure was deduced 
using InterproScan, PSIPRED and DISOPRED capable of domain recognition, secondary 
structure prediction, and protein disorder determination, respectively (Figure 6.3). Interpro 
identified both the DABB (IPR011008) and SRABB (IPR013097) domains in OAC between 
amino acids 3 to 99 (Zdobnov and Apweiler, 2001). PSIPRED results indicated that OAC 
possesses multiple α-helices and β-pleats that fit an α + β classification (Jones, 1999). Results 
from DISOPRED strongly suggested that OAC is an ordered protein with a stable secondary 
structure possessing low flexibility in solution (Ward et al., 2004).   
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Figure 6.2  Sequence alignment of OAC and homologs. 
This alignment was used to determine conserved amino acid residues, some of which (boxed) were targeted for SDM. Conserved residues that are identical are 
shown in red, whereas amino acids that share similarity are drawn in blue. 
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Figure 6.3  Prediction of OAC Secondary Structure. 
The OAC protein sequence was evaluated using: (A) Interpro, (B) PSIPRED, and (C) 
DISOPRED. (A) Interpro identified the DABB and SRABB motifs in OAC. (B) PSIPRED, 
which is capable of predicting the probablilty of protein regions to exist as a (red) helix, (yellow) 
extended β-sheet or as a (green) coil, indicates the α + β components in OAC. (C) DISOPRED 
determines the ordered state of a protein; results indicate that OAC is an ordered protein, as is 
depicted by the appearance of dashes (for order) instead of asterisks (for disorder).  
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To identify suitable structural homologs from which an OAC structure model could be predicted, 
the OAC protein sequence was evaluated using the template identification feature provided by 
the Swiss Model Workspace (Altschul et al., 1997; Arnold et al., 2006) (Figure 6.4). Three 
protein structures were identified by Gapped Blast and ten protein structures were identified by 
HHSeach Template Library searches. 
  
 
Figure 6.4  Swiss Model template retrieval of OAC. 
A template search using the OAC protein sequence identified three suitable matches when a 
Gapped Blast was performed and ten templates when the HHSeach Template Library Search was 
used. Both 1Q53 and 1TR0 were each used to develop separate OAC models due to their good 
representation in each search. 
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Two homology models of OAC were created using the Swiss-Model automated service 
that were based on either A. thaliana HS1 (annotated in protein databank (pdb) 1Q53) or P. 
tremula SP1 (pdb 1TR0) (Figure 6.5). The first OAC model (OAC Model 1) used 1Q53 (chains 
A and B) as a template, since the template identification feature identified AtHS1 as the most 
probable candidate in both Gapped Blast and HHSeaches. The resulting QMEAN Z-score, an 
estimate of the quality of the created model, has a value of -3.25 (based on a scoring range 
between -4 to +4). Therefore, another model (OAC Model 2) was created using 1TR0 as a 
template, since it was also well represented in both searches; this second model was a good 
prediction according to its QMEAN Z-score of -1.2. Although both models were created using 
separate templates, they are visually similar. Models used two chains from each respective 
protein to create a homodimeric model. Each monomer contains four β-strands that align with 
the opposing monomer’s β-strands resulting in a barrel-shaped structure at the core of the 
protein. Two α-helices project away from the β-sheet core in each monomer. Viewing the space-
filling representation of the 1Q53 based OAC model reveals a crevice between the α-helices and 
the β-sheets (Figure 6.6). A similar crevice is also detected in the 1TR0 based OAC model. 
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Figure 6.5  Templates and models for OAC. 
(A) AtHS1 and (B) PtSP1 were each used to predict OAC models shown to the right of each 
template. All protein structures are shown as homodimers with separate monomers displayed in 
blue and red. Structures were positioned as AtHS1. 
 
Figure 6.6  Space filled model of OAC. 
OAC Model 1 from Figure 6.5A is shown tilted to highlight a crevice found between the α-
helices and β-sheet, and proposed to act as the substrate-binding pocket. The model on the left is 
the same as the one on the right save for the addition of the space-filling features. Although not 
seen, a similar pocket also exists in the other monomer. 
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6.3.2 The Expression and Activity of OAC Mutants  
The structure/function relationship of various AAs in OAC was explored by substituting alanine 
at AA sites conserved between SRABB homologs, in addition to His75 and His78, which are not 
conserved in the P. tremula homolog (Figure 6.2). Experiments were conducted on two 
occasions (experiments A and B) and were initially designed to compare the activity of 12 OAC 
mutants with the wild-type, but later included another three mutants (i.e. K4A, K38A, and 
D45A). The expression level of mutant proteins was determined by comparing their yields 
following IMAC purification to that of wtOAC (Table 6.2). Cultures expressing the Y72A, 
H78A, and D96A mutants in experiment A, and the D45A, H78A, and D96A mutants in 
experiment B produced the greatest amounts of total protein. The smallest amounts of protein 
were produced in cultures expressing the F11A, L30A, and G43A mutants during experiment A, 
and the F11A, W42A, and T56A mutants during experiment B. Cultures expressing the K12A 
and Y72A mutants showed the largest fluctuation in protein yields between experiments A and 
B; cultures expressing the K12A mutant yielded 75% less protein in those expressing wtOAC in 
experiment A, but no such loss was seen in experiment B; cultures expressing the Y72A mutant 
yielded 70% more protein in cultures expressing wtOAC during experiment A, yet yielded 7% 
less protein in its wtOAC counterpart during experiment B. Other than these two mutants, the 
amounts of protein produced by cultures showed the same trend between experiments A and B. 
The SDS-PAGE of wtOAC and mutants was conducted prior to experiment A (Figure 6.7). This 
gel does not include the K4A, K38A, and D45A mutants. 
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Table 6.2 OAC constructs and their yields 
  
Experiment A Experiment B 
OAC plasmid volume concentration yield expression volume concentration yield expression 
version (µL) (mg/mL) (µg)   (µL) (mg/mL) (µg)   
wt* pJE60174 200 1.01 202 100% 100 2.50 250 100% 
K4A pJE60187 n/a  n/a  n/a   n/a  100 0.600 60 24% 
H5A pJE60175 100 0.780 78 39% 100 1.94 194 78% 
F11A pJE60176 60.0 0.430 25.8 13% 100 0.760 76 30% 
K12A pJE60177 60.0 0.850 51.0 25% 100 2.49 249 100% 
L30A pJE60178 60.0 0.400 24 12% 100 1.41 141 56% 
K38A pJE60188 n/a   n/a  n/a   n/a  100 2.22 222 89% 
W42A pJE60179 60.0 0.620 37.2 18% 100 0.850 85 34% 
G43A pJE60180 60.0 0.450 27 13% 100 1.39 139 56% 
D45A pJE60189  n/a  n/a  n/a   n/a  100 3.93 393 160% 
T56A pJE60181 100 0.330 33.0 16% 100 1.16 116 46% 
H57A pJE60182 100 0.580 58 29% 100 1.46 146 58% 
Y72A pJE60183 100 3.33 333 170% 100 2.32 232 93% 
H75A pJE60184 60.0 0.850 51 25% 100 1.47 147 59% 
H78A pJE60185 100 2.18 218 110% 100 3.42 342 140% 
D96A pJE60186 500 0.610 305 150% 100 6.39 639 260% 
*wt is the wild-type OAC which did not contain any amino acid substitution. Constructs which were not included 
during the experiment are labelled as not applicable (n/a). 
 
 
Figure 6.7  SDS-PAGE of wtOAC and mutants. 
Proteins purified by IMAC were loaded onto a 15% acrylamide gel to confirm their presence and 
abundance. A 5 µg aliquot of wild-type OAC (wtOAC) and mutant OAC loaded on equal protein 
basis (names above the lanes) were run at 200 V for 45 min beside molecular weight standards 
(MW). Numbers on the left of the gel correspond to the kDa weight of MW. Proteins of interest 
are seen at the 13 kDa mark. 
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Although assays performed in experiments A and B are similar, they were conducted 
under different conditions (where the production of OA was further optimized during experiment 
B), and absolute amounts are therefore not averaged. Instead, results are presented separately, 
and the observable trends are compared. All reaction products were analyzed by LCMS, and 
results are reported as the total pmol yields determined by LC at 270 nm (For Experiment A see 
Figure 6.8; For Experiment B see Figure 6.9).  
6.3.2.1 Experiment A 
The activities of OAC mutants were compared to the wild-type enzyme by assaying each protein 
with TKS and MCS. The amount of HTAL collected during assays was between 36 ± 6 pmol and 
54 ± 24 pmol (Figure 6.8A). A larger amount of variation (± 20 pmol) was detected in assays that 
accumulated greater than 45 pmol of HTAL, which included the L30A, W42A and D96A 
constructs. The largest amount of HTAL was detected from D96A assays, whereas the lowest 
amount was detected from G43A assays. The amount of PDAL synthesized during each assay 
appears static, the lowest amount was seen from G43A assays (376 ± 90 pmol); the largest 
amount was detected from H78A assays (484 ± 84 pmol), with the exception of the no-OAC 
control (580 ± 252 pmol) (Figure 6.8B). Other than wtOAC assays, which produced 167 ± 34 
pmol, OA was only detected in assays performed using K12A, G43A, and D96A constructs, 
where they accumulated 42 ± 13 pmol, 14 ± 6 pmol, and 32 ± 14 pmol, respectively (Figure 
6.8C). The standard deviation of olivetol produced during assays appear the most dynamic, 
where the least amount of variation was detected from assays that used wtOAC (45 ± 21 pmol), 
and the largest amount from L30A assays (327 ± 169 pmol) (Figure 6.8D).  
 181 
 
 
Figure 6.8  LC results for OAC mutant assays - Experiment A 
Product yields for (A) HTAL, (B) PDAL, (C) OA, and (D) olivetol biosynthesized during 
TKS/OAC assays conducted in the presence of wild-type (wt) or mutant OAC was determined 
by LCMS analysis. Error bars are the SD where n=3. 
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6.3.2.2 Experiment B 
Experimental conditions for this experiment differed from those in experiment A; conditions 
were optimized for greater production of OA (see Section 6.2.3.2.). Due to the number of 
samples tested and the necessity of processing the assays rapidly, a no-OAC control assay was 
not performed. All enzymes were independently expressed and purified for this experiment. The 
amount of HTAL collected from the assays ranged between 32 ± 7 pmol and 48 ± 16 pmol, and 
appeared static throughout the assays (Figure 6.9A). The largest amount of HTAL was detected 
from wtOAC assays, whereas the least amount was detected from both H57A and Y72A assays 
(Figure 6.9A). The amount of PDAL produced during each assay also appear static, where the 
least amount detected was 474 ± 39 pmol from D96A assays, and the largest amount was 560 ± 
70 pmol during H5A assays (Figure 6.9B). Similar to experiment A, OA was detected in assays 
using wtOAC, K12A, G43A, and D96A constructs, where they accumulated 360 ± 134 pmol, 
179 ± 16 pmol, 35 ± 13 pmol, and 23 ± 2 pmol, respectively. It was additionally detected in 
assays using the K4A, K38A, and D45A mutantsm, which produced 22 ± 8 pmol, 13 ± 5 pmol, 
258 ± 25 pmol, respectively (Figure 6.9C). A trace amount of OA was also detected from H75A, 
which accumulated 4 ± 2 pmol. The dynamic behavior of olivetol production was also evident 
during this experiment, where the smallest amount detected was obtained from D45A, which 
accumulated  61 ± 18 pmol, and the largest amount was detected from H5A, which accumulated 
402 ± 49 pmol (Figure 6.9D).  
The amounts of OA detected during experiments A and B, as well as the relative activity 
compared to wtOAC are tabulated in Table 6.3. The location of amino acids targeted for SDM 
are shown on the OAC model designed from the 1Q53 template (Figures 6.2 and 6.10). 
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Figure 6.9  LC results for OAC mutant assays - Experiment B. 
Product yields for (A) HTAL, (B) PDAL, (C) OA, and (D) olivetol biosynthesized during 
TKS/OAC assays conducted in the presence of wild-type (wt) and mutant OAC constructs was 
determined by LCMS analysis. Error bars are the SD where n=3. 
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Table 6.3 Successful OA biosynthesis by OAC point mutants 
 
Experiment A Experiment B 
OAC OA OAC OA OAC Average relative 
version (pmol) activity (pmol) activity OAC activity 
wt* 167 100% 360 100% 100% 
K4A n/a  n/a  22 6.1% n/a 
K12A 42 25.1% 179 49.7% 37.4% 
K38A n/a   n/a  13 3.6% n/a 
G43A 14 8.3% 35 9.7% 9.0% 
D45A  n/a  n/a  258 71.7% n/a 
H75A 0 0% 4 1.1% 0.6% 
D96A 32 19.2% 23 6.4% 12.8% 
*wt is the unmutated OAC. n/a samples were not tested. 
 
Figure 6.10  Location of SDM target sites mapped on the OAC model. 
The 15 amino acids that were targeted in this study have been mapped onto the OAC model 
derived from the 1Q53 template. Sites are either mapped on or next to the actual location. The 
L30 site shown in grey exists in the α-helix drawn near the back of the figure. 
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6.3.3 MS/MS Monitoring of the TKS and TKS/OAC Reactions 
In an attempt to detect the presence of a CoA-linked polyketide intermediate (Figure 6.1), the 
TKS and TKS/OAC reactions were monitored using tandem mass spectrometry. Specifically, 
both precursor ion scanning and selected reaction monitoring modes were used to screen the 
reaction mixture for CoA-linked intermediates (de Hoffmann, 1996; Glish and Vachet, 2003). 
Enzyme assays were analyzed using tandem mass spectrometry during multiple reaction 
monitoring (MRM) for parent ion and daughter ion pairs resulting from neutral loss of 507 amu, 
as well as 428 amu which are attributed to CoA tethered compounds of interest. Using these 
methods, the dissipation and generation of reaction substrates and CoA compounds was 
observed. 
A parent ion scan was used to analyze: 1) a blank sample containing the reaction mixture 
but no enzymes, 2) a TKS reaction, and 3) a TKS/OAC reaction (Figure 6.11). All ions of 
interest included free CoA (768 m/z), acetyl-CoA (810 m/z), malonyl-CoA (854 m/z), hexanoyl-
CoA (866 m/z), proposed intermediate (992 m/z), and formyl-CoA (796 m/z). Reactions were 
also analyzed using spectrometry in MRM mode and resulted in the same trends as those 
appearing during parent ion scans (Figure 6.12). Although reaction blanks did not noticeably 
change over time, TKS and TKS/OAC reactions accumulated large amounts of free CoA and 
acetyl-CoA, associated with a loss of malonyl-CoA and hexanoyl-CoA. Although not visible in 
Figure 6.12, trace amounts of the proposed tetraketide intermediate were detected (Table 6.4).  
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Figure 6.11 Parent ion scan of TKS and TKS/OAC reactions. 
MS analysis of CoA-linked compounds was conducted on (A) a reaction blank, (B) a 60 min 
TKS only reaction, and (C) a 60 min TKS/OAC reaction. Parent ion scans detected fragments of 
428 m/z. 
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Figure 6.12 Multiple Reaction Monitoring of TKS and TKS/OAC reactions. 
TKS and TKS/OAC reactions were analyzed by MS for CoA-linked compounds.  Results are 
plotted as the ion abundance following 1 h incubation at 37°C. 
Table 6.4 Area response obtained during the MRM analysis of TKS assays 
 
AREA 
sample mal-CoA hex-CoA CoA (free) acetyl-CoA intermediate-CoA formyl-CoA 
TKS 1435 193633 686457 272484 449 9 
TKS + OAC 12047 206387 713452 256350 471 11 
reaction blank 497697 933147 60587 28518 4 0 
 
A TKS reaction and sample blank were also monitored for the neutral loss of CoA (507 
m/z), resulting in the same trends detected previously during MS analyses (Figure 6.13). 
Compared to sample blanks, TKS assays showed a 60% reduction in hexanoyl-CoA, and a 99% 
reduction in malonyl-CoA associated with an increase of free CoA and acetyl-CoA. Neither a 
tetraketide intermediate nor a hypothetical formyl-CoA byproduct were detected during MRM 
screens.  
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Figure 6.13 MRM for the neutral loss of CoA during a TKS reaction. 
Tandem mass spectrometry was used to analyze (left side) a sample blank containing no enzyme, 
and (right side) a TKS reaction by screening for daughter ion pairs resulting from the neutral loss 
of CoA fragments (507 m/z). Samples were screened for (A) a tetraketide CoA intermediate, (B) 
hexanoyl-CoA, (C) malonyl-CoA, (D) acetyl-CoA, (E) formyl-CoA, and (F) free CoA. Results 
are plotted as the % relative intensity relative to time (min).   
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6.4 Discussion 
6.4.1 Primary and Secondary Structure 
Results indicate that OAC is a DABB protein belonging to the SRABB family. Repeated BLAST 
searches using the OAC primary sequence suggest a close relationship to several plant homologs. 
These homologs were used to create an alignment that led to the identification of conserved 
amino acids constituting an overall 18% coverage of the SRABB homologs. The high degree of 
sequence similarity suggests a strong relationship exists between structure and function, likely 
due to the smaller size of the proteins, resulting in the retention of their specific shape, which is 
required for activity. OAC models predicted from AtHS1 and PtSP1 templates confirm that OAC 
is a DABB protein made up of two alternating βαβ motifs. Specifically, the βαβ motifs appear 
more like a βαββααβ, but note that the repeated αα helices are really one α helix that have 
adopted a kink halfway through its span. This kink provides a necessary space between the α-
helices and β-sheet previously proposed and shown to bind substrates in a number of other 
DABB proteins including S. coelicolor ActVa-Orf6, S. galilaeus AknX, and S. aureus IsdG 
(Chung et al., 2002; Lee et al., 2008; Sciara et al., 2003).  
The 1Q53 and 1TR0 structures served as appropriate templates to model an OAC 
structure. Lower-quality modeling using the 1Q53 template may have been due to the NMR 
method of deduction used to solve its structure, which may have resulted in the exclusion of 
some functions that the modelling software requires, since the software was primarily designed 
for structures obtained by crystallography. The OAC model developed from the 1TR0 template 
resulted in a similar OAC structure obtained from 1Q53, although less error was produced 
possibly due to the methods of crystal elucidation used for 1TR0. 
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6.4.2 Site-Directed Mutagenesis 
SDM-targeted amino acids, in most cases, resulted in the abolishment of OAC activity. Amino 
acid targets themselves were based on their conservation within OAC homologs, but also placed 
some priority on establishing whether or not they played a critical role in OAC activity. Some 
amino acids were not suspected to play any role in activity, such as G43, yet their substitution 
resulted in a dramatic loss of activity. Again, this suggests that a strong relationship exists 
between structure and function in these proteins, probably due to its smaller size, resulting in 
misfolding of mutant proteins upon their expression. The inclusion of K4, K38, and D45 during 
the second round of experiments was an attempt to delineate their potential roles in either Schiff 
base formation, which would implicate a class I aldolase mechanism, or through an acid/base-
catalyzed reaction, which could involve an aspartate residue. The substitution of these residues, 
as well as with K12 and D96, did not result in the total loss of function, which would have 
otherwise suggested their direct involvement in the OAC mechanism. Instead, the K4A, K38A, 
and D45A mutants, apart from G43A and H75A, were the only mutants that retained any OAC 
activity, whereas all other mutants failed to produce OA when assayed with TKS. 
The identification of OAC as a putative cyclase was originally based on its structural 
similarity with another class of DABB proteins, the PKCs. The PKC family is exemplified by 
TcmI, the only characterized PKC to date. TcmI is part of the tetracenomycin biosynthesis gene 
cluster found in Streptomyces glaucescens and was shown to cyclize Tcm F2 to Tcm F1, both 
intermediates involved in the biosynthesis of the antitumor antibiotic Tcm C, without requiring a 
cofactor or metal ion (Shen and Hutchinson, 1993b). Since the structural elucidation of TcmI 
lacks an enzyme-substrate complex, the active site was inferred to exist at an analogous α/β 
interface as proposed in ActVa-Orf6 (Sciara et al., 2003). In TcmI, the proposed active site is 
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lined with many hydrophobic residues conducive to binding polyaromatic compounds, where a 
single sulfate ion was shown bound to R40 and H26 at the back of the pocket. TcmI residues 
(H26, D27, R40, and H51) that were putatively involved in catalysis were mutagenized, but 
results indicate the residues are most likely involved in hydrogen bonding or polar interactions 
and are not critical for enzyme activity. Although no specific mechanism was offered by 
Thompson et al. (2004), they suggested that the role of TcmI was to position the substrate in a 
way which accommodates for a water-facilitated reaction. I also postulate that the active site for 
OAC exists in the analogous α/β interface proposed in other DABB proteins; similar to TcmI, 
this interface also contains many hydrophobic residues that could potentially bind and aid in the 
cyclization of a tetraketide intermediate (Figure 6.14).  
The intramolecular aldol condensation performed by TcmI is also reminiscent of similar 
cyclization reactions mediated by SnoaL-like polyketide cyclases (interpro domain IPR009959), 
which also require neither Schiff-base formation nor a metal ion (Sultana et al., 2004). Although 
not structurally related, S. nogalater SnoaL is a polyketide cyclase involved in the biosynthesis 
of nogalaviketone, where a conserved D121 is thought to act as an acid/base catalyst. Notably, 
this distinct SnoaL motif is sometimes found fused to ABM members and is also found upstream 
from TcmI, where it is involved in an earlier polyketide cyclization. SRABB homologs, 
including OAC, also contain a conserved aspartate residue (D96) analogous to the D121 residue 
found in SnoaL. The D96A mutant was created to determine whether or not this residue was 
involved in an acid/base mechanism critical for OAC activity, however assay results disqualify 
this scenario. Based on its location and assay results, this residue may instead be involved in 
either attracting the substrate to the active site cavity, or the stabilization of the dimer interface. 
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Figure 6.14 The proposed active site for OAC. 
The proposed active site found between the α/β interface is lined with many hydrophobic 
residues conducive to the potential binding of tetraketide intermediates. These amino acids also 
include two tyrosine residues (oxygen marked in red) and two histidine residues (nitrogen 
marked in blue) that could assist in cyclization. 
 
Figure 6.15 The structure of SnoaL and TcmI. 
(A) The structure for SnoaL (pdb 1SJW) has been shown to bind substrates between a β-sheet 
and its α-helices, which has also been proposed to occur in (B) TcmI (pdb 1TUW), a PKC 
belonging to a different family of proteins than SnoaL. Both enzymes perform aldol-like 
reactions on polyketide-derived intermediates.  
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6.4.3 CoA analysis of the TKS reaction 
The MS/MS MRM analyses were conducted to detect CoA-linked intermediates which could 
help resolve TKS and OAC reaction mechanisms. Reactions were specifically monitored for the 
presence of TKS substrates, as well as for putative reaction products and intermediates including 
free CoA, acetyl-CoA, and a hypothetical tetraketo-CoA ester. Experiments also monitored 
formyl-CoA, which could have indicated an exit strategy for CO2 during the formation of 
olivetol, but this hypothetical model was abandoned after no formyl-CoA was detected. All 
MS/MS analyses indicate that the TKS reactions proceeded until malonyl-CoA, but not 
hexanoyl-CoA, was depleted. The analyses also show that acetyl-CoA is produced during TKS 
reactions. This is likely due to the escape of enol intermediates from the TKS active site 
following the decarboxylation of malonyl-CoA. Normally, this decarboxylation drives the 
addition of acetyl groups onto a nascent polyketide (Austin and Noel, 2003), but suboptimal in 
vitro conditions could result in the diffusion of labile ethenol-CoA esters into the surrounding 
medium. The detection of acetyl-CoA may also raise questions as to why it is not being used to 
produce truncated methyl resorcinol/ate analogs such as those observed during TKS assays that 
used acetyl-CoA as a starter compound (Section 4.2.10.5), but this growing acetyl-CoA pool 
would be in direct competition with hexanoyl-CoA in an ever dwindling pool of malonyl-CoA. 
 Although MRM for neutral loss of CoA was incapable of detecting any polyketide 
intermediate (992 m/z), MS analyses using a SIR of 428 m/z successfully detected trace amounts 
of a putative tetraketo-CoA ester during TKS and TKS/OAC reaction monitoring, which notably 
was not detected in sample blanks. Although the trace detection of this intermediate using these 
methods could be credited as a success, results are inconclusive. The detection of a tetraketo 
CoA-ester may be limited due to its lability under harsh conditions created during MS ionization.  
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7. GENERAL DISCUSSION 
 
7.1 Introduction 
Throughout this study TKS assays conducted in the presence of malonyl-CoA and hexanoyl-
CoA have repeatedly produced HTAL, PDAL and olivetol. The addition of OAC to this reaction 
resulted in the additional biosynthesis of OA. The results have also shown that neither TKS nor 
OAC are capable of producing OA without each other’s activity. As well, TKS and OAC do not 
appear to physically interact, and OAC retains activity even when TKS was removed from 
solution, therefore dismissing the notion that an allosteric relationship is involved between TKS 
and OAC (Chapter 5). Additionally, results have indicated that TKS and OAC do not require a 
metal, or Schiff base formation, dismissing the traditional class I and class II aldolase 
mechanisms. Instead OAC activity is reminiscent of other unrelated polyketide cyclases, namely 
SnoaL, which also does not rely on class I or class II aldolase mechanisms to achieve cyclization. 
Instead, these results suggest that an intermediate is produced by TKS, which is released into the 
medium and then cyclized to OA by OAC. It was demonstrated that, although TKS produces 
HTAL, PDAL and olivetol, these compounds are unlikely the substrate for OAC (Chapter 4). 
Attempts to detect an intermediate were equivocal, yet trace amounts of intermediate were 
detectable in TKS and TKS/OAC assays when they were analyzed by tandem mass spectrometry 
(Table 6.4), which were not present in reaction controls (Figure 6.13).  
Although my observations do not provide conclusive evidence on either the TKS or OAC 
mechanism, this study does provide the first evidence allowing model mechanisms to be 
hypothesized. The simple most important question to address is waht is the substrate for OAC; o 
sot a CoA-linked intermediate, or a free tetraketoacid? This question will be discussed in the 
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following section, first addressing the TKS reaction and its products, and then the OAC reaction 
and how it utilizes the TKS product. 
7.2 A Mechanistic View on the Synthesis of a Linear Tetraketide  
TKS is involved in the production of not only a resorcinol, but also that of two lactone products, 
HTAL and PDAL. The biosynthesis of lactones by type III PKS is not a new observation; many 
instances of lactone production have been documented, where PKSs that are putatively involved 
in the biosynthesis of natural products yield lactone products instead of the proposed end 
products (Figure 2.7). As well, the production of lactones by PKSs is not only exclusive to type 
III PKSs. It has been reported that the reconstruction of the modular type I PKS, DEBS, and the 
following repositioning of the thioesterase domain from the terminus of module 6 to a preceding 
module 2 resulted in the interruption of chain elongation and premature release of triketide 
lactones (Staunton and Weissman, 2001). In their review, Staunton and Weissman (2001) also 
note that many α-pyrones are produced during experiments using minimal or depleted PKSs, and 
remark that the formation of these α-pyrones could provide a favorable mechanism for product 
release. In contrast to type I PKSs, type III PKSs do not possess a transesterase domain, and the 
issue of product release remains somewhat obscure  (Austin and Noel, 2003; Jez et al., 2000). It 
is my proposal that with regard to TKS, and in agreement with Staunton and Weismann, lactones 
are artifacts of premature off-loading, but can also result during the re-loading of the active site 
with a tetraketide that is incapable of further extension due to constraints in the active site. 
Specifically, PDAL may be due to the premature off-loading of an enzyme-bound triketide. The 
loss of a hydrogen at the C4 position results in enolate formation. This leads to a C5O  C1 
attack, resulting in the formation of PDAL, as well as its release from the enzyme (Figure 7.1). 
On the other hand, HTAL biosynthesis results following the reattachment of a tetraketide to the 
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active site cysteine. This intermediate can either be released by hydrolysis as a free acid, or by 
cyclization to HTAL following a C5O  C1 attack (Figure 7.1). This proposal has been written 
with consideration to current type III PKS models explaining polyketide biosynthetic activity, as 
proposed by Jez et al (2000), who successfully elucidated the active site for 2–pyrone synthase in 
Gerbera hybrida. 
The proposed TKS mechanism involves the release of a CoA-tethered linear tetraketide. 
This is an important conclusion which is supported by several observations. Firstly, product ratio 
comparison between TKS assays conducted with or without OAC show that OA is produced at 
the cost of olivetol production, but that HTAL production remains the same whether OAC is 
present or not (Figure 4.7). The constant amount of HTAL synthesized indicates that, although a 
common intermediate exists between olivetol and OA, HTAL production appears independent. 
This phenomenon is explained using my proposed mechanism, which shows that HTAL results 
from the reattachment of a CoA-tethered tetraketide to the TKS active site instead of its diffusion 
into the surrounding solution (Figure 7.1). Additionally, studies by Harris and Carney (1966, 
1967) that focused on the cyclization of polyketoacids (and not their CoA analogs) failed to 
report the detection of any lactones during their experiments, indicating that pyrones cannot be 
spontaneously formed from free polyketoacids and that their production results from either CoA 
polyketoesters or, as I propose, due to enzyme binding of CoA-esters (Harris and Carney, 1966; 
Harris and Carney, 1967). Factors that markedly affected lactone production included starter 
compound availability (Chapter 3), which would directly affect competition for TKS active site 
attachment and result in less HTAL production, as more hexanoyl-CoA becomes available, and 
the adhering of TKS to Talon, which could potentially help to stabilize the movement and 
architecture of the TKS active site during in vitro reaction.  
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Figure 7.1  A proposed mechanism for TKS. 
(A) A starter molecule is attached to the TKS active site Cys157 resulting in the loss of CoA. (B) Acetyl-CoA is 
activated following the decarboxylation of malonyl-CoA, (C) and attacks the starter’s C1 carbonyl (D) releasing the 
starter from Cys157 and resulting in the formation of diketide. (E) This process is repeated by using the extended 
polyketide as a starter compound, resulting in the formation of a triketide. Once the triketide is reattached to the 
enzyme, the intermediate may either (F) spontaneously cyclize following the abstraction of hydrogen and a C5O  
C1 attack, (G) releasing the lactone from Cys157, and (H) forming PDAL by tautomerization; or (I) be extended by 
another two carbons forming a tetraketide, that may either be: (J) reattached to the enzyme, and form a lactone (F); 
or (K) diffuse to the environment. A portion of this figure was adapted from Austin and Noel (2003). 
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7.3 The Biosynthesis of Olivetol and OA 
If there does exist a diffusible, labile tetraketo-CoA ester, the mechanism for olivetol and OA 
biosynthesis would still require the displacement of the CoA moiety. Olivetol biosynthesis itself 
requires the hydrolysis of the CoA thioester, as well as a decarboxylation and, although we have 
seen that the decarboxylation of cannabinoid acids occurs at higher temperatures and over 
extended storage times, the in vitro decarboxylation of any polyketide in solution would drive 
further chemical modification, such as cyclization. The biosynthesis of OA and olivetol are 
substantially different in that the biosynthesis of olivetol is preceded by the hydrolysis of CoA, 
whereas the biosynthesis of OA requires the retention of the CoA ester, which is hydrolyzed only 
after the cyclization reaction is complete.  
7.3.1 The Biosynthesis of Olivetol 
The biosynthesis of olivetol requires a free tetraketoacid in solution, and is preceded by the 
hydrolysis of the CoA ester prior to decarboxylation and cyclization of the tetraketoacid (Figure 
7.2). Following hydrolysis, the loss of the acidic hydrogen from the carboxyl group subsequently 
results in the decarboxylation of the tetraketoacid resulting in the loss of C1. The 
decarboxylation results in the production of a short-lived enolate. The enolate is acts as a strong 
nucleophile allowing a C2  C7 nucleophilic attack to proceed, resulting in the cyclization of 
the intermediate to a phenolic alcohol. The phenolic alcohol is dehydrated, which results in the 
biosynthesis of the tautomeric form of olivetol. Note that the hydrolysis of the CoA-tetraketoacid 
leads to its spontaneous decarboxylation, which ultimately drives the cyclization to the final 
product.   
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Figure 7.2  A proposed reaction mechanism for the synthesis of olivetol. 
In this scheme, the R-substitutent is representing a pentyl chain, but may also occur in nature as a 
shorter (propyl) or longer (heptyl) alkyl chain.  
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7.3.2 The Biosynthesis of OA 
I proposed that the biosynthesis of OA requires a tetraketo-CoA ester, which makes the 
tetraketide intermediate resilient to decarboxylation (Figure 7.3). Since CoA acts as a protecting 
group which is itself susceptible to hydrolysis in aqueous solutions, the biosynthesis of OA also 
requires OAC to anchor and retain the CoA ester during OA cyclization. The biosynthesis of OA 
proceeds once the C2 α-hydrogen is abstracted by a base, resulting in the formation of an enolate 
at the C1 position. This nucleophile does not hydrolyze CoA due to its position within OAC. 
This enolate drives the C2  C7 cyclization, resulting in the formation of an alkoxide. The 
alkoxide abstracts hydrogen (presumably from the acid/base that is initially involved) to form an 
alcohol. Another α-hydrogen is abstracted from the C2 position, leading to the formation of the 
C3 enolate, which is followed by the protonation of the alcohol (again from the acid/base that is 
initially involved). The intermediate is then isomerized and dehydrated, resulting in the synthesis 
of a CoA-tethered OA tautomer. The ester is hydrolyzed, liberating free CoA and OA (Figure 
7.3).  
 This model for OA biosynthesis shows why OAC is required for proper cyclization, since 
without this enzyme, tetraketo-CoA esters would simply hydrolyze and lead to the spontaneous 
cyclization of olivetol. Classical aldol-type mechanisms for OAC may be excluded based on the 
observations that alanine substitution of lysine residues only resulted in decreased OAC activity 
and that OAC does not require a metal. Notably, OAC mutants harboring alanine substitutions at 
histidine residues positioned at 5, 75, and 78, which are all located near the proposed active site, 
result in the abolishment of OAC activity. Given that optimum OAC activity occurs at a pH of 
6.4 (Chapter 4), and that the average pKa of hisitidine is 6.5, it seems likely that these histidine 
residues play an important part during the acid/base reactions required to drive OA biosynthesis. 
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Figure 7.3  A proposed reaction mechanism for the biosynthesis of OA. 
The biosynthesis of OA is preceded by the attachement of a tetraketo-CoA ester to OAC.  
OAC 
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7.4 Cannabinoid Biosynthesis 
A revised biosynthetic pathway for all cannabinoids produced in cannabis is here proposed. 
Although the discovery of oxidoreductases involved in the cyclization of CBGA have 
contributed to the delineation of later cannabinoid biosynthesis, including the biosynthesis of 
THCA by THCA synthase (Taura et al., 1995), and for CBDA by CBDA synthase (Taura et al., 
1996), the earlier step involving OA biosynthesis has eluded description due to the lack of a PKS 
capable of independently producing OA. The recruitment of OAC during this preliminary step 
allows OA to be successfully biosynthesized, and together with TKS, the inclusion of OAC 
clarifies the cannabinoid biosynthetic pathway (Figure 7.4). Given its activity and abundance in 
trichome cDNA libraries, OAC is a key enzyme in the cannabinoid biosynthetic pathway. 
7.5 Metabolic Engineering of Cannabinoid Biosynthesis 
The engineering of secondary plant metabolites is an important field that has provided 
economically important chemicals to be produced in higher yields that are more financially 
worthwhile (Verpoorte et al., 2007). The discovery of OAC may play a role in the future 
metabolic engineering of cannabis to either augment or abolish cannabinoid content. These 
achievements would result in cannabis strains that have either increased medicinal value or, 
conversely, being devoid of cannabinoids, in an agricultural benefit due to the illegality of 
psychotropic cannabis. Whether it is used to increase or decrease cannabinoid content, OAC will 
undoubtedly play a role in the future engineering of cannabis. A practical application of OAC 
during in vitro syntheses will also benefit the future development of synthetic cannabinoid 
biosynthesis. The in vitro biosynthesis of cannabinoids has been hampered in part by the lack of 
OA production; the inclusion of OAC could ameliorate this problem by providing a suitable 
substrate for GOT to produce CBGA.  
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Figure 7.4  A proposed biosynthesis of cannabinoids. 
The biosynthesis of cannabinoids is preceded by the biosynthesis of OA by TKS and OAC. 
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7.6 DABB Cyclases May Play a Large Role in Plants 
Given their abundance and conservation, OAC-like DABB proteins are possibly involved in a 
variety of metabolic processes in plants other than cannabis. Although the occurrence of OA is 
rare, other stilbene carboxylic acids in plants have been detected and are known to occur, such as 
hydrangeic acid and lunularic acid in Hydrangea macrophylla (Zhang et al., 2009). Although one 
study has attributed STCS activity as being responsible for the production of stilbene 
carboxylates in Hydrangea, the lack of resolution and detection suggest another factor, or more 
specifically another protein with a similar function as OAC, is required for the biosynthesis of 
stilbene carboxylates (Eckermann et al., 2003). Similarly, the in vitro biosynthesis of derailed 
pyrones instead of anticipated end products, such as in the case of anthrone biosynthesis in Aloe 
arborescens, may require an OAC-like cyclase to fold large polyketide into their anticipated 
form (Mizuuchi et al., 2009). Furthermore, the associations of OAC-like proteins with plant 
stress and defense responses have been noted with regards to PtSP1 (Park et al., 2007; Zhu et al., 
2008). Given the defense-inducing effects of jasmonic acid, a plant hormone associated with 
stress which is known to increase trichome production in plants, it is plausible that OAC-like 
proteins may be involved in the mediation of unfavorable conditions, such as salt and heat stress, 
in plants (Traw and Bergelson, 2003; van Schie et al., 2007). It is possible that OAC-like 
proteins are involved in the production of bioactive stilbene carboxylic acids in response to plant 
stresses in an attempt to produce antibiotic/antifungal/antiherbivore compounds in a more global 
context (Park et al., 2007). 
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7.7 Conclusion 
This study set out to determine why OA was not being produced by a type III PKS implicitly 
involved in cannabinoid biosynthesis. The hypothesis that a putative cyclase was involved led to 
the discovery of OAC, a 12 kDa DABB protein belonging to the family of SRABB plant proteins 
of unknown function. The biochemical characterization of TKS and OAC has shown that, 
although TKS is capable of producing HTAL, PDAL, and olivetol, the inclusion of OAC during 
in vitro assays is required for the successful biosynthesis OA. Furthermore, TKS and OAC 
activities are physically independent. It is proposed that TKS generates a linear polyketide that is 
subsequently cyclized either spontaneously to a pyrone or olivetol as a result of enzyme product 
release, or the hydrolytic release of CoA, respectively. The fate of CoA-linked tetraketide 
intermediates is influenced in the presence of OAC, which is able to cyclize the intermediate to 
its proper resorcylic acid without a concurrent decarboxylation. In addition to proposing the 
mechanistic polyketide origins of OA and olivetol, this work also suggests a plausible 
mechanism for biosynthesis of lactones, alternatively known as derailment products, by type III 
PKS. The discovery of OAC also attributes the first known function to any protein belonging to 
the SRABB protein family. Lastly, this discovery resolves the enigmatic step of OA biosynthesis 
which is required during the biosynthesis of cannabinoids. 
7.8 Future Directions 
The discovery of OAC and its involvement in polyketide biosynthesis will undoubtedly play an 
important role in the identification and characterization of other OAC-like proteins in the future. 
The possibililty that other plant ‘type II’ PKCs are involved in type III PKS product cyclization 
is itself a novel finding that should generate a fresh perspective regarding plant natural product 
biosynthesis. It will be interesting to see if other plant OAC-like proteins are involved in 
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polyketide cyclizations. Regardless, OAC itself is an interesting protein, being the first plant 
polyketide cyclase that has ever been identified. Much more work will be required to clarify its 
mechanisms, which will necessitate more structure/function studies that will hopefully target and 
substitute other amino acids putatively involved in OAC activity. Also, the structural 
characterization of OAC should be conducted, either by NMR or by X-ray crystallography, to 
determine with highest certainty the positions and orientation of OAC’s structural elements.  
It will also be interesting to see if OAC is capable of participating in cyclization reactions 
not related to cannabinoid biosynthesis. For example, the effect that OAC has when it is assayed 
with other interesting plant PKSs, such as Aloe arborescens octaketide synthase, which 
accumulates SEK4 and SEK4b instead of chrysophanol anthrone, would be very interesting to 
see (Figure 2.7). Similarly, the role that OAC could have during other cyclization reactions that 
do not occur in plants, but in fungi and streptomycetes, will also be interesting to perform, since 
this could generate a plethora of new compounds, which could be of extreme medical benefit as 
potentially new antibiotics or anti-tumor compounds. It will be interesting to see how the role of 
OAC plays out in the future. 
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APPENDIX A 
Determining the concentration of PDAL, HTAL, OA, and olivetol. 
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Figure A1 Standard curves used for product determination. Error bars are the range in duplicate 
samples. Equations are the linear regression lines with correlation coefficient expressed as R2. 
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APPENDIX B 
Table B1 Injection and bleed times for the generation of antibodies targetting TKS 
Description Date Day # 
Pre-immune and 1° injection 1-Jun-2009 0 
2° Injection 22-Jun-2009 21 
1° bleed 2-Jul-2009 31 
3° Injection 13-Jul-2009 43 
2° bleed 23-Jul-2009 52 
4° Injection 10-Aug-2009 70 
3° bleed / Final 80 days 20-Aug-2009 80 
5° injection (facultative) 7-Sep-2009 98 
4° bleed 17-Sep-2009 108 
6° injection (facultative) 5-Oct-2009 126 
5° bleed 15-Oct-2009 136 
7° injection (facultative) 2-Nov-2009 154 
6° bleed / Final 164 day 12-Nov-2009 164 
8° injection (facultative) 30-Nov-2009 182 
7° bleed 10-Dec-2009 192 
9° injection (facultative) 28-Dec-2009 210 
8° bleed 7-Jan-2010 220 
10° injection (facultative) 25-Jan-2010 238 
9° bleed / Final 248 days 4-Feb-2010 248 
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APPENDIX C 
Q-TOF MS/MS Analysis of an unknown protein. 
The identification of an unknown 60 kDa protein was also purified from both recombinant and trichome 
extracts, and sent to the PBI mass lab for Q-TOF MS/MS analysis. The unknown protein(s) was identified 
as an A. thaliana chaperonin homolog (annotated NP_175945) (Section 3.2.4.2). 
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APPENDIX D 
The identification of  TKS was also confirmed by Q-TOF MS/MS analysis (Section 3.2.4.2). 
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APPENDIX E 
A total of 93 OAC-like sequences (including OAC) were aligned using ClustalW provided in 
Mega5 (Tamura et al., 2011) with parameters: Pairwise Alignment: Gap Opening Penalty 10; 
Gap Extension Penalty 0.1; Multiple Alignment: Gap Opening Penalty 10; Gap Extension 
Penalty 0.2; Protein Weight Matrix Gonnet; Residue-specific Penalties ON; Hydrophobic 
Penalties ON; Gap Separation Distance 4; End Gap Separation OFF; Use Negative Matrix OFF; 
Delay Divergent Cutoff (%) 30%. 
Phylogenetic Relationship Analysis used the following parameters: Phylogeny Reconstruction; 
Statistical Method: Maximum Likelihood; Test of Phylogeny: Bootstrap method; Number of 
Bootstrap Replications: 1000; Substitution Model: Amino acid; Model/Method: Jones-Taylor-
Thornton (JTT) + Gamma model; Rates among Sites: Uniform rates; Gaps/Missing Data 
Treatment: Complete deletion; ML Heuristic Method: Nearest-Neighbor-Interchange (NNI); 
Initial Tree for ML: Make initial tree automatically. 
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APPENDIX F 
Sequences used during the phylogenetic analysis of OAC. 
>A. coerulea 027_00390 
MGDLKHMVLVKFKEDVVVEDILKGMEKLASEVDSIKSFEWGQDLESEEMLRQGFTHVFTMTFG
SSEDFAACQTHPSHVEFSTTFSAAIEKILLFHFPAVLVKAPAA 
>A. coerulea 029_00097 
MEEAKGVVKHVLMAKFKDEITPDRIDLLIKGYANLVPLIPPMKAFHWGKDVSIENLHQGFTHVF
ESTFESLEGVAEYISHPAHVEFATEFLTALDKVIVIDYKPTIANH 
>A. lyrata 941765 
MATSGFKHLVVVKFKEDAKVDEILEGLENLVSQIDTVKSFEWGEDKESHEMLRQGFTHAFSMTF
ENKDGYVAFTSHPLHVEFSAAFTAVIDKIVLLDFPVAAVKSSVVVTP 
>A. thaliana AT3G17210 
MAEAKGAVVKHVLLAKFKDGVSPETIEELIKGYANLVNLIEPMKAFHWGEDVSIENLHQGYTHI
FESTFETKEAVAEYIAHPAHVEFATIFLGSLDKALVIDYKPTSVSL 
>A. thaliana AT5G22580 
MATSGFKHLVVVKFKEDTKVDEILKGLENLVSQIDTVKSFEWGEDKESHDMLRQGFTHAFSMTF
ENKDGYVAFTSHPLHVEFSAAFTAVIDKIVLLDFPVAAVKSSVVATP 
>A. thaliana TA34447_3702 
GSKMEEAKGPVKHVLLASFKDGVSPEKIEELIKGYANLVNLIEPMKAFHWGKDVSIENLHQGYT
HIFESTFESKEAVAEYIAHPAHVEFATIFLGSLDKVLVIDYKPTSVSL 
>B. distachyon 4g04380 
MAGSGVVKHILLARFKDEVTPERLDQLIRGYAGLVAVVPSMKAFHWGTDVSIENMHQGFTHVF
ESTFESTEGVKEYIEHPNHVDFATEFLALAEKVIIIDYKPTAAT 
>B. distachyon 4g42625 
MGEFKHLCLVRFKEGVVVDNIIQELSKLATELDTVKYFGWGKDVLEQEALTQGFTHVFSMSFAT
AGDLAACMAHEKHAAFAATFMAALDKVVVMDFPFVTVKPAPEPEPAT 
>B. rapa 021232 
MEEAKGPVKHVLLAKFKDDVTPEKIDELIKGYANLVNLIEPMKAFHWGKDVSIENLHQGFTHIF
ESTFDSKEAVAEYVAHPIHVEFANMFLGSLDKVLVIDYKPTSV 
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>B. rapa Bra002422 
MATSGFKHLVVVKFKEDAKVDEILKGLENLVSQIDSVKSFEWGEDNESHEMLRQGFTHAFSMTF
ENKDAYVSFTGHPLHVEFSAAFTAVIDKIVVMDFTVAAVKSPVVVAP 
>B. rapa Bra020198 
MAASEFKHLVVVKFKEDAKADEILKGSENLVSQIDSVKSFEWGEDKESHEMLRQGFTHAFSMTF
ENKDAYVSFTKHPLHVKFSAAFTAVIEKIVILDFTVAAVKSPVVVPP 
>C. annuum TA6827_4072 
NFASLINTATEQSRRRVGEMEGTKGGVVKHILLAKFKDEISPDKIDQLIKQYANLVNLIEPMKAS
HWGKDVSTENLQQGFTHVFESTFDSTEGVAEYVSHPVHVEFANLMLPQLEKVLVIDYKPEKVRP
LN 
>C. clementina 025762m 
MKAETKGRDMEEAKGVVKHVLLAKFKEGTAQDQIDQLIKDYANLVNLIEPMKSFQWGKDVSIE
NLHQGFTHIFESTFESTEGVAEYVAHPAHVEYANLFLANLEKVLVIDYKPTTVRV 
>C. clementina 025899m 
MGEGEEAAMGEFKHLVIVKFKEGVVVEDIVKGMKKLVSEIDAVKSFEWGQDVEGQEMLRQGF
THAFLMTFNKKEDYTTFASHPSHVEFSATFSAAIEKIVLLDFPTVLGKAPAA 
>C. papaya 146.67 
MEEAKGVVKHVLVAKFKEETLPAQIDELIKGYANLVNLIEPMKSFHWGKDVSIENLHQGFTHVF
ESAFESTEGIAEYIDHPAHVEFANLFLPVLEKFVVIDYKPTTVSF 
>C. rubella 10014967m 
MEEANKGPVKHILLAKFKDGVSPEKIEELIKGYANLVNLIEPMKAFHWGEDVSIENLHQGYTHIF
ESTFESKEAVAEYVAHPVHVEFATMFLGSLDKVLVIDYKPTSVSL 
>C. rubella v10002301m 
MATSGFKHLVVVKFKEDTKVDEILKGLENLVSQIDTVKSFEWGEDKESHEMLRQGFTHAFSMNF
ENKDGYVAFTSHPLHVEFSAAFTAVIDKIVVLDFPVAAVKSSVAV 
>C. sativa OAC 
MAVKHLIVLKFKDEITEAQKEEFFKTYVNLVNIIPAMKDVYWGKDVTQKNKEEGYTHIVEVTFE
SVETIQDYIIHPAHVGFGDVYRSFWEKLLIFDYTPRK 
>C. sativa PK00183 
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MEKANKGVVKHLVIMKFKDGISDDQIEQMNKEYANLLNLVPSMKTLQLGKVVEMSPGNYKHG
NGGYTHIFESTFESMEGVAEYTFHPAHLHLGHLYSHTFDKVLVFDYIIPITTIS 
>C. sativa PK17532 
MGEANKGVVKHVFILKMKEGLSNDQIEQMNKDYANLVNLVPSMKALQWGKLEVNNKLGNGG
YTHIFESTFESMEGVAEYADHPAHLHLRNLYFHTLDKFLVFDYKPTIVLPNSSY 
>C. sativa PK18164 
MEEAKGVVKHVLLAKFKEGTSDDQIQQLIKGYANLLNLIPSMKSFHWGKDVSFENLHQGFTHIF
ESTFENTEGVAEYVAHPAHVEFANVFLSNLDKVVVFDYKPTTVLLP 
>C. sativa PK28464 
MEEAKGVVKHIVLLKFKDGITDDEIQQFINAYANIVNKIPVMKDFNWGKDVSCVNLHGGFTHIL
ASTFESIEDVAKYVHHPVHVEFGNLYHHNLEKFLIFDYKPTIFLP 
>C. sativus 199990 
MGEFKHLVVAKFKEGLNVDEIVAQVEKMVSDIDSVKSFEWGHDVEGQDMLTQGFTHVFSMTF
DDKEAITSFLTHPKHLEFCPTFSAAIDKIVVLDFPSILVKAAVPPPSPQPPPALEETPEAAVPPPSPQP
PPALEETPEAALPPVLTSTPLPTPATAAAATPASASA 
>C. sativus 252360 
MGDSKGVVKHILLAKFKNGISEEQIDQLIKGYANLVNLIEPMKAFQCGKDVSIENLHQGFTHVFE
STFESTQGIAEYISHPAHVEFANKFLSSLDKVIVIDYKPTLICN 
>C. sativus 385330 
MGEEFKHLVLVKFKEGAAVEEILKGMENLVSEVEAVKSFEWGQEMEGPEMLTQGFTHAFLMTF
ENKEAHTAFVGHPKHVEFSATFSAAIDKIVVLDFPAIRAKPPLPA 
>C. sinensis 1g033664m 
MGEGEEAAMGEFKHLVIVKFKEGVVVEDIVKGMKKLVSEIDAVKSFEWGQDVEGQEMLRQGF
THAFLMTFNKKEDYTTFASHPSHVEFSATFSAAIEKIVLLDFPTVLGKAPAA 
>C. sinensis 1g033887m 
MEEAKGVVKHVLLAKFKEGTAQDQIDQLIKDYANLVNLIEPMKSFQWGKNVSIENLHQGFTHIF
ESTFESTEGVAEYVAHPAHVEYANLFLANLEKVLVIDYKPTTVRV 
>E. grandis B02216 
MEEAKGLVRRVHLVKFKDGTPLARIEEILKNYANLVNLIEPLKSWHMGKNVSIIYLDQGFTDVFE
VTFESAEGLAEYADHPIHTEFSKQTRPYLDKVIAITYEPTV-CT 
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>E. grandis B02218 
MEEAKGLAKRVLLVKFKDGTPPARLEEILKNYANLVNLVEPLKSWRMGKNVSFMNLDQGFTH
VFELTFESAKGLAEYADHPAHTEFSSQCRPYLDKFVVINYEPTVFCT 
>E. grandis B03989 
MEEASRPKEKTMEEAKGFVRRVLLFKFKAETAPDHIEQLIKDHSNLVNLVESLKSWHMGKDVS
VKYSNEGFTHVIELTFESTEGIAAYMGHPAHLEMHERIWPHLEKIVVIDYKPTLCN 
>G. arboreum BM360640 
ALREVRLMEEAKGVVKHILLAKFKDEIPPDKIEELIKGYANLVNLIHPMKAFHWGKDVSIENLHQ
GFTHVFESTFEST 
>G. hirsutum TA22147_3635 
LALREVRLMEEAKGVVKHILLAKFKDEIPPEKIEELIKGYANLVNLIHPMKAFHWGKDVSIENLH
QGFTHVFESTFESTEGIAEYIAHPAHVEFANLFLPSLDKVIVFDYKPTVVRC 
>G. max 04g08730 
MEEAKGVVKHVLLAKFKDDVTPERIEELIKDYANLVNLIPPMKSFHWGKDVSAENLHQGFTHVF
ESTFESPEGVAEYVAHPAHVEYANLFLSCLEKVIVIDYKPTVVKL 
>G. max 06g08830 
MEEAKGVVKHVFLAKFKDDVTPERIEELIKDYANLVNLIPPMKSFHWGKDVSAENMHQGFTHV
FESTFESTEGIAEYTAHPAHVEYATLFLSYLDKVIVIDYKPTIVKL 
>G. max 09g23640 
MGTFNHYVIVKLKDGVAVDELIQGLEKMVSGIDHVKSFEWGKDIESHDMLRQGFTHDFLMAFN
RKEEFNAFQTHLTHLEFTRVFSPAIEKIVVLDFPSNLVKAPA 
>G. max 13g11380 
MGTFNHYVIVKFNDGVAVDELIQGLEKMVSGIDHVKSFERGKDIESHDMLRQGFTHVFLMAFN
GKEEFNAFQTHVNDLEFTGLFSPAIEKIVVLDFPSNLMKAPA 
>G. raimondii TA16529_29730 
LALREVRLMEEAKGVVKHILLAKFKDEIPPEKIEELIKGYANLVNLIHPMKAFHWGKDVSIENLH
QGFTHVFESTFESTEGIAEYIAHPAHVEFANLFLPSLDKVIVFDYKPTVVRC 
>G. soja TA2928_3848 
EEEMEEAKGVVKHVLLAKFKDDVTPERIEELIKDYANLVNLIPPMKSFHWGKDVSAENLHQGFT
HVFESTFESPEGVAEYVAHPAHVEYANLFLSCLEKVIVIDYKPTVVKL 
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>H. lupus CL734Contig1 
MEEAKGVVKHVLLAKFKEGIPDDQIEQLIKGYANLVNLIPPMKSFHWGKDVSFENLHQGFTHIFE
STFETTEGVAEYVAHPAHVEFANVFLSVLDKVVVFDYKPTTVLP 
>L. usitatissimum 10037823 
MEEGKGEVKHVLLAKFKPEISGEEIEKLIKDYANLVTLIEPMKAFHWGTDVSIENMHQGFTHIFV
STFESTEGIAEYVAHPVHVEFANLFLAALDKVLVFDYKPTSVK 
>L. usitatissimum Lus10009407 
MAAPEFKHLAIIKEGVVVDEMIKGMEKLVSEISLIKSLEWGQDLEGHEMLTQGFTHAFTLTFNSK
EDYIAYDNHPTHLEYAAAFSASIEKFVVLNYPTVLLSQT 
>L. usitatissimum Lus10020555 
MAAPEFKHLAIIKFKEGVVVDEMIKGMEKLVSQISLIKSLEWGQDLEGHEMLTQGFTHAFTLTFN
SKEDYIAYENHPTHLEYAAGFSASIEKFVVLNYPTVLLKQT 
>M. acuminata 6T20510 
MAVKHVLLAKFKEEVSPEAVDDLIKGYANLVSLITPMKAFHWGRDVSIENLHQGFTHVFESTFD
GVEGIAEYIAHPAHVEFANKFLPALEKVIVIDYAPTAVN 
>M. acuminata 9T09110 
MGSIRHLVLAKFKDEAAVEELLQGLQKLVSEIDVVKSFEWGEDVLKDERLGQGFTHAFLLTFGS
AEDLATYIKHPSHVAFGKAFRAAIDKILAIDFPVVTNEISA 
>M. domestica MDP0000213440 
MEEAKGVVKHVVLAKFKDGIAENKIEEIIKGFANLVNLIEPMKSFNWGKDVSSENLHQGFTHIFE
STFESTEGVAEYVAHPAHVDFANLFLSHLEKVIVIDYKPTAVSV 
>M. domestica MDP0000528167 
MEEAKGGELKNILMAKFKEGTSESQIEQLIESFANLVNLVEPMKSFHWGKELSIEKEEEGYIHVFE
TTFESVEGMAEYAVHPAHHDFAKLFLPNLEKMCSIGYRLVRRRDGTGQDGTGRDGTEQRFRVM
FGTSKMEQNGTGLND 
>M. esculenta 019718m 
MEEAKGVVKHVLLAKFKEGISSDEIEKLIKGYANLVNLIEPMKAFHWGTDVSIENLHQGFTHVFE
STFESTEGVAEYISHPAHVDFANLFLPALEKVVVIDYKPTTVRL 
>M. esculenta 019824m 
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MGFEHLVIVRFKEGAVVADIMKGLEKLVSDVDLVKTFAWGEDLESPEMLTQGFTHAISMTFDK
KQDYTAFQTHPSHVEFSATFSAAIEKIVVLCFSSVQVKPAIA 
>M. esculenta 029781m 
MAEAKGVAKHIVLVKFKEEVSAEEIEQLIKGYANLVNLIPPMKSFRWGIDAGIENLTQGYTHAFE
STFETTQGIAEYVAHPAHIEFSNQLAPALHQVLTINYQSNTVHL 
>M. esculenta 030990m 
MGGYKHLVIFRFKAGAEVEEIMKGLEKLVSETDLVKSFEWGRDLDNPEILTQEFTHAISMTFDKK
QDYDAFQNLPSHIDFSLTFSTAVQKIVVLCFPSVQVKPAVA 
>M. guttatus mgv1a016735m 
MATEFKHLVLVKFKNDVVVGDVMKGLEKLVLEMDTVKSFVWGEDIESHEMLRQGFTHAFLMT
FGSKEDFTAFTSHPTHVDFSSTFSTAVDKAVLLDFPSVTVKPPPAAA 
>M. guttatus mgv1a016769m 
MEEGEVKHIVLAKFKESVSEEEIQESIKQYANLVNLVPSMKAFSWGKDLSKENMQQGFTHVFES
TFESTQGVAEYVSHPSHVEYATLLLSQLDNVIVVDYKPTPVRL 
>M. guttatus mgv1a016804m 
MEGEVKHILLAKFKQGITEDQIEEYIKQYANLVNLVPSMKSFSWGKDVSIENLNEGYTHIFESTFE
STQGIADYISHPDHVQYANTLLPQLEKVLVVDYKPTKVHL 
>M. guttatus mgv1a024900m 
GKHEVKHMLLAKLKQGISEDEIEGYIKQYANLVNLVPSMKAFAWGKDVSIENLNDGFTHVFEST
FASTQGIAEYLSDPDHVAFANTLLPQLDKVLVVDYMPTKVKL 
>M. truncatula 019717m 
MEEAKGVVKHIFLAKFKEEISSDQIEKLIKGYANLVNLIEPMKAFHWGTDVSNENLHQGFTHVFE
STFESTEGVAEYVSHPAHVEFANLFLAAAEKVIVIDYKPTTVRL 
>M. truncatula 019718m 
MEEAKGVVKHVLLAKFKEGISSDEIEKLIKGYANLVNLIEPMKAFHWGTDVSIENLHQGFTHVFE
STFESTEGVAEYISHPAHVDFANLFLPALEKVVVIDYKPTTVRL 
>M. truncatula 019720m 
MEEAKGVVKHIFLAKFKEEISSDQIEKLIKGYANLVNLIEPMKAFHWGTDVSNENLHQGFTHVFE
STFESTEGVAEYVSHPAHVEFANLFLAAAEKVIVIDYKPTTVRL 
>M. truncatula 019721m 
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MEEAKGVVKHIFLAKFKEEISSDQIEKLIKGYANLVNLIEPMKAFHWGTDVSNENLHQGFTHVFE
STFESTEGVAEYVSHPAHVEFANLFLAAAEKVIVIDYKPTTVRL 
>N. benthamiana CK296232 
FGMEGGKVKHILLAKFKDGIPADQIDQLIKQYANLVNLIEPMKAFHWGENVSIENFHQGFTHVFE
STFDSTEGIAEYIDHPAHVEYANTLLPQLEKVLVIDYKPEKVGP 
>N. benthamiana CK296233 
FGMEGGKVKHILLAKFKDGIPADQIDQLIKQYANLVNLIEPMKAFHWGENVSIENFHQGFTHVFE
STFDSTEGIAEYIDHPAHVEYANTLLPQLEKVLVIDYKPEKVGP 
>N. benthamiana EH366633 
FGMEGGKVKHILLAKFKDGIPADQIDQLIKQYANLVNLIEPMKAFHWGENVSIQNFHQGFTHVF
ESTFDSTEGIAEYIDHPAHVEYANTLLPQLEKVLVIDYKPEKVGP 
>N. tabacum EB446961 
FGMDAAKGGGVVKHILLAEFKDGIPADQIDQLIKQYANLVNLIEPMKAFHWGENVSIENFHQGF
THVFESTFDSTEGIAEYIDHPTHVEYANILLPQLEKVLVIDYKPEKVGP 
>O. sativa Os01g33160 
MAAETPAAGRSGVLKHIVLARFKEEVTPERLDHLIRGFGGLVNLVPSMKAFNWGTDVSIENMHH
GFTHVFECTFESTEGVKEYIEHPAHLEFAKEILLAMEKTLIIDYMPTAVNNS 
>O. sativa Os11g05290 
MGEVKHLCLVKFKEEVLVDDILQGMTKLVSEMDMVKSFEWGKDVLNQEMLTQGFTHVFSLTF
ASSEDLTTYMSHERHQEFAGTFMAAIDKVVVVDFPVVASKPAPPAAPAAAA 
>P. patens Pp1s189_106V6 
MGEVKHLCLVKFKEGVVVEDVLKGMTDLVAGMDMVKSFEWGQDVLNQEMLTQGFTHVFSLT
FAFADDLATYMGHDRHAAFAATFMAALDKVVVIDFPVVVAKPPPPA 
>P. patens Pp1s85_83V6 
MSGVVKHILLLKFKDSISPDEQTALIQKYAALPNSISAMKGFEWGTDISVENMHQGFTHAFISTFD
SPQGRDEYLVHPVHDSFAKELLGAVDNALVFDFNPTVALKANS 
>P. persica ppa013300m 
MGSAVDLGNNNMGEFKHLVIVKFKEDVVVDDILKGLENLVAEIDAVKSFEWGQDLESQELLRQ
GFTHVFLMTFDKKDDYAVFQSHPKHQEFSAIFSTVIEKLVLLDFPPTLVKTPPKAAPPEAPPEAPP
A 
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>P. persica ppa013682m 
MEEAKGVVKHVLLAKFKEGISENQIEELTKGYAKLVDLIEPMKSFHWGKDVSIENLHQGFTHIFE
STFESMEGVTEYVAHPAHVDFANLFLSHVEKVIVFDYKPTMVRV 
>P. trichocarpa 0010s04670 
MPRCSMRLVQWKKNVKKASSLVFKKPDSLSVGRNLEETKTESKRERERERDTVLMEEAK-G-
VVKHVLLAKFKEGIPSDEIEKLIKGYANLVNLIEPMKAFEWGTDVSIENMHQGFTHIFESTCESKE
GIAEYIGHPAHVDFGGLFLPALEKVIVFDYKPTVARF 
>P. trichocarpa 0010s04700 
MSKRRPAWFSSRNLEETKTESKRERDTVVMEEAKGVVKHVLLAKFKEGIPSDEIEKLIKGYANL
VNLIEPMKAFEWGTDVSIENMHQGFTHIFESTFESKEGIAEYIGHPAHVDFGGLFLPALEKVIVFD
YKPTVARF 
>P. trichocarpa 0010s16070 
MEQVKGVVKHIVLAKFKEGVTEEEIEKHIKDYANLLNHIEHMKSFHWGTDVSIENLHQGFTHIFE
ITFETLDGRSAYVAHPAHVDFGTAFLTILEKIVVVDFVPTLVKL 
>P. trichocarpa 0010s16080 
MEGGKGVVKHIVLAKFKEGTTEEEIEKHIKNYADLLNHIEHMKSFEWGTDVSIENLHQGFTHIFE
ATFETLEGRSAYVAHPAHVKFGTALFPTLEKVIVFDYVPKA 
>P. vulgaris 091002521m 
MEEAKGVVKHIVLAKFKDDITAEKIEELIKGYANLVNLVPPMKSFHWGTDVSAENLHQGFTHVF
ESTFESTEGVAEYVAHPAHVEFANLFISSTEKVIVIDYKPTI 
>P. vulgaris 091014673m 
MRACCIGLCIYTWLLGTTFIHKSCVVAMGDFNHYVVVKFKDGVAVEELIQGLEKMVSGIHEVKS
FEWGKDIESHDMLRQGFTHVFLMTFNGKEEFNTFRTHPNHIEFSGVFSPSIEKIVVLDFPSKLVKA
PA 
>P. vulgaris 091024159m 
MLAMGEFKHFVIVKFKEGVAVDELTKGMEKLVSEIDAVKAFEWGRDIESLDVLRQGFTHAFLM
TFNKKEDFAAFQSHPNHVEFSTTFSAAIENIVLLDFPSTLVKAPA 
>R. communis 29889.m003356 
MAEEVKEVHHLVMAKFKEDITPEKIEELIEGYANLVNLVPPMKAFHWGTDVSIENLNEGFTHIFH
ATIESREGLAEYVNHPAHIEFGNLMTPAMEKVIVVDFSPSLVQLQRE 
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>R. communis 29988.t000006 
MAGFKHLVIVKFKEDAAVEEIVKGMEKLVSESDLVKSFAWGQDSEGPEMLTQGFTHAFSMTFD
KKEDYTAFQTHPNHVEYSATFSAAIEKIVVLFFPYVQVKATASA 
>R. communis 30170.m013937 
MEEAKGVVKHVLLAKFKDEIPTHEIDKLIKGYANLVNLIPPMKAFHWGSDVSIENLHQGFTHVFE
SSFESTEDIAEYISHPAHVEFANLFLRAVDKVIVIDYKPTIVHL 
>S. bicolor 03g027060.1 
MASGGVVKHILLARFKEDVTQERLDELIRGYAALVAAVPSMKAFHWGTDVSIENMHQGFTHVF
ESTFESTEGIKEYIEHPKHVEFANVFLPVLDKVIVIDYKPTSVN 
>S. italic 003420m 
MAAGGGSGVVKHIVLARFKEEVTPERLDQLIQGYAALVDAVPSMKSFHWGTNVSIENTHEGFT
HVFESTFESTEGIKEYVKHPAHVEYANEFLSVSEKILIIDYKPTSVN 
>S. italica Si011410m 
MAEVKHLCLVKFKEGVVVEDILKGMADLAAQMDMVKSFEWGKDVLNQEMLTQGFTHVFSLT
FASADDLTAYMAHEKHAAFAATFMAALEKVVVIDFPVVIAKPPPQA 
>S. italica Si027006m 
MAPRSIALALRSSLQSHSECGMGEVKHLCLVKFKEGVVVEDVLKGMADLAAQMDMVKSFEWG
QDVLNQEMLTQGFTHVFSLTFASADDLTAYVSHEKHAAFAATFMAALEKVVVIDFPVAIAKPPP
QA 
>S. lycopersicum 05g053310 
MEGGKGGVVKHILLAKFKDGIPPEQIDQLIKQYANLVNLVEPMKAFQWGKDVSIENLHQGFTHV
FESTFDSLEGVAEYIAHPVHVEYANTLLPQLEKFLIVDYKPQ 
>S. lycopersicum 11g066950 
MANEFKHLVLVKFKEDVVVEDILKELEKLVQEMDIVKSFVWGKDVESHEMLRQGFTHAIIMTF
NSKEDYQTFANHPNHVGFSATFATVIDKAVLLDFTAISGKAT 
>S. moellendorffii 98687 
MAQENPKSGLKHVLLARFKPEISEEEVASLIAGYEALPQSIEAMKGFEWGTDVSVENLHQDFTH
VFTSTFESPEGRDAYLVHPAHTAYANKLLPALDKVIVLDFHPKVVCHRS 
>S. tuberosum TA38774_4113 
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SRKKSEKIEMEGGKGGVVKHILLAKFKDGIPPEQIDQLIKQYANLVNLVEPMKAFHWGKDVSIE
NLHQGFTHVFESTFDSLEGVAEYVAHPVHVEFANTMLPQLEKVLIIDYKPQ 
>T. cacao Tc05_g028060 
MVLIKRKHVGPSQNQTQIKPSKFKDETTAEKIEELIKGYANLVNLIEPMKAFQWGKDVSIENLHQ
GFTHVFESTFESTEGIAEYVAHPVHVQFANLFLGHLEKVLVIDYKPTIARC 
>T. halophilav10015069m 
MATSGFKHLVVVKFKEDAKIDEILKGLENLVSQIDSVKSFEWGEDKESHEMLRQGFTHAFSMTF
ENKDAYVSFTSHPLHVEFSTAFTAAIDKIVLLDFTVAAVKSPVEASP 
>V. vinifera GSVIVP00011995001 
MEEAKGLVKHVLLAKFKDSTPPDQIEELIKGYANLVNLVPPMKAFHWGKDVSIENMHQGFTHV
FESTFESVEGIAEYVSHPAHVEFANLFLPHLEKVIVFDYKPITVHL 
>V. vinifera GSVIVP00019670001 
MCGQLKRVEEGKGVVKHVLLAKFKDSTPPDQIEELIKSYANLVSLIPPMKAFHWGKDVSIENMH
QGFTHVFESTFESVEGMAEYVSHPAHVEAANRFLPHLEKVIVLDYKPTAVHL 
>V. vinifera GSVIVP00033194001 
MIFYKEIASFFYIYNREEGKGVVKHVLLAKFKDSTPPDQIEELIKSYTNLVSLIPPMKAFHWGKDV
SIENMHQGFTHVFESTFESVEGMAEYVSHPAHVEAANRFLPHLEKVIVLDYKPTAVHL 
>Z. mays GRMZM2G050730 
MGEVKHLCLAKFKDGVVVDDVLKGMTDLAAGMDTVKSFEWGQDVLNQEMLTQGFTHVFSLT
FASAADLAAYMAHDSHTAFAATFMAAIDKVLVVDFPVVVAKPPPPA 
>Z. mays GRMZM2G351990 
MPTASSRRTFSEAVSTDDEEAARGGKVGRPSPPRCSSRRGTDVSIENMHQGFTHVFESTFESTEGI
KEYIEHPAHVEFASVFLPVLEKVLIIDYKPTSAN  
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APPENDIX G 
The Relationship of Type III PKS by J. Schröder (2010). Available at http://www.biologie.uni-
freiburg.de/data/bio2/schroeder/Plant_TypeIII_Tree.pdf 
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